≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other mental disorders due to brain damage and dysfunction and to physical disease

EFO MESH Endpoint Browser PheWeb

F5_MENTORG

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F06
  • Hospital discharge: ICD-9 — 2938|2939
  • Hospital discharge: ICD-8 — 294|309
  • Hospital discharge: excluded ICD-8 — 2944|2943
  • Cause of death: ICD-10 — F06
  • Cause of death: ICD-9 — 2938|2939
  • Cause of death: ICD-8 — 294|309

2 out of 7 registries used, show all original rules.

5372

4. Check minimum number of events

None

5372

5. Include endpoints

None

5372

6. Filter based on genotype QC (FinnGen only)

5209

Control definitions (FinnGen only)

Control exclude
F5_ORGANIC

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F04-F09
Name in latin
Aliae perturbationes mentis ab laesione sive dysfunctione cerebri sive morbo somatico inductae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 38591 19809 18505
Only index persons 33680 17739 15941
Unadjusted period prevalence (%)
Whole population 0.54 0.57 0.52
Only index persons 0.63 0.65 0.61
Median age at first event (years)
Whole population 71.15 74.89 67.27
Only index persons 71.89 75.22 68.19

-FinnGen-

Key figures

All Female Male
Number of individuals 5209 2579 2630
Unadjusted period prevalence (%) 1.06 0.92 1.21
Median age at first event (years) 72.89 73.41 72.39

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
5372
Matched controls
53720
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G30.0
ICD-10 Finland
Alzheimer disease with early onset
119.3
318.7
162
14
F06.0
ICD-10 Finland
Organic hallucinosis
660.3
318.3
312
5
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
150.0
307.7
528
39
G30.8
ICD-10 Finland
Other Alzheimer disease
46.7
307.7
317
72
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.3
307.7
983
2670
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
68.9
307.7
390
61
F03
ICD-10 Finland
Unspecified dementia
25.8
307.7
623
272
R41.3
ICD-10 Finland
Other amnesia
8.3
307.7
486
635
F29
ICD-10 Finland
Unspecified nonorganic psychosis
9.6
307.7
407
455
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
46.5
307.7
397
92
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.4
307.7
742
1547
N06DA04
ATC
galantamine; oral
107.0
307.7
303
30
P70
ICPC
Dementia
29.9
307.7
415
150
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
656.2
307.7
368
6
N06DA02
ATC
donepezil; oral
86.9
307.7
965
135
AA1AD
NOMESCO Finland
CT of head and brain
3.0
307.7
2531
12399
N05AH03
ATC
olanzapine; systemic
7.7
307.7
734
1078
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.8
307.7
759
1476
AXX01
NOMESCO Finland
Memory assessment
33.2
307.7
238
75
OAB41
NOMESCO Finland
Guidance and counselling related to ageing
56.9
307.7
187
34
N06DX01
ATC
memantine; oral
123.0
307.7
1227
129
XA800
NOMESCO Finland
Neuropsychological investigation
10.8
307.7
663
692
P20
ICPC
Memory disturbance
8.5
307.7
2281
4298
N05AH04
ATC
quetiapine; oral
5.8
307.7
1688
3959
N05AX08
ATC
risperidone; systemic
11.8
307.7
1300
1415
G30.1
ICD-10 Finland
Alzheimer disease with late onset
41.5
307.7
856
244
N06DA03
ATC
rivastigmine; oral, transdermal
97.2
307.7
717
85
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
11.4
307.7
1950
2566
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
307.7
426
*
F05.9
ICD-10 Finland
Delirium, unspecified
66.3
307.7
330
53
SPAT1053
SPAT
Memory test
5.3
307.7
1981
5303
R1250
NOMESCO Finland
Evaluation of functional capability
9.7
307.7
395
438
F06.7
ICD-10 Finland
Mild cognitive disorder
376.2
307.7
3703
315
TAB00
NOMESCO Finland
Lumbar puncture
9.2
307.7
606
734
N03AG01
ATC
valproic acid; systemic, rectal
6.8
307.7
657
1075
G30
ICD-10 Finland
Alzheimer disease
70.3
289.2
157
23
N06AX11
ATC
mirtazapine; oral
2.8
284.4
2433
12319
R41.0
ICD-10 Finland
Disorientation, unspecified
7.0
259.3
414
636
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.6
254.8
664
1598
F01.9
ICD-10 Finland
Vascular dementia, unspecified
31.5
253.4
165
54
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.9
246.0
814
2339
N05BA04
ATC
oxazepam; oral
2.6
225.4
1849
8948
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.5
224.0
871
2781
N06AB10
ATC
escitalopram; oral
3.0
218.6
1237
4933
A28
ICPC
Limited function/disability NOS
2.6
214.4
1689
7981
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
1080.5
214.0
208
*
F06.32
ICD-10 Finland
Organic depression
283.6
213.9
217
8
SPAT1234
SPAT
Support of social functional capacity
4.2
198.1
583
1530
SPAT1216
SPAT
Assessment of functional ability
2.7
194.6
1355
5985
F06.8
ICD-10 Finland
Other specified mental disorders due to brain damage and dysfunction and to physical disease
935.1
185.6
181
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
4.5
183.9
472
1114
Z2445
NOMESCO Finland
Psychologist
6.4
181.3
310
509
SPAT1301
SPAT
No procedures
2.3
180.0
2189
12385
N06AB04
ATC
citalopram; systemic
2.5
178.0
1417
6644
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
177.9
1672
8458
N06AX26
ATC
vortioxetine; oral
4.1
177.4
523
1371
N03AX09
ATC
lamotrigine; oral
5.4
171.3
352
688
R53
ICD-10 Finland
Malaise and fatigue
2.3
169.5
1734
9071
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.2
167.3
475
1210
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.5
163.9
1268
5838
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
6.8
163.5
263
405
F05.8
ICD-10 Finland
Other delirium
50.3
162.9
94
19
OAB48
NOMESCO Finland
Lifestyle advice and guidance
35.8
162.9
102
29
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
162.5
2252
13299
N05AX12
ATC
aripiprazole; systemic
6.3
159.8
275
454
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.2
158.7
443
1113
A04
ICPC
Weakness/tiredness general
2.5
155.8
1217
5613
OAB76
NOMESCO Finland
General guidance on nutrition and food
58.2
153.3
86
15
SPAT1101
SPAT
Orthostatic test
3.8
149.1
495
1407
T90.5
ICD-10 Finland
Sequelae of intracranial injury
10.8
148.0
161
153
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
377.6
147.8
148
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.2
145.7
310
624
N05BA06
ATC
lorazepam; systemic, sublingual
3.7
142.0
483
1395
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
24.9
139.2
98
40
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.0
138.8
313
662
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
7.7
137.5
196
264
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
7.1
135.6
206
298
F06.30
ICD-10 Finland
Organic manic syndrome
+∞
132.8
127
*
SPAT1254
SPAT
Administration of medicine
2.4
132.8
1121
5315
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
6.5
129.9
217
347
N05AD01
ATC
haloperidol; systemic
4.9
129.0
295
631
P29
ICPC
Psychological sympt/compl other
3.9
128.8
409
1125
N06AX16
ATC
venlafaxine; oral
2.7
127.2
809
3352
F22.0
ICD-10 Finland
Delusional disorder
7.8
126.6
177
233
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
7.0
125.9
196
291
AXX01, ,
SPAT
3.8
124.2
398
1101
F06.4
ICD-10 Finland
Organic anxiety disorder
216.7
123.3
127
6
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.9
121.2
614
2255
N06AB06
ATC
sertraline; oral
2.8
121.1
663
2539
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.8
119.9
280
609
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
5.9
119.6
220
387
S06.0
ICD-10 Finland
Concussion
2.7
118.2
746
3072
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.6
118.2
229
423
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.5
117.9
299
695
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.4
117.8
453
1413
R42
ICD-10 Finland
Dizziness and giddiness
2.1
117.4
1655
9575
N03AF02
ATC
oxcarbazepine; oral
4.6
117.4
285
640
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.8
114.7
368
1018
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.9
112.4
570
2091
N05AA02
ATC
levomepromazine; systemic
4.0
111.7
329
856
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.4
111.7
927
4332
IGY02
NOMESCO Finland
Psychiatric monitoring contact
5.4
110.9
223
426
183
Kela drug reimbursment
Lamotrigin and topiramate
13.7
109.2
102
76
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
549.1
109.2
108
*
N05AH02
ATC
clozapine; systemic
8.2
108.7
146
183
30920
ICD-8 Finland
Mental disorders not specified as psychotic associated with physical conditions, Brain trauma
+∞
107.7
103
*
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.6
107.4
725
3078
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
5.7
106.3
200
359
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.2
105.2
436
1422
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.0
104.3
504
1798
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.8
104.1
566
2153
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
7.5
101.6
147
201
N05AN01
ATC
lithium; oral
5.8
101.2
187
330
G31.0
ICD-10 Finland
Circumscribed brain atrophy
14.4
100.7
91
64
P99
ICPC
Psychological disorders other
5.3
100.4
208
408
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
6.7
97.6
157
241
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
6.8
97.5
154
232
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
96.4
1117
5949
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
7.9
96.0
133
173
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.5
95.3
666
2865
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
6.8
94.5
149
224
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.2
93.7
198
395
SPAT1229
SPAT
Assessment of need for aid
2.5
92.6
627
2656
ZY000
NOMESCO Finland
Hospital inpatient
8.6
91.9
118
140
IHA10
NOMESCO Finland
Structured mapping of problematic alcohol use
9.5
89.9
107
115
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
234.0
89.8
92
*
N05BA01
ATC
diazepam; systemic, rectal
2.2
89.4
857
4225
N05AB03
ATC
perphenazine; systemic, rectal
4.0
86.8
255
661
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
8.2
86.6
116
145
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.9
86.4
439
1605
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.7
84.7
277
774
N03AX14
ATC
levetiracetam; systemic
4.1
84.2
239
604
Z13.3
ICD-10 Finland
Special screening examination for mental and behavioural disorders
37.5
83.9
52
14
ZY010
NOMESCO Finland
Hospital outpatient
3.5
83.1
305
920
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
5.9
82.8
151
263
N04AA02
ATC
biperiden; systemic
5.6
82.7
159
291
S01.0
ICD-10 Finland
Open wound of scalp
2.5
81.2
577
2493
F05.1
ICD-10 Finland
Delirium superimposed on dementia
408.7
81.1
81
*
SPAT1263
SPAT
Sampling
1.7
81.0
2325
16395
SPAT1307
SPAT
Psychosocial counselling and guidance
3.6
80.4
270
768
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
24.6
79.1
56
23
N05CD07
ATC
temazepam; oral
2.1
78.4
873
4547
F0019, G301,
ICD-10 Finland
+∞
77.3
74
*
L28
ICPC
Limited function/disability (L)
1.9
76.3
1339
8143
F06.39
ICD-10 Finland
Organic mood syndrome UNS
260.8
75.6
77
*
N06AX21
ATC
duloxetine; oral
2.2
75.0
676
3235
N03AX18
ATC
lacosamide; systemic
10.3
75.0
84
83
R44.0
ICD-10 Finland
Auditory hallucinations
11.6
74.9
77
67
N05CF01
ATC
zopiclone; oral
1.7
74.1
1986
13649
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
14.9
73.3
65
44
SPAT1260
SPAT
Consultation of another employee
1.9
73.1
1080
6203
SPAT1240
SPAT
Therapeutic discussion
2.5
72.6
481
2008
R44.3
ICD-10 Finland
Hallucinations, unspecified
10.4
72.1
80
78
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
5.5
71.6
141
264
N03AE01
ATC
clonazepam; systemic
2.8
70.8
389
1479
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
8.1
70.8
95
119
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.6
70.0
243
706
SPAT1252
SPAT
Overall medication plan or its review
2.4
69.8
502
2176
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
6.3
69.6
117
188
N06AX12
ATC
bupropion; oral
3.1
69.4
304
1020
I95.1
ICD-10 Finland
Orthostatic hypotension
2.9
68.6
351
1285
IGY99
NOMESCO Finland
Other psychiatric treatment contact
6.0
68.3
121
205
N06AX03
ATC
mianserin; oral
2.8
66.9
343
1257
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.1
66.6
294
991
N02BE01
ATC
paracetamol; systemic, rectal
2.1
66.5
4774
42387
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
5.6
65.9
127
233
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.1
65.3
286
959
Z01.9
ICD-10 Finland
Special examination, unspecified
2.6
64.4
407
1658
W19
ICD-10 Finland
Unspecified fall
2.2
64.2
635
3144
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
5.7
64.2
120
214
R55
ICD-10 Finland
Syncope and collapse
2.0
63.6
774
4141
SPAT1310
SPAT
Counselling related to known health issue
1.7
63.5
1729
11816
N06AB03
ATC
fluoxetine; oral
2.1
63.5
660
3331
U04
ICPC
Incontinence urine
2.4
63.3
459
1994
F60.9
ICD-10 Finland
Personality disorder, unspecified
7.7
63.2
89
118
P72
ICPC
Schizophrenia
5.2
62.9
130
254
F39
ICD-10 Finland
Unspecified mood [affective] disorder
6.4
62.6
104
165
A06AD11
ATC
lactulose; oral
1.9
62.6
1029
6083
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
7.3
62.2
91
126
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.7
62.2
1683
11472
SPAT1312
SPAT
General health counselling
1.7
62.0
1672
11383
P76
ICPC
Depressive disorder
2.9
61.3
309
1121
S06.2
ICD-10 Finland
Diffuse brain injury
6.6
61.1
98
150
Z02.7
ICD-10 Finland
Issue of medical certificate
2.3
60.6
487
2212
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
10.1
60.2
68
68
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
12.1
60.0
60
50
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
59.2
1684
11594
N05BA09
ATC
clobazam; oral
11.9
59.2
60
51
A01
ICPC
Pain general/multiple sites
2.1
58.9
664
3448
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
58.9
899
5181
IGV01
NOMESCO Finland
Psychiatric network contact
8.6
58.9
75
88
XF606
NOMESCO Finland
Ortostatic test
6.0
58.9
105
179
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
5.0
58.6
126
255
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
17.6
57.5
47
27
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
57.3
1262
8107
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
4.0
57.3
164
417
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
6.6
56.0
90
138
G04BD12
ATC
mirabegron; oral
1.9
55.9
828
4720
N03AF01
ATC
carbamazepine; oral, rectal
2.6
55.6
347
1404
F01.2
ICD-10 Finland
Subcortical vascular dementia
19.7
55.5
43
22
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.6
55.2
132
292
N07BB01
ATC
disulfiram; oral
3.2
55.1
228
739
SPAT1304
SPAT
Counselling and guidance related to ageing
2.1
54.4
579
2940
F06.33
ICD-10 Finland
Organic mood syndrome
+∞
54.3
52
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
7.0
54.1
82
118
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.0
53.7
82
119
F06.31
ICD-10 Finland
Organic bipolar syndrome
533.3
53.6
53
*
N05AF03
ATC
chlorprothixene; systemic
3.9
53.4
160
420
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.0
53.4
626
3291
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
4.5
53.0
132
302
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
7.0
52.5
80
116
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
9.5
52.4
62
66
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
8.0
52.4
71
90
R51.80
ICD-10 Finland
Headache
1.9
52.4
750
4222
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
52.2
871
5146
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.5
51.5
180
525
N03AX12
ATC
[U] gabapentin; oral
1.8
51.5
928
5608
F34.1
ICD-10 Finland
Dysthymia
3.3
51.2
201
631
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
51.2
964
5901
IGP01
NOMESCO Finland
Psychiatric family contact
10.5
50.8
56
54
F31.8
ICD-10 Finland
Other bipolar affective disorders
5.3
50.6
102
195
P03
ICPC
Feeling depressed
2.3
50.6
398
1788
G40
ICD-10 Finland
Epilepsy
7.0
50.4
77
112
F10.25
ICD-10 Finland
Alcohol dependence continuous use
4.6
50.3
121
269
N06AB05
ATC
paroxetine; oral
2.6
49.9
302
1203
KMAK, ,
NOMESCO Finland
1.5
49.8
2279
17372
G20
ICD-10 Finland
Parkinson disease
2.9
49.6
238
840
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.8
49.5
111
233
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
49.1
1585
11152
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
7.1
49.1
74
106
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
49.0
458
2209
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
131.3
48.8
52
*
SPAT1172
SPAT
Guidance concerning hydration
3.2
48.8
202
655
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
48.7
2820
22571
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
6.1
48.7
85
142
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
5.9
48.6
87
149
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.6
48.5
117
261
N88
ICPC
Epilepsy
7.8
48.4
67
87
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.4
48.4
343
1471
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.8
48.2
151
409
N05BE01
ATC
buspirone; oral
3.4
47.9
176
530
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.0
47.7
583
3106
P98
ICPC
Psychosis NOS/other
10.3
47.5
53
52
S06.3
ICD-10 Finland
Focal brain injury
4.9
47.4
106
222
SPAT1246
SPAT
Screening of depression or other psychiatric problem
3.5
47.2
163
472
F06.6
ICD-10 Finland
Organic emotionally labile [asthenic] disorder
+∞
46.9
45
*
N06AG02
ATC
moclobemide; oral
2.7
45.9
262
1013
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
+∞
45.9
44
*
N05BA12
ATC
alprazolam; oral
2.0
45.3
537
2827
N87
ICPC
Parkinsonism
4.1
45.3
127
318
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.7
45.2
258
997
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
13.1
45.1
43
33
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
98.9
44.8
49
5
-, ,
ICD-10 Finland
3.2
44.8
177
558
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
121.1
44.8
48
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.1
44.4
93
184
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
2.9
44.3
212
747
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.6
44.3
105
231
F32
ICD-10 Finland
Depressive episode
2.7
44.0
238
895
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
6.4
43.8
72
113
ZXY02
NOMESCO Finland
Neuropsychologist
8.6
43.8
56
66
P01
ICPC
Feeling anxious/nervous/tense
2.2
43.7
415
2011
N17
ICPC
Vertigo/dizziness
1.8
43.7
808
4899
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
6.9
43.6
67
98
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
8.1
43.5
58
72
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.0
43.4
551
2969
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
43.3
947
6014
N30.0
ICD-10 Finland
Acute cystitis
1.7
43.2
935
5921
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.1
43.1
182
597
F31
ICD-10 Finland
Bipolar affective disorder
6.1
43.1
75
125
E86
ICD-10 Finland
Volume depletion
3.0
43.0
197
677
R44.1
ICD-10 Finland
Visual hallucinations
7.7
42.9
60
79
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.6
42.8
265
1066
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.0
42.8
121
305
N03AX11
ATC
topiramate; oral
4.1
42.7
120
301
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
15.5
42.6
37
24
SPAT1251
SPAT
Organisation of medication
2.6
42.2
250
984
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
42.2
739
4408
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
42.1
984
6356
S70.0
ICD-10 Finland
Contusion of hip
2.5
41.8
274
1133
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
5.0
41.7
89
179
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.8
41.7
724
4305
AA400
NOMESCO Finland
Electroconvulsive therapy
6.8
41.1
64
95
F61.0
ICD-10 Finland
Mixed personality disorders
5.0
41.0
89
182
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
40.9
1068
7091
F30.0
ICD-10 Finland
Hypomania
15.1
40.8
36
24
C10AA01
ATC
simvastatin; oral
1.5
40.6
2599
20917
K59.09
ICD-10 Finland
Constipation, unspecified
2.0
40.5
463
2404
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
10.3
40.4
45
44
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
40.0
971
6324
S72.0
ICD-10 Finland
Fracture of neck of femur
2.3
40.0
306
1356
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
40.0
3232
27181
R5110, ,
SPAT
1.9
39.7
569
3189
N06AA09
ATC
amitriptyline; systemic
1.9
39.6
560
3124
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
6.5
39.5
64
99
R25.1
ICD-10 Finland
Tremor, unspecified
2.7
39.4
218
830
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
5.8
39.2
71
123
P15
ICPC
Chronic alcohol abuse
3.3
39.2
151
469
A29
ICPC
General symptom/complaint other
1.7
39.2
787
4874
N06AX05
ATC
trazodone; oral
3.3
39.0
147
450
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
5.7
39.0
72
127
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
5.6
38.8
73
131
WYA20
NOMESCO Finland
Home visit
3.7
38.6
124
342
A05
ICPC
Feeling ill
2.4
38.6
288
1262
P28
ICPC
Limited function/disability (P)
6.2
38.6
66
108
G72.8
ICD-10 Finland
Other specified myopathies
3.5
38.2
130
373
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
5.4
38.0
75
141
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
37.9
1463
10596
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.7
37.8
122
338
-1, ,
NOMESCO Finland
1.5
37.1
1415
10213
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.6
37.0
1167
8079
SPAT1360
SPAT
Extensive global examination
2.0
36.8
401
2044
E0000UV, ,
ATC
1.5
36.7
2042
15893
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
12.5
36.6
36
29
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
36.6
1918
14756
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
4.0
36.5
105
268
N06AX22
ATC
agomelatine; oral
3.8
36.5
111
295
F06.5
ICD-10 Finland
Organic dissociative disorder
+∞
36.5
35
*
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.8
36.3
113
305
Z2446
NOMESCO Finland
Social worker
2.1
36.3
350
1705
R4150
NOMESCO Finland
Neuropsychological rehabilitation
6.6
36.1
58
89
N02AA05
ATC
oxycodone; systemic
1.6
36.0
1137
7869
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
2.8
35.9
182
662
EBA00
NOMESCO Finland
Extraction of tooth
1.5
35.8
1694
12762
C07AA05
ATC
propranolol; systemic
1.6
35.6
882
5758
F06.1
ICD-10 Finland
Organic catatonic disorder
+∞
35.4
34
*
F10.24
ICD-10 Finland
Alcohol depence active use
4.3
35.3
90
210
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
35.1
864
5631
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.7
35.0
745
4675
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
5.2
34.7
71
138
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
34.6
2028
15891
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
8.8
34.5
43
49
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.2
34.5
288
1324
N03AX16
ATC
[U] pregabalin
1.5
34.4
1213
8587
N29
ICPC
Neurological sympt/complt other
3.3
34.4
131
404
K02.1
ICD-10 Finland
Caries of dentine
1.4
34.3
2540
20757
RT250, ,
NOMESCO Finland
12.8
34.0
33
26
N05AC02
ATC
thioridazine; oral
3.6
34.0
114
324
K08.3
ICD-10 Finland
Retained dental root
1.9
33.9
444
2411
IHA21
NOMESCO Finland
Mini-intervention for hazardous and harmful alcohol use
45.9
33.7
41
9
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
33.6
1928
15025
SPAT1284
SPAT
Extensive health certificate
3.1
33.6
145
482
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
4.6
33.5
80
177
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
3.8
33.4
104
281
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
33.4
571
3369
J01DB01
ATC
cefalexin; oral
1.5
33.3
4117
36854
OAB43, ,
SPAT
0.4
33.3
219
4801
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
2.3
33.2
265
1195
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
33.1
646
3956
F07.8
ICD-10 Finland
Other organic personality and behavioural disorders due to brain disease, damage and dysfunction
329.2
32.9
33
*
P74
ICPC
Anxiety disorder/anxiety state
2.7
32.8
183
700
F32.8
ICD-10 Finland
Other depressive episodes
4.2
32.7
88
214
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
32.6
1573
11852
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.0
32.5
94
241
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
32.4
826
5419
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
32.4
1242
8933
SPAT1139
SPAT
Nutrition survey
2.5
32.4
204
828
F51.0
ICD-10 Finland
Nonorganic insomnia
1.7
32.1
696
4382
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.8
32.1
161
582
N06AA12
ATC
doxepin; systemic
2.1
32.1
315
1544
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
32.1
953
6484
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
34.4
31.8
41
12
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
88.1
31.7
35
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.7
31.7
697
4404
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.1
31.6
318
1573
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.3
31.5
238
1048
P27
ICPC
Fear of mental disorder
4.7
31.5
73
158
N05AL01
ATC
sulpiride; systemic
3.7
31.4
101
279
R1210, ,
SPAT
5.9
31.3
56
96
F009, G309,
ICD-10 Finland
+∞
31.3
30
*
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
8.3
31.2
41
50
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
4.0
31.2
88
222
G91.0
ICD-10 Finland
Communicating hydrocephalus
6.1
30.9
53
87
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
9.5
30.6
36
38
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
7.0
30.5
46
66
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
6.2
30.5
52
85
G04CA02
ATC
tamsulosin; oral
1.5
30.5
1408
10494
WX720
NOMESCO Finland
Own respiration
2.2
30.4
280
1339
L17
ICPC
Foot/toe symptom/complaint
1.4
30.3
1584
12080
SPAT1167
SPAT
Insertion of urinary catheter
2.3
30.1
226
993
F00
ICD-10 Finland
Dementia in Alzheimer disease
32.7
29.9
39
12
F01
ICD-10 Finland
Vascular dementia
12.1
29.9
30
25
SPAT1279
SPAT
Preparation of immediate hospitalisation
3.8
29.7
92
248
A27
ICPC
Fear of other disease NOS
2.1
29.6
297
1467
SPAT1285
SPAT
Provision of consultation response
2.1
29.5
295
1456
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.2
29.5
260
1222
D12
ICPC
Constipation
2.2
29.3
250
1160
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
3.3
29.2
109
332
Z08
ICPC
Social welfare problem
4.0
29.2
84
215
WYA20, ,
SPAT
4.6
29.1
68
148
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
8.3
29.1
38
46
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.9
29.0
399
2200
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
28.9
1594
12255
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.0
28.9
132
454
Z75.5
ICD-10 Finland
Holiday relief care
5.0
28.8
62
126
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
6.9
28.8
44
64
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
28.8
1921
15268
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
28.6
408
2274
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.9
28.5
138
490
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
11.2
28.4
30
27
N05BA02
ATC
chlordiazepoxide; systemic
2.8
28.4
146
535
30180
ICD-8 Finland
Personality disorders, Immatura
7.4
28.4
41
56
R11
ICD-10 Finland
Nausea and vomiting
1.8
28.0
473
2776
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
5.1
28.0
58
114
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
5.6
28.0
53
96
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.8
27.6
431
2470
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.3
27.6
102
309
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
5.0
27.5
58
116
Z71.8
ICD-10 Finland
Other specified counselling
1.4
27.4
1545
11899
G40.10
ICD-10 Finland
Simple partial seizures
5.5
27.4
53
98
Z29
ICPC
Social problem NOS
3.0
27.3
121
409
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
6.5
27.2
44
68
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.7
27.1
506
3053
M79.6
ICD-10 Finland
Pain in limb
1.4
27.1
2115
17203
G44.2
ICD-10 Finland
Tension-type headache
1.7
26.9
593
3742
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
4.0
26.8
77
197
SPAT1243
SPAT
Psychiatric/psychological examination
3.5
26.8
93
271
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.5
26.7
51
93
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.1
26.7
266
1310
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
140.7
26.6
28
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
26.6
2103
17127
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.0
26.6
74
185
F30.9
ICD-10 Finland
Manic episode, unspecified
10.1
26.5
30
30
SPAT1325
SPAT
Vaccination
1.4
26.5
1825
14531
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.2
26.4
221
1017
N05AD03
ATC
melperone; systemic
3.9
26.3
78
204
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.2
26.3
235
1110
R44
ICPC
Respiratory, Preventive immunization/medic
2.9
26.2
120
413
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.2
26.2
220
1013
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.0
26.2
113
376
R60.0
ICD-10 Finland
Localized oedema
1.6
26.2
768
5190
SPAT1081
SPAT
Cardiorespiratory global assessment
1.9
26.1
344
1869
N03AB02
ATC
phenytoin; systemic
3.6
26.0
84
233
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
25.9
2827
24174
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
5.1
25.8
54
107
N05CF02
ATC
zolpidem; oral
1.5
25.8
786
5353
P18
ICPC
Medication abuse
5.8
25.8
47
82
R13
ICD-10 Finland
Dysphagia
1.8
25.8
418
2422
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
25.6
3276
28691
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
6.6
25.5
41
63
K59.0
ICD-10 Finland
Constipation
1.9
25.5
337
1833
A02BC03
ATC
lansoprazole; oral
1.4
25.5
1481
11441
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.5
25.1
154
618
N05AF05
ATC
zuclopenthixol; systemic
4.9
25.0
54
110
C03CA01
ATC
furosemide; systemic
1.4
25.0
2065
16879
Z00.0
ICD-10 Finland
General medical examination
1.5
24.9
958
6848
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
3.7
24.9
78
212
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.5
24.8
156
633
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
24.8
1622
12772
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
24.6
1469
11386
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
8.7
24.5
31
36
H25.1
ICD-10 Finland
Senile nuclear cataract
1.4
24.4
1898
15352
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
24.2
658
4365
D11
ICPC
Diarrhoea
1.7
24.1
507
3156
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
3.4
24.0
86
256
F07.0
ICD-10 Finland
Organic personality disorder
+∞
24.0
23
*
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
6.3
24.0
40
64
N27
ICPC
Fear of neurological disease other
2.9
23.9
114
402
M54.5
ICD-10 Finland
Low back pain
1.4
23.9
1672
13291
J01MA02
ATC
ciprofloxacin; systemic
1.4
23.9
2045
16778
Z00.8
ICD-10 Finland
Other general examinations
1.8
23.9
389
2257
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.8
23.9
396
2310
188
Kela drug reimbursment
Psychosis requiring demanding treatment
4.7
23.8
54
115
H03AA01
ATC
levothyroxine sodium; systemic
1.4
23.7
1114
8267
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
7.0
23.7
36
52
XQ855, ,
SPAT
3.3
23.7
87
263
R33
ICD-10 Finland
Retention of urine
1.7
23.7
493
3062
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
23.6
558
3577
F07.2
ICD-10 Finland
Postconcussional syndrome
125.6
23.6
25
*
WX725
NOMESCO Finland
Noninvasive ventilation
1.9
23.5
290
1541
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
23.5
1829
14776
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
5.9
23.5
42
72
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.4
23.5
167
717
N05AE04
ATC
ziprasidone; systemic
8.2
23.5
31
38
A98
ICPC
Health maint/preventive medicine
1.6
23.5
4782
44968
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.3
23.4
2382
20032
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.4
23.4
1139
8504
G41.9
ICD-10 Finland
Status epilepticus, unspecified
5.5
23.3
45
83
N05AA01
ATC
chlorpromazine; systemic, rectal
3.7
23.3
72
194
R35
ICD-10 Finland
Polyuria
1.8
23.3
401
2363
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
7.3
23.3
34
47
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
23.2
2270
18970
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.4
23.2
164
703
J01EA01
ATC
trimethoprim; systemic
1.4
23.1
1294
9902
SFA10
NOMESCO Finland
One-surface restoration
1.3
23.0
2356
19820
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
22.9
22
*
WYA10
NOMESCO Finland
Emergency care or similar visit
1.9
22.9
316
1743
WX704
NOMESCO Finland
Intubation
1.7
22.8
397
2346
IGY02, ,
SPAT
3.8
22.8
68
179
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
22.8
1656
13223
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.7
22.7
462
2851
G04BD07
ATC
tolterodine; oral
1.9
22.7
308
1690
UJF32
NOMESCO Finland
Coloscopy
1.4
22.7
1405
10932
S18
ICPC
Laceration/cut
1.3
22.5
2440
20669
S00.0
ICD-10 Finland
Superficial injury of scalp
2.5
22.5
148
614
SPAT1097
SPAT
Recording of ECG
1.5
22.4
804
5657
N01
ICPC
Headache
1.7
22.4
413
2482
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
4.6
22.4
53
117
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.3
22.2
174
779
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
4.4
22.2
55
126
N04BD01
ATC
selegiline; oral
3.2
22.1
89
285
S22.3
ICD-10 Finland
Fracture of rib
1.7
22.1
382
2254
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
5.1
22.1
46
91
R07.3
ICD-10 Finland
Other chest pain
1.6
22.0
541
3501
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.9
22.0
65
170
V03AA01, ,
ATC
3.2
22.0
88
281
P19
ICPC
Drug abuse
5.7
21.9
40
70
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.8
21.9
322
1811
F0029, G308,
ICD-10 Finland
+∞
21.9
21
*
F21
ICD-10 Finland
Schizotypal disorder
6.5
21.7
35
54
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.7
21.7
416
2526
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
38.8
21.7
27
7
A86
ICD-10 Finland
Unspecified viral encephalitis
5.6
21.3
40
72
P73
ICPC
Affective psychosis
7.9
21.3
29
37
S09.9
ICD-10 Finland
Unspecified injury of head
2.9
21.2
101
356
F61
ICD-10 Finland
Mixed and other personality disorders
7.5
21.2
30
40
N04BC04
ATC
ropinirole; oral
3.5
21.2
73
212
F23.8
ICD-10 Finland
Other acute and transient psychotic disorders
9.0
21.2
26
29
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
7.2
21.2
31
43
OAA67, ,
SPAT
0.4
21.2
114
2727
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.0
21.0
222
1118
N06AB08
ATC
fluvoxamine; oral
2.5
21.0
133
542
AA1ED
NOMESCO Finland
Trauma CT of head and neck
4.4
21.0
52
119
XF600, ,
SPAT
2.0
20.9
220
1106
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
8.0
20.9
28
35
ICB01, ,
SPAT
4.8
20.8
46
96
U02
ICPC
Urinary frequency/urgency
1.5
20.8
746
5246
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
3.0
20.7
89
296
G04CB01
ATC
finasteride; oral
1.5
20.7
664
4562
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
8.7
20.6
26
30
U05
ICPC
Urination problems other
1.8
20.6
320
1829
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
5.0
20.6
44
89
XF600
NOMESCO Finland
Bloodpressure measurement
1.8
20.6
331
1912
P05
ICPC
Senility, feeling/behaving old
4.9
20.6
45
93
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
20.5
271
1474
IEY01
NOMESCO Finland
Psychoeducation, individual
5.9
20.4
36
61
P04
ICPC
Feeling/behaving irritable/angry
6.2
20.2
34
55
H13
ICPC
Plugged feeling ear
1.4
20.1
1094
8302
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3.1
20.1
83
270
A11
ICPC
Chest pain NOS
1.6
20.0
482
3101
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
7.6
19.9
28
37
Z72.8
ICD-10 Finland
Other problems related to lifestyle
7.0
19.9
30
43
F33.01
ICD-10 Finland
Recurrent depression, mild episode of somatic syndrome
7.0
19.9
30
43
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
3.8
19.9
61
164
F41.8
ICD-10 Finland
Other specified anxiety disorders
2.8
19.9
97
347
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.6
19.8
110
421
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.2
19.8
160
727
R32
ICD-10 Finland
Unspecified urinary incontinence
2.2
19.8
174
818
G04BD08
ATC
solifenacin; oral
1.7
19.7
377
2288
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
19.7
1052
13596
ZXD35
NOMESCO Finland
Usual procedure
2.2
19.6
172
808
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
200.7
19.6
20
*
F09
ICD-10 Finland
Unspecified organic or symptomatic mental disorder
200.7
19.6
20
*
N06AA06
ATC
trimipramine; systemic
2.5
19.3
124
509
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.4
19.2
126
522
F32.1
ICD-10 Finland
Moderate depressive episode
2.1
19.2
182
881
XQ858, ,
SPAT
4.1
19.1
52
128
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
4.8
19.1
43
91
EBA30
NOMESCO Finland
Extraction of root of tooth
1.8
19.1
304
1751
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
7.2
19.1
28
39
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
18.2
19.1
29
16
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
6.0
19.0
33
55
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
18.9
1353
10716
WZA90
NOMESCO Finland
Other medical or dental certificate
1.4
18.8
989
7452
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.0
18.8
218
1135
30998
ICD-8 Finland
Mental disorders not specified as psychotic associated with physical conditions, Aliae definitae
+∞
18.8
18
*
B01AC04
ATC
clopidogrel; oral
1.4
18.7
1007
7616
Z72.1
ICD-10 Finland
Alcohol use
3.6
18.7
61
171
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
18.7
1244
9739
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
7.7
18.7
26
34
U13
ICPC
Bladder symptom/complaint other
2.2
18.6
166
785
UKC02
NOMESCO Finland
Cystoscopy
1.4
18.6
919
6850
F06.3
ICD-10 Finland
Organic mood [affective] disorders
190.6
18.5
19
*
H53.4
ICD-10 Finland
Visual field defects
2.4
18.5
124
519
A99
ICPC
Disease/condition unspecnature/site
1.5
18.5
531
3555
N04BC05
ATC
pramipexole; oral
1.6
18.5
407
2559
SPAT1050
SPAT
Extensive neurological examination
2.5
18.5
115
465
G40.89
ICD-10 Finland
Other epilepsy
5.4
18.5
36
67
N02BF01
ATC
gabapentin; oral
1.6
18.5
501
3312
C07AB07
ATC
bisoprolol; oral
1.3
18.5
2791
24474
SPAT1262
SPAT
Handing over of treatment supplies
1.4
18.4
882
6536
WX892
NOMESCO Finland
Monitored bed care
1.6
18.4
417
2642
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
18.4
634
4416
P06
ICPC
Sleep disturbance
1.6
18.3
518
3459
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
6.6
18.3
29
44
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
4.3
18.3
47
111
F60.0
ICD-10 Finland
Paranoid personality disorder
7.8
18.3
25
32
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
4.6
18.2
43
95
N99
ICPC
Neurological disease other
3.0
18.2
78
260
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
18.1
1191
9302
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.3
18.0
1875
15639
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
18.0
594
4097
G04BD09
ATC
trospium; oral
2.2
18.0
149
684
F60.7
ICD-10 Finland
Dependent personality disorder
6.3
18.0
30
48
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
2.0
17.9
184
918
D07AA02
ATC
hydrocortisone; topical
1.5
17.9
577
3961
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
17.8
1539
12513
H50.31
ICD-10 Finland
Intermittent exotropia
4.7
17.7
40
85
30999
ICD-8 Finland
Mental disorders not specified as psychotic associated with physical conditions, Other or unspecified physical condition
+∞
17.7
17
*
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
1.9
17.7
220
1174
B01AA03
ATC
warfarin; systemic
1.4
17.6
1211
9514
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
4.2
17.6
46
110
N05AC01
ATC
periciazine; systemic
5.7
17.6
32
56
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
17.5
1119
8694
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
5.3
17.5
35
67
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
5.5
17.4
33
60
W06
ICD-10 Finland
Fall involving bed
3.5
17.4
59
170
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
6.8
17.4
27
40
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
7.4
17.4
25
34
-1, ,
ICPC
2.0
17.3
185
936
G47.3
ICD-10 Finland
Sleep apnoea
1.4
17.2
985
7516
SFA00
NOMESCO Finland
Small restoration
1.5
17.1
587
4079
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
5.8
17.1
31
54
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
17.1
607
4250
N05AF01
ATC
flupentixol; systemic
2.7
17.0
88
325
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
4.6
17.0
40
88
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.9
16.9
217
1169
R02
ICPC
Shortness of breath/dyspnoea
1.4
16.9
739
5382
Z03
ICPC
Housing/neighbourhood problem
4.2
16.9
44
105
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.1
16.8
165
810
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.4
16.8
928
7040
G81.9
ICD-10 Finland
Hemiplegia, unspecified
3.3
16.8
63
194
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.7
16.7
321
1949
F0009, G300,
ICD-10 Finland
+∞
16.7
16
*
F0203, G310,
ICD-10 Finland
+∞
16.7
16
*
N04BX02
ATC
entacapone; oral
5.8
16.6
30
52
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
7.0
16.5
25
36
RT150, ,
NOMESCO Finland
13.4
16.4
28
21
A02BC01
ATC
omeprazole; systemic
1.3
16.4
1370
11058
K90
ICPC
Stroke/cerebrovascular accident
2.0
16.4
181
927
R4120
NOMESCO Finland
Occupational therapy
1.7
16.4
305
1837
ZXD05
NOMESCO Finland
Urgent procedure
1.3
16.3
1417
11497
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.9
16.3
77
271
A46
ICD-10 Finland
Erysipelas
1.4
16.3
814
6066
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
4.1
16.3
44
108
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
16.3
423
2769
R50.9
ICD-10 Finland
Fever, unspecified
1.4
16.2
701
5094
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
6.5
16.2
26
40
S16
ICPC
Bruise/contusion
2.0
16.2
182
939
IBA03
NOMESCO Finland
Psychotherapy evaluation
4.9
16.1
35
72
SPAT1210
SPAT
Application of cast or individual aid
1.9
16.1
192
1010
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
4.5
16.1
38
84
D07AC01
ATC
betamethasone; topical
1.3
16.1
1700
14159
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
2.2
16.1
135
624
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.6
16.0
400
2594
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.2
16.0
127
574
M48.0
ICD-10 Finland
Spinal stenosis
1.4
16.0
704
5132
U07
ICPC
Urine symptom/complaint other
1.5
15.9
453
3025
K03.66
ICD-10 Finland
Tooth plaque
1.6
15.9
349
2193
H02AA02
ATC
fludrocortisone; oral
3.7
15.9
50
137
N30.9
ICD-10 Finland
Cystitis, unspecified
1.6
15.9
333
2069
W10
ICD-10 Finland
Fall on and from stairs and steps
1.8
15.8
258
1497
X58
ICD-10 Finland
Exposure to other specified factors
1.5
15.8
604
4287
C07AB02
ATC
metoprolol; systemic
1.3
15.8
1168
9257
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
4.2
15.7
41
98
J01CA08
ATC
pivmecillinam; oral
1.3
15.7
1746
14625
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
15.7
2026
17294
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.5
15.6
609
4339
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.1
15.6
150
731
F10.73
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol dementia
17.2
15.6
24
14
M02AA07
ATC
piroxicam; topical
1.3
15.5
1802
15170
N28
ICPC
Limited function/disability (N)
2.5
15.5
99
406
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
11.7
15.5
28
24
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
3.1
15.5
64
209
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
15.5
1167
9272
WX290
NOMESCO Finland
Other blockage of nerve
1.3
15.4
1721
14413
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.6
15.4
413
2721
VALMI, ,
NOMESCO Finland
1.4
15.4
902
6897
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.1
15.3
147
716
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.5
15.3
516
3572
Y94.0
ICD-10 Finland
Accident at home
2.4
15.3
108
464
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
5.2
15.3
31
60
T74.1
ICD-10 Finland
Physical abuse
3.3
15.3
57
175
SFA30
NOMESCO Finland
Three-surface restoration
1.3
15.3
1770
14892
C10AA05
ATC
atorvastatin; oral
1.3
15.2
2281
19802
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
15.2
1339
10872
F34.8
ICD-10 Finland
Other persistent mood [affective] disorders
13.1
15.1
26
20
A69
ICPC
General and Unspecified, Other reason for encounter NEC
2.1
15.1
148
726
XCK00
NOMESCO Finland
Perimetry
1.6
15.1
338
2135
LAITO, ,
NOMESCO Finland
20.1
15.1
22
11
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
15.1
606
4342
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
3.4
15.0
53
157
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
6.3
15.0
25
40
A02BC02
ATC
pantoprazole; systemic
1.3
15.0
3430
31259
D01
ICPC
Abdominal pain/cramps general
1.5
15.0
512
3554
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
15.0
1262
10179
F33.8
ICD-10 Finland
Other recurrent depressive disorders
4.5
14.9
36
81
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
14.9
1225
9844
XF606, ,
SPAT
3.4
14.9
52
153
S01
ICD-10 Finland
Open wound of head
2.9
14.9
69
241
N05AX13
ATC
paliperidone; systemic
6.8
14.8
23
34
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
5.5
14.8
28
51
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.5
14.7
504
3498
Z28
ICPC
Limited function/disability (Z)
4.3
14.7
37
86
XA400
NOMESCO Finland
EEG
4.4
14.7
36
82
R39.1
ICD-10 Finland
Other difficulties with micturition
1.9
14.7
175
921
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
14.7
465
3177
OAA80, ,
SPAT
0.3
14.7
49
1457
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.7
14.5
255
1511
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
6.3
14.5
24
38
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
6.3
14.5
24
38
F33
ICD-10 Finland
Recurrent depressive disorder
2.8
14.5
71
255
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
2.8
14.5
71
255
N03AX23
ATC
brivaracetam; systemic
14.2
14.5
24
17
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
3.0
14.5
62
207
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
6.6
14.5
23
35
G93.4
ICD-10 Finland
Encephalopathy, unspecified
6.6
14.5
23
35
X78
ICD-10 Finland
Intentional self-harm by sharp object
5.4
14.5
28
52
AA1DD
NOMESCO Finland
Head and neck CT
4.6
14.4
34
75
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
15.4
14.4
23
15
E000001, ,
ATC
1.4
14.4
826
6292
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.9
14.3
192
1050
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
14.3
480
3320
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
14.3
294
1819
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
3.4
14.2
49
143
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.7
14.2
286
1758
N05AB01
ATC
dixyrazine; systemic
2.9
14.2
67
236
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
14.2
3458
31628
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.5
14.2
525
3699
N80
ICPC
Head injury other
2.3
14.2
106
467
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.3
14.2
1320
10778
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
5.3
14.2
28
53
Z01.7
ICD-10 Finland
Laboratory examination
1.4
14.1
751
5648
SCA01
NOMESCO Finland
Preventive oral health care, short
1.3
14.1
1015
8000
A02BA02
ATC
ranitidine; systemic
1.3
14.0
988
7758
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
12.0
14.0
25
21
SPAT1370
SPAT
Other health check-up
1.9
14.0
189
1036
K29.7
ICD-10 Finland
Gastritis, unspecified
1.9
14.0
182
986
IFA99, ,
SPAT
6.7
14.0
22
33
WX212
NOMESCO Finland
Femoral plexus blockade
2.0
14.0
140
693
SPAT1153
SPAT
Removal of sutures
1.3
14.0
1563
13058
T90
ICPC
Diabetes non-insulin dependent
1.3
14.0
1253
10178
S22.4
ICD-10 Finland
Multiple fractures of ribs
2.2
13.9
111
503
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.5
13.8
458
3157
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
13.8
496
3475
30188
ICD-8 Finland
Personality disorders, Alia definita
4.7
13.7
31
66
R06.0
ICD-10 Finland
Dyspnoea
1.3
13.7
1443
11961
J01FA06
ATC
roxithromycin; oral
1.3
13.7
1798
15307
J01CA04
ATC
amoxicillin; systemic
1.3
13.7
3785
35053
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
2.4
13.7
91
381
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
10.4
13.7
26
25
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
1.7
13.7
236
1393
30041
ICD-8 Finland
Neuroses, Depressiva
2.6
13.6
75
287
H53.1
ICD-10 Finland
Subjective visual disturbances
1.6
13.6
314
1998
IHZ05, ,
SPAT
2.2
13.6
112
515
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
2.6
13.6
78
305
WVA20, ,
SPAT
1.9
13.5
174
941
Z43.5
ICD-10 Finland
Attention to cystostomy
3.6
13.5
44
124
F0014, G301,
ICD-10 Finland
140.4
13.4
14
*
F00.24
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
140.4
13.4
14
*
R52.2
ICD-10 Finland
Other chronic pain
1.9
13.4
174
942
R07.2
ICD-10 Finland
Precordial pain
2.2
13.4
117
550
UDC00
NOMESCO Finland
Ear microscopy
1.6
13.4
343
2238
Z27
ICPC
Fear of a social problem
5.0
13.3
28
56
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
13.3
1048
8354
J01DA01
ATC
[U] cefalexin
1.2
13.3
2857
25674
F23.91
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
11.5
13.3
24
21
D21
ICPC
Swallowing problem
2.4
13.2
91
387
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
1.9
13.2
157
826
N06AA04
ATC
clomipramine; systemic
2.5
13.2
78
309
F10.52
ICD-10 Finland
Psychotic alcohol hallucination
13.8
13.2
22
16
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
13.2
648
4805
ZYC01
NOMESCO Finland
Remote contact by phone
1.7
13.2
260
1590
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
2.3
13.1
94
407
F43.00
ICD-10 Finland
Acute stress reaction mild
2.5
13.1
79
316
JAETT, ,
NOMESCO Finland
3.7
13.1
40
108
30088
ICD-8 Finland
Neuroses, Other
4.6
13.0
30
65
S80.0
ICD-10 Finland
Contusion of knee
1.6
13.0
294
1861
L99
ICPC
Musculoskeletal disease other
2.1
13.0
119
570
P16
ICPC
Acute alcohol abuse
2.8
13.0
65
237
ZX120, ,
SPAT
2.5
13.0
78
312
F60.5
ICD-10 Finland
Anankastic personality disorder
3.8
13.0
39
104
N19
ICPC
Speech disorder
2.6
12.9
73
283
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
9.3
12.9
26
28
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
12.9
872
6799
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
12.9
1312
10813
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.4
12.9
497
3530
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
5.0
12.9
27
54
R03AC02
ATC
salbutamol; inhalant
1.2
12.9
2439
21591
D64.9
ICD-10 Finland
Anaemia, unspecified
1.4
12.9
642
4774
130
Kela drug reimbursment
Malignant tumour
0.6
12.8
230
3724
SFA20
NOMESCO Finland
Two-surface restoration
1.2
12.8
2343
20657
SPAT1394
SPAT
Counselling and guidance related to living conditions
4.7
12.8
29
62
F22.8
ICD-10 Finland
Other persistent delusional disorders
11.5
12.8
23
20
SPAT1058
SPAT
PEF monitoring instruction
1.5
12.8
382
2579
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
5.3
12.8
25
47
Z01.2
ICD-10 Finland
Dental examination
1.2
12.7
1842
15825
30799
ICD-8 Finland
Transient situational disturbances
5.8
12.7
23
40
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
2.2
12.7
106
490
N06AX17
ATC
milnacipran; oral
3.3
12.7
46
139
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.0
12.7
130
650
NB6AA
NOMESCO Finland
Humerus X-ray examination
2.0
12.7
127
630
W17
ICD-10 Finland
Other fall from one level to another
1.8
12.7
180
1004
K91
ICPC
Cerebrovascular disease
2.4
12.6
86
365
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
70.0
12.6
14
*
F60.8
ICD-10 Finland
Other specific personality disorders
4.6
12.6
29
63
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
+∞
12.5
12
*
2938D
ICD-9 Finland
Transient organic psychotic conditions, Other specified transient organic mental disorders[SYNDROMA AFFECTIVUM PSYCHOORGANICUM ALIUD]
+∞
12.5
12
*
F28
ICD-10 Finland
Other nonorganic psychotic disorders
11.0
12.5
23
21
A10AB05
ATC
insulin aspart; parenteral
1.5
12.5
352
2346
R63.4
ICD-10 Finland
Abnormal weight loss
1.7
12.5
211
1239
P80
ICPC
Personality disorder
9.3
12.4
25
27
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.4
12.4
83
349
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
2.9
12.4
56
193
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.5
12.4
74
295
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.7
12.4
233
1408
R06AE07
ATC
cetirizine; oral
1.2
12.4
1801
15468
WX110, ,
SPAT
1.7
12.3
212
1250
L03
ICPC
Low back symptom/complaint
1.3
12.3
1269
10466
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.4
12.3
571
4192
G04BD04
ATC
oxybutynin; oral, transdermal
1.6
12.3
295
1897
ZXY49
NOMESCO Finland
Other health care provider
5.8
12.2
22
38
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
3.8
12.2
37
99
S29
ICPC
Skin symptom/complaint other
1.3
12.2
970
7732
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
2.6
12.2
71
280
A10AE04
ATC
insulin glargine; parenteral
1.5
12.2
458
3237
ZXE10
NOMESCO Finland
More than one and less than three hours
1.2
12.2
1687
14406
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
3.3
12.1
45
138
ZYY02
NOMESCO Finland
Contact between professionals and family members
15.9
12.1
19
12
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
2.4
12.1
83
353
ZXA00
NOMESCO Finland
Right side
1.3
12.1
1322
10983
ZXA05
NOMESCO Finland
Left side
1.3
12.0
1234
10167
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
12.0
859
6746
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
12.0
819
6389
XKD00
NOMESCO Finland
Uroflowmetry
1.3
12.0
844
6613
IEV99
NOMESCO Finland
Other psychiatric network intervention
8.7
12.0
25
29
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.7
11.9
212
1262
Y96.9
ICD-10 Finland
Unspecified type of accident
2.3
11.9
89
393
OAB50, ,
SPAT
1.5
11.9
378
2584
Z51.88
ICD-10 Finland
Other specified medical care
2.1
11.9
108
517
F45.0
ICD-10 Finland
Somatization disorder
4.5
11.9
28
62
-2, ,
ICPC
3.6
11.9
38
106
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.4
11.8
460
3272
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
2.8
11.8
57
204
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
11.8
343
2301
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
11.8
627
4708
S01.8
ICD-10 Finland
Open wound of other parts of head
2.4
11.8
77
321
RS220, ,
NOMESCO Finland
2.8
11.7
59
216
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.0
11.7
133
690
ZYY01
NOMESCO Finland
Contact between professionals
5.1
11.7
24
47
F34.0
ICD-10 Finland
Cyclothymia
8.9
11.7
24
27
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.8
11.7
181
1036
34599
ICD-8 Finland
Epilepsy, Other and unspecified
4.2
11.7
30
71
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.5
11.7
425
2984
R4130
NOMESCO Finland
Speech therapy
2.0
11.7
128
656
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.0
11.7
119
595
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
11.6
320
2121
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
2.5
11.6
72
293
S20.2
ICD-10 Finland
Contusion of thorax
1.6
11.6
237
1465
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.8
11.6
182
1047
TPH04, ,
SPAT
2.6
11.6
64
246
N03AX22
ATC
perampanel; oral
18.9
11.6
17
9
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
11.5
520
3799
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
11.1
11.5
21
19
SPAT1043
SPAT
Audiometry
1.4
11.5
559
4137
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
9.2
11.5
23
25
F0204, G310,
ICD-10 Finland
+∞
11.5
11
*
F01.1
ICD-10 Finland
Multi-infarct dementia
+∞
11.5
11
*
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
+∞
11.5
11
*
B03BA03
ATC
hydroxocobalamin; parenteral
1.6
11.4
299
1960
G04CB02
ATC
dutasteride; oral
1.5
11.4
409
2863
N06AA10
ATC
nortriptyline; systemic
2.3
11.4
87
388
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.3
11.4
1420
11967
B18.2
ICD-10 Finland
Chronic viral hepatitis C
3.4
11.3
40
119
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
11.3
609
4580
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
11.3
588
4399
H53.2
ICD-10 Finland
Diplopia
1.8
11.3
161
900
IEP99
NOMESCO Finland
Other psychiatric family intervention
15.0
11.3
18
12
F41.00
ICD-10 Finland
Moderate panic disorder
2.9
11.3
50
171
A78
ICPC
Infectious disease other/NOS
2.5
11.3
71
291
N05CD08
ATC
midazolam; nasal, systemic
2.0
11.2
119
603
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.7
11.2
183
1064
F41.3
ICD-10 Finland
Other mixed anxiety disorders
3.3
11.2
41
125
A10BA02
ATC
metformin; oral
1.2
11.2
1458
12341
S22
ICPC
Nail symptom/complaint
1.5
11.2
314
2092
E87.6
ICD-10 Finland
Hypokalaemia
1.8
11.1
177
1023
AA1BD
NOMESCO Finland
Extensive CT of head and brain
1.9
11.1
127
662
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
8.0
11.0
24
30
R54
ICD-10 Finland
Senility
3.6
11.0
35
97
A31
ICPC
General and Unspecified, Medical examin/health eval partial
2.0
11.0
122
629
L84
ICD-10 Finland
Corns and callosities
1.8
11.0
168
960
R1430, ,
SPAT
2.4
10.9
70
289
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
4.0
10.9
30
75
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.6
10.9
242
1527
A02BC05
ATC
esomeprazole; systemic
1.2
10.9
1866
16258
EB1AA, ,
SPAT
1.6
10.9
249
1584
Z3226
NOMESCO Finland
Physiotherapist
1.3
10.8
824
6522
G43.9
ICD-10 Finland
Migraine, unspecified
1.8
10.8
152
846
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
10.8
2073
18260
F30.20
ICD-10 Finland
Mania with mood-congruent psychotic symptoms
11.9
10.8
19
16
AA1AA
NOMESCO Finland
Head X-ray examination
3.0
10.8
47
159
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
5.1
10.8
22
43
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
5.1
10.8
22
43
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.3
10.8
711
5516
WX872
NOMESCO Finland
Intensive care
1.6
10.8
256
1643
N18
ICPC
Paralysis/weakness
2.0
10.7
107
531
D09
ICPC
Nausea
1.8
10.7
172
996
F41.01
ICD-10 Finland
Severe panic disorder
4.9
10.7
23
47
F01.24
ICD-10 Finland
Subcortical vascular dementia other additional symptoms of mixed type
28.1
10.7
14
5
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
1.8
10.7
147
813
A23
ICPC
Risk factor NOS
1.5
10.7
355
2449
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
10.6
242
1537
C01DA14
ATC
isosorbide mononitrate; oral
1.3
10.6
1030
8413
193
Kela drug reimbursment
Rasagiline
3.6
10.6
34
95
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
10.6
377
2637
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
3.7
10.6
32
86
S06
ICPC
Rash localized
1.6
10.6
264
1714
R52.9
ICD-10 Finland
Pain, unspecified
1.4
10.5
452
3272
SCA02
NOMESCO Finland
Preventive oral health care
1.5
10.5
340
2333
F50.9
ICD-10 Finland
Eating disorder, unspecified
5.0
10.5
22
44
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.3
10.5
954
7729
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.9
10.5
47
162
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
10.5
727
5681
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
4.6
10.5
24
52
R1100, ,
SPAT
2.4
10.4
72
308
F01.34
ICD-10 Finland
Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type
110.2
10.4
11
*
2938B
ICD-9 Finland
Transient organic psychotic conditions, Other specified transient organic mental disorders[SYNDROMA DELUSIONALE PSYCHOORGANICUM ALIUD]
+∞
10.4
10
*
F009, F03,
ICD-10 Finland
+∞
10.4
10
*
F0011, G301,
ICD-10 Finland
+∞
10.4
10
*
F00, F03,
ICD-10 Finland
+∞
10.4
10
*
R1250, ,
SPAT
1.8
10.4
139
762
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.7
10.4
195
1179
H04.10
ICD-10 Finland
Dry eye syndrome
1.4
10.4
496
3658
SDA01
NOMESCO Finland
Periodontal treatment, very brief
1.3
10.4
1044
8565
F30.1
ICD-10 Finland
Mania without psychotic symptoms
12.0
10.3
18
15
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
12.0
10.3
18
15
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
1.9
10.3
119
622
I25
ICD-10 Finland
Chronic ischaemic heart disease
1.5
10.3
281
1860
N06BA04
ATC
methylphenidate; oral
2.5
10.3
65
267
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
3.4
10.3
35
102
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
1.9
10.3
129
694
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.5
10.2
301
2025
N03AG04
ATC
vigabatrin; oral
18.8
10.2
15
8
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
1.9
10.2
126
673
WYA30, ,
SPAT
3.3
10.2
37
112
T68
ICD-10 Finland
Hypothermia
4.0
10.2
28
70
OAB95, ,
SPAT
0.3
10.2
37
1051
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.8
10.2
138
760
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
1.8
10.2
144
804
R1260
NOMESCO Finland
Evaluation of communicative skills
2.2
10.2
86
401
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
1.7
10.2
168
982
F25.01
ICD-10 Finland
Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms
7.4
10.2
23
31
R60.9
ICD-10 Finland
Oedema, unspecified
1.5
10.1
291
1948
S62.6
ICD-10 Finland
Fracture of other finger
1.7
10.1
162
938
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.4
10.1
526
3934
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
10.1
315
2146
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
5.3
10.1
20
38
S10
ICPC
Boil/carbuncle
1.6
10.1
248
1604
I95.9
ICD-10 Finland
Hypotension, unspecified
2.1
10.1
88
416
L12
ICPC
Hand/finger symptom/complaint
1.3
10.1
714
5595
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
4.3
10.0
25
58
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
5.0
10.0
21
42
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.3
10.0
594
4533
R52.1
ICD-10 Finland
Chronic intractable pain
2.9
10.0
44
150
GD1AA, ,
SPAT
0.7
10.0
274
4038
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
2.1
10.0
91
437
F20.8
ICD-10 Finland
Other schizophrenia
4.6
10.0
23
50
R47.1
ICD-10 Finland
Dysarthria and anarthria
2.5
10.0
60
241
D17
ICPC
Incontinence of bowel
2.5
10.0
61
247
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
3.4
10.0
35
104
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
2.6
9.9
55
212
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
1.9
9.9
113
588
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.9
9.9
129
703
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
3.7
9.8
30
81
P01AB01
ATC
metronidazole; oral, rectal
1.2
9.8
1648
14287
S02.10
ICD-10 Finland
Fracture of base of skull, closed
4.3
9.8
25
59
C08CA01
ATC
amlodipine; oral
1.2
9.8
2118
18821
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
26.1
9.8
13
5
K04.0
ICD-10 Finland
Pulpitis
1.5
9.8
269
1785
R99
ICPC
Respiratory disease other
2.1
9.8
91
441
IER01
NOMESCO Finland
Psychoeducation, group
4.5
9.8
23
51
XJH00
NOMESCO Finland
Transanal ultrasonography
1.5
9.7
319
2195
Z51.5
ICD-10 Finland
Palliative care
1.4
9.7
511
3827
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
2.1
9.7
94
462
S97
ICPC
Chronic ulcer skin
1.5
9.7
338
2354
F20.0
ICD-10 Finland
Paranoid schizophrenia
3.7
9.7
30
82
J01DA09
ATC
[U] cefadroxil
1.3
9.7
1069
8858
R20.2
ICD-10 Finland
Paraesthesia of skin
1.5
9.7
262
1733
S51.8
ICD-10 Finland
Open wound of other parts of forearm
2.5
9.7
57
227
RS221, ,
NOMESCO Finland
2.4
9.6
62
258
T03
ICPC
Loss of appetite
3.7
9.6
29
78
D01AC02
ATC
miconazole; topical
1.4
9.6
354
2495
SPAT1241
SPAT
Extensive assessment of psychosocial situation
3.3
9.6
35
107
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.5
9.5
255
1682
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.5
9.5
249
1634
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
4.8
9.5
21
44
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
3.0
9.5
40
133
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
10.0
9.5
18
18
N04BD02
ATC
rasagiline; oral
3.1
9.5
39
128
N07
ICPC
Convulsion/seizure
7.1
9.5
22
31
A97
ICPC
No disease
1.3
9.5
907
7387
F21, ,
ICPC
2.8
9.4
45
161
F01.80
ICD-10 Finland
Other specified vascular dementia without additional symptoms
30.1
9.4
12
*
ZXE20
NOMESCO Finland
More than three and less than five hours
1.3
9.4
624
4843
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.6
9.4
214
1361
F0013, G301,
ICD-10 Finland
+∞
9.4
9
*
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
+∞
9.4
9
*
F064, G310,
ICD-10 Finland
+∞
9.4
9
*
F062, G310,
ICD-10 Finland
+∞
9.4
9
*
F20
ICD-10 Finland
Schizophrenia
3.6
9.4
30
84
ZXY61
NOMESCO Finland
2-person team, special workers
12.3
9.3
16
13
F23.29
ICD-10 Finland
Acute schizophrenia-like psychosis UNS
21.7
9.3
13
6
ZYB03
NOMESCO Finland
Outreach service at primary care or social services unit
21.7
9.3
13
6
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
9.3
865
7016
WZC00
NOMESCO Finland
Treatment plan or consultation
1.2
9.3
1611
13993
SPAT1257
SPAT
Teaching of medicine inhalation technique
1.7
9.3
171
1029
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
1.6
9.3
193
1199
S02.30
ICD-10 Finland
Fracture of orbital floor, closed
2.8
9.3
45
162
F45.9
ICD-10 Finland
Somatoform disorder, unspecified
4.9
9.3
20
41
SPAT1042
SPAT
Guidance concerning balance maintenance
3.2
9.3
35
109
W0A10
NOMESCO Finland
Mapping of psychosocial situation
10.7
9.3
17
16
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
1.8
9.3
133
747
G93.1
ICD-10 Finland
Anoxic brain damage, not elsewhere classified
3.6
9.2
29
80
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
4.0
9.2
25
62
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.6
9.2
196
1226
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
9.2
120
655
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.5
9.2
319
2223
J01FF01
ATC
clindamycin; systemic
1.2
9.1
1164
9793
S82.6
ICD-10 Finland
Fracture of lateral malleolus
1.5
9.1
256
1706
S04
ICPC
Lump/swelling localized
1.4
9.1
453
3361
M01AC06
ATC
meloxicam; systemic, rectal
1.2
9.1
1583
13752
G35
ICD-10 Finland
Multiple sclerosis
2.7
9.1
48
181
K59.1
ICD-10 Finland
Functional diarrhoea
1.5
9.1
246
1627
Z50.5
ICD-10 Finland
Speech therapy
2.5
9.1
55
222
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
3.1
9.1
37
121
J01AA02
ATC
doxycycline; systemic
1.2
9.1
3723
34985
A41.9
ICD-10 Finland
Sepsis, unspecified
1.6
9.0
188
1169
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
1.6
9.0
182
1123
EBA10
NOMESCO Finland
Operative extraction of tooth
1.4
9.0
385
2785
E03.89
ICD-10 Finland
Other specified hypothyroidism
1.7
9.0
173
1054
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.4
9.0
471
3524
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
36.7
9.0
11
*
F40.1
ICD-10 Finland
Social phobias
2.4
9.0
57
235
F10.4
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium
9.0
9.0
18
20
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
10.0
9.0
17
17
3454B
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]
10.0
9.0
17
17
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
2.9
9.0
41
143
SPAT1244
SPAT
Occupational therapy
2.6
9.0
49
188
H02
ICPC
Hearing complaint
1.3
9.0
797
6428
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
2.4
8.9
60
255
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.3
8.9
67
299
3459X
ICD-9 Finland
Epilepsy, unspecified
6.8
8.8
21
31
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
1.9
8.8
103
542
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.6
8.8
211
1358
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.4
8.8
60
256
F29
ICPC
Eye symptom/complaint other
1.4
8.8
433
3209
R21
ICPC
Throat symptom/complaint
1.3
8.8
640
5029
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.9
8.8
105
557
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.6
8.8
193
1218
IHZ01, ,
SPAT
3.2
8.7
33
103
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.8
8.7
117
644
S89.9
ICD-10 Finland
Unspecified injury of lower leg
1.8
8.7
122
681
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.6
8.7
186
1166
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
50.1
8.7
10
*
F01.8
ICD-10 Finland
Other vascular dementia
50.1
8.7
10
*
R5140, ,
SPAT
2.2
8.6
68
309
A08
ICPC
Swelling
1.5
8.6
302
2107
G43.3
ICD-10 Finland
Complicated migraine
2.7
8.6
45
169
AAF00
NOMESCO Finland
Ventriculostomy
3.2
8.6
33
104
JN3AD
NOMESCO Finland
Abdominal CT examination
1.3
8.6
616
4829
F20.10
ICD-10 Finland
Raise schizophrenia continuously
4.4
8.6
21
48
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
3.2
8.6
32
99
U01
ICPC
Dysuria/painful urination
1.4
8.6
329
2335
N02AX02
ATC
tramadol; systemic, rectal
1.2
8.5
2053
18355
N05AX15
ATC
cariprazine; oral
6.9
8.5
20
29
F60.2
ICD-10 Finland
Dissocial personality disorder
6.9
8.5
20
29
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.2
8.5
1044
8740
WPA10, ,
SPAT
4.0
8.5
23
57
S00.8
ICD-10 Finland
Superficial injury of other parts of head
2.0
8.5
85
424
D07CC01
ATC
betamethasone and antibiotics; topical
1.3
8.5
498
3794
Z71.9
ICD-10 Finland
Counselling, unspecified
1.4
8.5
328
2332
IAB12
NOMESCO Finland
Psychiatric psychosis consultation
27.5
8.5
11
*
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.2
8.5
67
305
S42.0
ICD-10 Finland
Fracture of clavicle
1.8
8.5
111
607
SPA60
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 1 to 3 units
2.1
8.4
80
391
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
3.0
8.4
36
121
N06AX18
ATC
reboxetine; oral
2.6
8.4
45
171
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
8.4
2159
19403
IAB11
NOMESCO Finland
Psychiatric mood consultation
7.3
8.4
19
26
F01.21
ICD-10 Finland
Subcortical vascular dementia without additional symptoms, mainly paranoidism
90.2
8.4
9
*
F06
ICD-10 Finland
Other mental disorders due to brain damage and dysfunction and to physical disease
90.2
8.4
9
*
R31
ICD-10 Finland
Unspecified haematuria
1.3
8.4
523
4020
SPAT1247
SPAT
Outpatient detoxication and monitoring
4.3
8.4
21
49
B01AB05
ATC
enoxaparin; parenteral
1.2
8.4
1520
13238
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
2.5
8.4
50
201
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
12.8
8.4
14
11
R07.1
ICD-10 Finland
Chest pain on breathing
2.2
8.4
65
294
SPAT1313
SPAT
Guidance and counselling related to accident prevention
3.1
8.4
33
106
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.5
8.4
64
1330
R27.0
ICD-10 Finland
Ataxia, unspecified
3.5
8.4
28
81
ZYD01
NOMESCO Finland
Emergency clinic
7.8
8.3
18
23
F0633, G310,
ICD-10 Finland
+∞
8.3
8
*
F00.01
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism
+∞
8.3
8
*
1541, ,
Kela drug reimbursment
+∞
8.3
8
*
N07AA05, ,
ATC
+∞
8.3
8
*
3069, ,
Kela drug reimbursment
+∞
8.3
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.5
8.3
60
1274
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.5
8.3
215
1409
R30.1
ICD-10 Finland
Vesical tenesmus
1.9
8.3
100
532
3451A
ICD-9 Finland
Epilepsy, Generalised convulsive epilepsy
8.5
8.3
17
20
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
8.5
8.3
17
20
-31
ICPC
Medical examin/health eval partial
1.4
8.3
304
2141
N30
ICD-10 Finland
Cystitis
1.4
8.3
315
2234
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
8.3
561
4366
H54.7
ICD-10 Finland
Unspecified visual loss
2.8
8.3
39
139
SPD00
NOMESCO Finland
Mucosa borne complete denture
2.3
8.2
59
258
S01.51
ICD-10 Finland
Open wound on lip
2.1
8.2
72
342
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
1.7
8.2
155
942
SPAT1138
SPAT
Guidance concerning bowel function
2.1
8.2
73
349
A13
ICPC
Concern/fear medical treatment
1.9
8.2
100
535
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.6
8.2
188
1200
A03FA02
ATC
cisapride; oral, rectal
1.4
8.2
356
2586
M03BX02
ATC
tizanidine; oral
1.2
8.1
2525
23040
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
2.5
8.1
49
198
A07AA02
ATC
nystatin; oral
1.5
8.1
277
1924
30099
ICD-8 Finland
Neuroses, Unspecified neurosis
4.5
8.1
19
42
OAB48, ,
SPAT
0.6
8.1
165
2591
SGC10
NOMESCO Finland
Pulp capping
1.5
8.1
242
1637
F01.0
ICD-10 Finland
Vascular dementia of acute onset
33.4
8.1
10
*
G21.0
ICD-10 Finland
Malignant neuroleptic syndrome
17.2
8.1
12
7
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
11.7
8.1
14
12
F32.0
ICD-10 Finland
Mild depressive episode
2.0
8.1
81
405
SP000, ,
NOMESCO Finland
3.8
8.1
24
64
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
3.2
8.1
30
93
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
6.8
8.0
19
28
L60.0
ICD-10 Finland
Ingrowing nail
1.6
8.0
194
1252
S01
ICPC
Pain/tenderness of skin
1.5
8.0
207
1356
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.6
8.0
197
1277
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.4
8.0
331
2382
F44.88
ICD-10 Finland
Other definite dissociation disorder
22.0
8.0
11
5
WW200, ,
SPAT
0.8
8.0
953
11323
WZC00, ,
SPAT
1.3
8.0
596
4699
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
8.0
781
6371
A02BA04
ATC
nizatidine; systemic
1.4
8.0
368
2700
D10
ICPC
Vomiting
1.7
8.0
151
919
M79.7
ICD-10 Finland
Fibromyalgia
1.8
7.9
109
605
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
7.2
7.9
18
25
R15
ICD-10 Finland
Faecal incontinence
1.7
7.9
141
843
F05
ICPC
Visual disturbance other
1.7
7.9
146
882
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
1.7
7.9
150
913
OAA65, ,
SPAT
0.6
7.9
164
2563
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
2.0
7.9
77
381
Z60.8
ICD-10 Finland
Other problems related to social environment
4.4
7.9
19
43
F43.28
ICD-10 Finland
Adaptive disorder with other predominant symptoms
4.4
7.9
19
43
J45
ICD-10 Finland
Asthma
1.4
7.9
402
2997
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
2.2
7.9
64
295
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
4.6
7.9
18
39
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
1.7
7.8
152
930
EMAK, ,
NOMESCO Finland
1.7
7.8
132
778
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
6.1
7.8
20
33
RF220, ,
NOMESCO Finland
2.2
7.8
66
309
SPF02
NOMESCO Finland
Impression for dental prosthesis repair, restricted
2.0
7.8
75
369
DJA10
NOMESCO Finland
Biopsy of septum of nose
8.4
7.8
16
19
IAB10
NOMESCO Finland
Psychiatric consultation concerning substance abuse
8.4
7.8
16
19
F23.00
ICD-10 Finland
Acute polymorphic psychosis without actual schizophrenic disease picture without acute stress factor
8.4
7.8
16
19
N03AX15
ATC
zonisamide; oral
8.4
7.8
16
19
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.5
7.8
48
196
G56.3
ICD-10 Finland
Lesion of radial nerve
2.9
7.8
34
116
D06AX01
ATC
fusidic acid; topical
1.4
7.8
363
2667
R03BA01
ATC
beclometasone; inhalant
1.3
7.8
598
4731
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
1.7
7.8
130
765
G23.8
ICD-10 Finland
Other specified degenerative diseases of basal ganglia
9.4
7.8
15
16
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.4
7.8
357
2617
A10BH01
ATC
sitagliptin; oral
1.3
7.7
457
3486
B01AC07
ATC
dipyridamole; systemic
1.5
7.7
254
1752
F01.23
ICD-10 Finland
Subcortical vascular dementia other additional symptoms, mainly depression
45.0
7.7
9
*
F01.39
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without information on additional symptoms
45.0
7.7
9
*
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
45.0
7.7
9
*
F69
ICD-10 Finland
Unspecified disorder of adult personality and behaviour
45.0
7.7
9
*
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
15.0
7.7
12
8
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
7.7
2868
26521
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.0
7.7
74
365
K89
ICPC
Transient cerebral ischaemia
2.2
7.7
63
292
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
7.4
7.7
17
23
N04BC09
ATC
rotigotine; transdermal
3.4
7.7
26
76
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
3.2
7.6
29
91
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
3.2
7.6
29
91
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
4.5
7.6
18
40
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
4.5
7.6
18
40
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
2.1
7.6
69
332
G04BD11
ATC
fesoterodine; oral
1.7
7.6
140
845
A03
ICPC
Fever
1.3
7.6
562
4422
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
2.7
7.6
40
151
R47.0
ICD-10 Finland
Dysphasia and aphasia
2.3
7.6
56
248
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
2.2
7.6
61
280
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.6
7.6
178
1142
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
8.0
7.6
16
20
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
8.0
7.6
16
20
SAA04
NOMESCO Finland
Special examination of mouth
1.6
7.6
184
1190
A10BH05
ATC
linagliptin; oral
1.4
7.6
273
1917
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
3.1
7.6
31
102
F91.9
ICD-10 Finland
Conduct disorder, unspecified
25.0
7.6
10
*
30899
ICD-8 Finland
Behaviour disorders of childhood
11.8
7.6
13
11
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.5
7.5
60
1228
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
7.5
308
2213
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
8.8
7.5
15
17
ZXE22
NOMESCO Finland
Procedure duration at least 4 but less than 5 hours
8.8
7.5
15
17
Z91.5
ICD-10 Finland
Personal history of self-harm
6.1
7.5
19
31
P77
ICPC
Suicide/suicide attempt
10.0
7.5
14
14
T91.8
ICD-10 Finland
Sequelae of other specified injuries of neck and trunk
10.0
7.5
14
14
R06.5
ICD-10 Finland
Mouth breathing
1.4
7.5
321
2324
2161
FHL
Neck ligation, big brain
3.8
7.5
22
58
AA1XD
NOMESCO Finland
Other special CT of head and brain
3.8
7.5
22
58
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
1.7
7.5
123
720
L01BC06
ATC
capecitabine; oral
0.5
7.5
57
1186
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
2.1
7.5
65
308
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
1.8
7.5
114
654
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
7.1
7.5
17
24
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.4
7.5
359
2652
L29.9
ICD-10 Finland
Pruritus, unspecified
1.7
7.4
117
677
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.7
7.4
133
798
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
4.4
7.4
18
41
F00.2
ICD-10 Finland
Dementia in Alzheimer disease, atypical or mixed type
80.2
7.4
8
*
G40.80
ICD-10 Finland
Epilepsy with continuous EEG spike-waves during slow wave sleep
80.2
7.4
8
*
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
2.4
7.4
49
207
H53.0
ICD-10 Finland
Amblyopia ex anopsia
2.8
7.4
35
125
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.7
7.4
239
3412
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
6.4
7.4
18
28
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
3.2
7.4
28
88
N05AE05
ATC
lurasidone; oral
7.6
7.4
16
21
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
3.3
7.4
26
78
G04CA01
ATC
alfuzosin; oral
1.3
7.4
602
4801
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
7.3
1686
14964
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
7.3
1360
11844
SPA50
NOMESCO Finland
Determination of bite and dental arch location
2.0
7.3
75
378
N02BF02
ATC
pregabalin; oral
1.4
7.3
270
1904
F0202, G310,
ICD-10 Finland
+∞
7.3
7
*
F0201, G310,
ICD-10 Finland
+∞
7.3
7
*
F0012, G301,
ICD-10 Finland
+∞
7.3
7
*
29420
ICD-8 Finland
Psychosis associated with other physical conditions, Systemic infections
+∞
7.3
7
*
N91.1
ICD-10 Finland
Secondary amenorrhoea
3.6
7.3
23
64
HAMTE, ,
NOMESCO Finland
2.6
7.3
39
149
K02
ICPC
Pressure/tightness of heart
1.8
7.3
111
637
N05CD02
ATC
nitrazepam; oral
1.9
7.3
85
449
N48.1
ICD-10 Finland
Balanoposthitis
1.8
7.3
105
593
K01
ICPC
Heart pain
2.0
7.3
72
359
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
3.5
7.3
24
69
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
3.2
7.2
28
89
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
2.2
7.2
55
247
SPAT1227
SPAT
Substance abuse rehabilitation
3.8
7.2
21
55
P48
ICPC
Psychological, Clarification/discussion RFE/demand
3.8
7.2
21
55
S21
ICPC
Skin texture symptom/complaint
1.3
7.2
702
5717
S01.9
ICD-10 Finland
Open wound of head, part unspecified
2.0
7.2
76
387
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.2
7.2
1321
11488
F10.50
ICD-10 Finland
Alcohol-related psychosis is schizophrenic
15.7
7.2
11
7
G41.1
ICD-10 Finland
Petit mal status epilepticus
15.7
7.2
11
7
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
1.5
7.2
186
1222
N04BB01
ATC
amantadine; oral
2.1
7.2
64
307
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
2.9
7.1
32
111
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
1.7
7.1
112
648
S02
ICPC
Pruritus
1.6
7.1
150
938
3313A
ICD-9 Finland
Other cerebral degenerations, Communicating hydrocephalus
20.0
7.1
10
5
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
1.9
7.1
79
411
ICB06, ,
NOMESCO Finland
4.1
7.1
19
47
AA3AD
NOMESCO Finland
CT of face
2.5
7.1
42
169
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.5
7.1
200
1339
R40.2
ICD-10 Finland
Coma, unspecified
2.5
7.1
43
175
K10.3
ICD-10 Finland
Alveolitis of jaws
1.6
7.0
143
887
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
3.0
7.0
29
96
H02AB02
ATC
dexamethasone; systemic
0.7
7.0
294
4011
G50.1
ICD-10 Finland
Atypical facial pain
2.1
7.0
66
323
Z10.0
ICD-10 Finland
Occupational health examination
0.5
7.0
72
1354
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.2
7.0
981
8314
H50.52
ICD-10 Finland
Exophoria
2.5
7.0
40
158
H81.9
ICD-10 Finland
Disorder of vestibular function, unspecified
2.1
7.0
65
317
T08
ICPC
Weight loss
1.9
6.9
83
442
F80.1
ICD-10 Finland
Expressive language disorder
2.6
6.9
38
147
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
6.3
6.9
17
27
H91.1
ICD-10 Finland
Presbycusis
1.3
6.9
415
3173
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
2.7
6.9
35
130
ICB03, ,
SPAT
5.8
6.9
18
31
J02AC01
ATC
fluconazole; systemic
1.2
6.9
1412
12396
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.7
6.9
126
761
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
7.5
6.9
15
20
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
2.3
6.9
47
202
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.7
6.9
126
762
A04AA02
ATC
granisetron; systemic, transdermal
0.6
6.8
123
1986
SPAT1255
SPAT
Intravenous administration of medicine
1.4
6.8
301
2192
R05
ICPC
Cough
1.2
6.8
1038
8865
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.2
6.8
798
6636
SPF10
NOMESCO Finland
Demanding reparation of dental prosthesis
1.8
6.8
94
524
F40.2
ICD-10 Finland
Specific (isolated) phobias
3.8
6.8
20
53
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.4
6.8
327
2417
F10.59
ICD-10 Finland
Alcohol psychosis, mixed type
10.9
6.8
12
11
85000
ICD-8 Finland
Concussion, Current or unspecified
1.9
6.8
85
460
WX290, ,
SPAT
1.8
6.8
100
569
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.6
6.8
136
842
L19
ICPC
Muscle symptom/complaint NOS
1.7
6.8
116
689
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
6.1
6.8
17
28
F25.0
ICD-10 Finland
Schizoaffective disorder, manic type
6.1
6.8
17
28
OAB36
NOMESCO Finland
Guidance and counselling related to exercise
3.0
6.8
28
93
R52.0
ICD-10 Finland
Acute pain
1.7
6.7
119
712
J46
ICD-10 Finland
Status asthmaticus
1.7
6.7
119
712
S06.8
ICD-10 Finland
Other intracranial injuries
5.6
6.7
18
32
E23.2
ICD-10 Finland
Diabetes insipidus
5.6
6.7
18
32
Z72.2
ICD-10 Finland
Drug use
4.3
6.7
17
40
ZYD04
NOMESCO Finland
Emergency outreach service, another specialty
16.7
6.7
10
6
F10.74
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol otherwise permanently impaired intelligence
16.7
6.7
10
6
N05AL05
ATC
amisulpride; oral
16.7
6.7
10
6
R05
ICD-10 Finland
Cough
1.2
6.7
917
7748
UJH02
NOMESCO Finland
Anoscopy
1.6
6.7
159
1024
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
0.1
6.7
*
228
SPD01
NOMESCO Finland
Mucosa-supported complete denture
2.2
6.7
52
236
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.3
6.7
466
3638
R06.4
ICD-10 Finland
Hyperventilation
2.1
6.7
56
262
N86
ICPC
Multiple sclerosis
3.2
6.7
25
78
IHZ07, ,
SPAT
2.9
6.7
29
99
PA7BD
NOMESCO Finland
CT angiography of neck and brain
2.0
6.7
71
364
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
6.6
1068
9169
NH1FA
NOMESCO Finland
Weight-bearing X-ray of ankle
2.3
6.6
46
199
L16
ICPC
Ankle symptom/complaint
1.3
6.6
465
3635
G41.0
ICD-10 Finland
Grand mal status epilepticus
6.4
6.6
16
25
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
6.4
6.6
16
25
IHZ04, ,
SPAT
2.3
6.6
48
212
RT130, ,
NOMESCO Finland
7.8
6.6
14
18
HA1RA, ,
SPAT
0.4
6.6
38
874
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
5.5
6.6
18
33
R96
ICPC
Asthma
1.3
6.6
415
3196
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
2.5
6.6
40
163
3094A
ICD-9 Finland
Adjustment reaction, With mixed disturbance of emotions and conduct
12.2
6.6
11
9
F44.7
ICD-10 Finland
Mixed dissociative [conversion] disorders
12.2
6.6
11
9
XA820, ,
NOMESCO Finland
12.2
6.6
11
9
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.2
6.6
886
7476
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
2.2
6.6
49
219
K85
ICPC
Elevated blood pressure
1.2
6.6
867
7301
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.1
6.6
60
291
G47.0
ICD-10 Finland
Disorders of initiating and maintaining sleep [insomnias]
1.8
6.6
84
458
SPAT1111
SPAT
Planning of analgesia
2.2
6.5
51
232
F23.9
ICD-10 Finland
Acute and transient psychotic disorder, unspecified
8.7
6.5
13
15
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
4.2
6.5
17
41
SPE01
NOMESCO Finland
Mucosa-supported partial denture
1.8
6.5
99
568
J45.1
ICD-10 Finland
Nonallergic asthma
1.4
6.5
293
2141
SPAT1014
SPAT
Treatment of eyes
1.8
6.5
86
473
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.0
6.5
62
305
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
1.9
6.5
78
416
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.6
6.5
117
1887
K04.08
ICD-10 Finland
Other specified pulpit
1.5
6.5
208
1430
M02AA10
ATC
ketoprofen; topical
1.2
6.4
704
5809
TAKUU, ,
NOMESCO Finland
2.6
6.4
35
135
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.3
6.4
514
4087
SDA03
NOMESCO Finland
Periodontal treatment
1.2
6.4
1497
13272
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.6
6.4
153
987
F01.84
ICD-10 Finland
Other specified vascular dementia other mixed symptoms of mixed type
69.9
6.4
7
*
30670
ICD-8 Finland
Special symptoms not elsewhere classified, Encopresis
69.9
6.4
7
*
N06AA22, ,
ATC
2.7
6.4
32
118
I49.5
ICD-10 Finland
Sick sinus syndrome
1.4
6.4
229
1607
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.3
6.4
431
3350
N05BB01
ATC
hydroxyzine; systemic
1.4
6.4
227
1591
R51
ICD-10 Finland
Headache
1.5
6.4
171
1132
F43.25
ICD-10 Finland
Adaptive disorder with mixed mental disorder and behavioral disorder
7.4
6.4
14
19
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
2.1
6.4
54
254
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.2
6.4
735
6099
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
14.3
6.4
10
7
SPAT1280
SPAT
Provision of administrative assistance
14.3
6.4
10
7
3017A
ICD-9 Finland
Personality disorders, Antisocial personality disorder
14.3
6.4
10
7
M01AX01
ATC
nabumetone; oral
1.5
6.4
174
1157
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
1.6
6.4
152
981
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
1.7
6.4
108
640
S01.40
ICD-10 Finland
Open wound on the cheek
2.5
6.3
36
142
OAB41, ,
SPAT
2.3
6.3
45
197
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
3.0
6.3
26
86
E66.8
ICD-10 Finland
Other obesity
1.6
6.3
151
975
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.6
6.3
135
849
R44.2
ICD-10 Finland
Other hallucinations
6.5
6.3
15
23
F93.89
ICD-10 Finland
Other childhood emotional disorders
8.1
6.3
13
16
C10AA02
ATC
lovastatin; oral
1.5
6.3
212
1471
H01
ICPC
Ear pain/earache
1.3
6.3
407
3145
K04.1
ICD-10 Finland
Necrosis of pulp
1.3
6.3
365
2777
SPA47
NOMESCO Finland
Precision impression for denture
1.7
6.3
118
718
M54
ICD-10 Finland
Dorsalgia
1.3
6.3
443
3464
N05AX16
ATC
brexpiprazole; oral
5.9
6.3
16
27
M79.1
ICD-10 Finland
Myalgia
1.3
6.3
549
4414
V03AB30, ,
ATC
2.6
6.3
34
131
Z63.0
ICD-10 Finland
Problems in relationship with spouse or partner
3.2
6.3
24
76
AAK00
NOMESCO Finland
Cranioplasty
9.2
6.3
12
13
F25.80
ICD-10 Finland
Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms
9.2
6.3
12
13
R41.2
ICD-10 Finland
Retrograde amnesia
9.2
6.3
12
13
IAB01, ,
SPAT
3.3
6.3
22
66
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
2.4
6.3
40
167
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
18.0
6.3
9
5
C01CA01
ATC
etilefrine; systemic
2.5
6.3
36
143
97010
ICD-8 Finland
Adverse effect of psychotherapeutics, Tranquillisers
3.8
6.2
18
47
F00.13
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression
+∞
6.2
6
*
F01.89
ICD-10 Finland
Other specified vascular dementia without information on additional symptoms
+∞
6.2
6
*
F060, G310,
ICD-10 Finland
+∞
6.2
6
*
F0200, G310,
ICD-10 Finland
+∞
6.2
6
*
F0024, G301,
ICD-10 Finland
+∞
6.2
6
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.2
6.2
849
7169
R3140
NOMESCO Finland
Training in communicative skills
26.7
6.2
8
*
G40.52
ICD-10 Finland
Epileptic seizures related to drugs
26.7
6.2
8
*
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
7.0
6.2
14
20
M19.2
ICD-10 Finland
Other secondary arthrosis
2.0
6.2
59
291
IGY99, ,
SPAT
2.4
6.2
40
168
L14
ICPC
Leg/thigh symptom/complaint
1.3
6.2
359
2733
SCC01
NOMESCO Finland
Fluoride application or other respective small prophylactic procedure
1.7
6.2
95
548
ZXD20
NOMESCO Finland
Day surgery
1.3
6.2
495
3938
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.3
6.2
462
3644
N05AE03
ATC
sertindole; oral
6.3
6.2
15
24
T89
ICPC
Diabetes insulin dependent
1.6
6.1
127
793
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.0
6.1
65
333
EBA00, ,
SPAT
1.7
6.1
97
564
Z59.8
ICD-10 Finland
Other problems related to housing and economic circumstances
7.7
6.1
13
17
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.2
6.1
816
6877
D02AE01
ATC
carbamide; topical
1.4
6.1
241
1724
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.5
6.1
159
1048
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
2.0
6.1
60
300
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
1.5
6.1
190
1301
R01AD59
ATC
mometasone, combinations; nasal
0.5
6.1
66
1217
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.2
6.1
1316
11592
D07BC01
ATC
betamethasone and antiseptics; topical
1.3
6.0
479
3805
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
2.0
6.0
63
321
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
2.2
6.0
49
227
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.5
6.0
188
1286
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
10.0
6.0
11
11
ZXY03
NOMESCO Finland
Occupational therapist
6.7
6.0
14
21
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.2
6.0
843
7138
E03
ICD-10 Finland
Other hypothyroidism
1.4
6.0
224
1586

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Psychiatry
26 [38004469]
1.8e+00
2.5e+00
2.9e+00
6.3e+00
3.3e+00
2.8e+00
2.2e+00
cases:15.24%
controls:3.01%
cases:14.35%
controls:1.39%
cases:8.50%
controls:0.50%
cases:19.15%
controls:0.04%
cases:11.50%
controls:0.47%
cases:18.57%
controls:1.35%
cases:22.30%
controls:2.96%
792
1565
4405
50377
746
722
4451
51220
442
261
4755
51681
995
23
4202
51919
593
242
4564
51469
901
657
3951
48114
820
1111
2857
36426
Alzheimer disease with late onset
G30.1 [45552521]
2.6e+00
3.1e+00
3.7e+00
1.0e+50
3.5e+00
4.7e+00
4.2e+00
cases:0.44%
controls:0.03%
cases:0.85%
controls:0.04%
cases:0.38%
controls:0.01%
cases:0.69%
controls:0.00%
cases:0.62%
controls:0.02%
cases:5.13%
controls:0.05%
cases:11.97%
controls:0.20%
23
18
5174
51924
44
20
5153
51922
20
5
5177
51937
36
0
5161
51942
32
10
5125
51701
249
25
4603
48746
440
76
3237
37461
Unspecified nonorganic psychosis
F29 [45533099]
2.5e+00
3.6e+00
4.3e+00
—
4.0e+00
3.6e+00
3.0e+00
cases:1.90%
controls:0.15%
cases:1.73%
controls:0.05%
cases:1.23%
controls:0.02%
—
—
cases:1.07%
controls:0.02%
cases:1.98%
controls:0.06%
cases:2.67%
controls:0.14%
99
79
5098
51863
90
24
5107
51918
64
9
5133
51933
—
55
10
5102
51701
96
27
4756
48744
98
52
3579
37485
Neurology
13 [38004458]
1.2e+00
2.0e+00
2.8e+00
7.5e+00
2.8e+00
2.5e+00
1.8e+00
cases:28.96%
controls:11.16%
cases:26.32%
controls:4.51%
cases:10.64%
controls:0.75%
cases:32.42%
controls:0.03%
cases:10.88%
controls:0.76%
cases:37.02%
controls:4.41%
cases:42.51%
controls:11.10%
1505
5797
3692
46145
1368
2340
3829
49602
553
392
4644
51550
1685
14
3512
51928
561
395
4596
51316
1796
2151
3056
46620
1563
4165
2114
33372
donepezil; oral
N06DA02 [21604795]
4.0e+00
5.0e+00
—
1.0e+50
—
6.5e+00
5.0e+00
cases:1.17%
controls:0.02%
cases:2.17%
controls:0.02%
—
—
cases:1.02%
controls:0.00%
—
—
cases:9.81%
controls:0.02%
cases:15.39%
controls:0.13%
61
11
5136
51931
113
8
5084
51934
—
53
0
5144
51942
—
476
8
4376
48763
566
47
3111
37490
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
2.2e+00
3.8e+00
4.6e+00
—
3.4e+00
3.2e+00
2.0e+00
cases:8.25%
controls:0.94%
cases:15.64%
controls:0.43%
cases:6.93%
controls:0.08%
—
—
cases:2.11%
controls:0.07%
cases:9.30%
controls:0.41%
cases:10.80%
controls:1.61%
429
489
4768
51453
813
222
4384
51720
360
40
4837
51902
—
109
36
5048
51675
451
200
4401
48571
397
604
3280
36933
memantine; oral
N06DX01 [21604799]
4.0e+00
4.3e+00
1.0e+50
1.0e+50
—
5.4e+00
5.1e+00
cases:0.85%
controls:0.02%
cases:1.21%
controls:0.02%
cases:0.71%
controls:0.00%
cases:0.25%
controls:0.00%
—
—
cases:6.29%
controls:0.03%
cases:20.34%
controls:0.15%
44
8
5153
51934
63
9
5134
51933
37
0
5160
51942
13
0
5184
51942
—
305
15
4547
48756
748
56
2929
37481
Geriatric Medicine
38 [38004478]
1.7e+00
3.0e+00
4.4e+00
—
3.6e+00
3.4e+00
2.5e+00
cases:3.81%
controls:0.71%
cases:7.18%
controls:0.39%
cases:4.73%
controls:0.06%
—
—
cases:2.66%
controls:0.07%
cases:13.46%
controls:0.49%
cases:15.88%
controls:1.54%
198
370
4999
51572
373
202
4824
51740
246
33
4951
51909
—
137
37
5020
51674
653
241
4199
48530
584
578
3093
36959
Unspecified dementia
F03 [45566772]
2.9e+00
4.8e+00
—
1.0e+50
3.7e+00
3.6e+00
3.3e+00
cases:1.29%
controls:0.07%
cases:3.31%
controls:0.03%
—
—
cases:0.56%
controls:0.00%
cases:0.54%
controls:0.01%
cases:2.00%
controls:0.05%
cases:4.95%
controls:0.19%
67
36
5130
51906
172
14
5025
51928
—
29
0
5168
51942
28
7
5129
51704
97
26
4755
48745
182
70
3495
37467
Other amnesia
R41.3 [45539342]
2.4e+00
3.9e+00
4.3e+00
—
3.2e+00
2.7e+00
1.7e+00
cases:2.29%
controls:0.22%
cases:3.83%
controls:0.08%
cases:1.25%
controls:0.02%
—
—
cases:0.27%
controls:0.01%
cases:1.15%
controls:0.08%
cases:1.74%
controls:0.33%
119
115
5078
51827
199
41
4998
51901
65
9
5132
51933
—
14
6
5143
51705
56
39
4796
48732
64
122
3613
37415
Mild cognitive disorder
F06.7 [45605450]
2.9e+00
4.0e+00
—
1.0e+50
—
6.2e+00
4.7e+00
cases:1.77%
controls:0.10%
cases:4.27%
controls:0.08%
—
—
cases:68.19%
controls:0.00%
—
—
cases:35.18%
controls:0.11%
cases:23.74%
controls:0.29%
92
50
5105
51892
222
42
4975
51900
—
3544
0
1653
51942
—
1707
54
3145
48717
873
109
2804
37428
Observation for suspected nervous system disorder
Z03.3 [45609903]
1.7e+00
3.2e+00
4.4e+00
—
3.2e+00
2.9e+00
2.0e+00
cases:2.91%
controls:0.54%
cases:4.25%
controls:0.18%
cases:1.62%
controls:0.02%
—
—
cases:0.48%
controls:0.02%
cases:2.82%
controls:0.16%
cases:4.08%
controls:0.56%
151
283
5046
51659
221
92
4976
51850
84
11
5113
51931
—
25
10
5132
51701
137
78
4715
48693
150
210
3527
37327
Geriatric Psychiatry
27 [38004470]
1.8e+00
2.7e+00
3.3e+00
—
3.7e+00
3.1e+00
2.6e+00
cases:1.65%
controls:0.29%
cases:2.19%
controls:0.15%
cases:1.29%
controls:0.05%
—
—
cases:2.15%
controls:0.06%
cases:3.98%
controls:0.18%
cases:3.75%
controls:0.29%
86
149
5111
51793
114
76
5083
51866
67
24
5130
51918
—
111
29
5046
51682
193
87
4659
48684
138
109
3539
37428
Memory disturbance
P20 [2002000816]
1.8e+00
3.1e+00
2.7e+00
2.5e+00
2.4e+00
2.2e+00
2.2e+00
cases:11.70%
controls:2.16%
cases:18.74%
controls:1.07%
cases:2.35%
controls:0.16%
cases:0.25%
controls:0.02%
cases:1.69%
controls:0.16%
cases:8.90%
controls:1.08%
cases:23.31%
controls:3.40%
608
1121
4589
50821
974
555
4223
51387
122
81
5075
51861
13
11
5184
51931
87
83
5070
51628
432
528
4420
48243
857
1275
2820
36262
Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
33203-1 [3042810]
2.8e+00
4.9e+00
1.0e+50
1.0e+50
1.0e+50
5.7e+00
3.4e+00
cases:1.04%
controls:0.07%
cases:2.02%
controls:0.02%
cases:0.35%
controls:0.00%
cases:0.42%
controls:0.00%
cases:1.09%
controls:0.00%
cases:2.82%
controls:0.01%
cases:1.28%
controls:0.04%
54
34
5143
51908
105
8
5092
51934
18
0
5179
51942
22
0
5175
51942
56
0
5101
51711
137
5
4715
48766
47
16
3630
37521
Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
72260-3 [43055225]
2.7e+00
4.9e+00
1.0e+50
1.0e+50
1.0e+50
5.7e+00
3.4e+00
cases:1.04%
controls:0.07%
cases:2.00%
controls:0.02%
cases:0.35%
controls:0.00%
cases:0.42%
controls:0.00%
cases:1.11%
controls:0.00%
cases:2.82%
controls:0.01%
cases:1.28%
controls:0.04%
54
35
5143
51907
104
8
5093
51934
18
0
5179
51942
22
0
5175
51942
57
0
5100
51711
137
5
4715
48766
47
16
3630
37521
Tau protein [Mass/volume] in Cerebral spinal fluid
30160-6 [3000242]
2.7e+00
4.9e+00
1.0e+50
1.0e+50
1.0e+50
5.7e+00
3.4e+00
cases:1.02%
controls:0.07%
cases:2.00%
controls:0.02%
cases:0.33%
controls:0.00%
cases:0.42%
controls:0.00%
cases:1.09%
controls:0.00%
cases:2.82%
controls:0.01%
cases:1.25%
controls:0.04%
53
35
5144
51907
104
8
5093
51934
17
0
5180
51942
22
0
5175
51942
56
0
5101
51711
137
5
4715
48766
46
16
3631
37521
Delusional disorder
F22.0 [45581451]
2.0e+00
2.8e+00
3.2e+00
—
2.9e+00
3.0e+00
2.5e+00
cases:0.60%
controls:0.08%
cases:0.81%
controls:0.05%
cases:0.48%
controls:0.02%
—
—
cases:0.27%
controls:0.02%
cases:0.85%
controls:0.04%
cases:1.39%
controls:0.11%
31
44
5166
51898
42
26
5155
51916
25
10
5172
51932
—
14
8
5143
51703
41
21
4811
48750
51
42
3626
37495
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
1.8e+00
2.2e+00
2.1e+00
3.7e+00
2.2e+00
2.1e+00
2.0e+00
cases:1.56%
controls:0.25%
cases:1.14%
controls:0.13%
cases:0.40%
controls:0.05%
cases:0.40%
controls:0.01%
cases:0.43%
controls:0.05%
cases:1.05%
controls:0.13%
cases:2.26%
controls:0.33%
81
130
5116
51812
59
68
5138
51874
21
25
5176
51917
21
5
5176
51937
22
24
5135
51687
51
63
4801
48708
83
122
3594
37415
Disorientation, unspecified
R41.0 [45558469]
1.7e+00
2.7e+00
4.3e+00
1.0e+50
3.1e+00
2.1e+00
2.0e+00
cases:1.17%
controls:0.22%
cases:1.35%
controls:0.09%
cases:0.73%
controls:0.01%
cases:0.46%
controls:0.00%
cases:0.31%
controls:0.01%
cases:1.11%
controls:0.14%
cases:2.77%
controls:0.39%
61
113
5136
51829
70
48
5127
51894
38
5
5159
51937
24
0
5173
51942
16
7
5141
51704
54
68
4798
48703
102
148
3575
37389
Sequelae of intracranial injury
T90.5 [45537098]
2.3e+00
3.2e+00
3.6e+00
—
—
3.3e+00
3.2e+00
cases:0.81%
controls:0.08%
cases:0.87%
controls:0.04%
cases:0.35%
controls:0.01%
—
—
—
—
cases:1.32%
controls:0.05%
cases:2.18%
controls:0.09%
42
44
5155
51898
45
19
5152
51923
18
5
5179
51937
—
—
64
23
4788
48748
80
33
3597
37504
Bipolar affective disorder, unspecified
F31.9 [45571758]
2.1e+00
2.4e+00
3.2e+00
1.0e+50
2.6e+00
2.8e+00
2.4e+00
cases:1.29%
controls:0.17%
cases:0.98%
controls:0.09%
cases:0.44%
controls:0.02%
cases:0.48%
controls:0.00%
cases:0.23%
controls:0.02%
cases:1.22%
controls:0.07%
cases:2.28%
controls:0.21%
67
87
5130
51855
51
48
5146
51894
23
9
5174
51933
25
0
5172
51942
12
9
5145
51702
59
35
4793
48736
84
77
3593
37460
risperidone; oral, parenteral
N05AX08 [21604559]
1.8e+00
2.2e+00
2.7e+00
—
3.0e+00
2.9e+00
2.8e+00
cases:3.46%
controls:0.59%
cases:3.83%
controls:0.42%
cases:2.35%
controls:0.17%
—
—
cases:3.47%
controls:0.17%
cases:7.56%
controls:0.43%
cases:13.35%
controls:0.96%
180
304
5017
51638
199
218
4998
51724
122
88
5075
51854
—
179
90
4978
51621
367
209
4485
48562
491
359
3186
37178
Bipolar affective disorder, current episode severe depression without psychotic symptoms
F31.4 [45581456]
1.9e+00
2.5e+00
3.0e+00
1.0e+50
2.4e+00
2.9e+00
2.6e+00
cases:0.54%
controls:0.08%
cases:0.38%
controls:0.03%
cases:0.23%
controls:0.01%
cases:0.10%
controls:0.00%
cases:0.16%
controls:0.01%
cases:0.45%
controls:0.02%
cases:0.82%
controls:0.06%
28
41
5169
51901
20
17
5177
51925
12
6
5185
51936
5
0
5192
51942
8
7
5149
51704
22
12
4830
48759
30
24
3647
37513
rivastigmine; oral, transdermal
N06DA03 [21604796]
3.5e+00
—
1.0e+50
1.0e+50
—
6.1e+00
5.4e+00
cases:0.52%
controls:0.02%
—
—
cases:0.42%
controls:0.00%
cases:0.23%
controls:0.00%
—
—
cases:5.23%
controls:0.01%
cases:11.01%
controls:0.06%
27
8
5170
51934
—
22
0
5175
51942
12
0
5185
51942
—
254
6
4598
48765
405
21
3272
37516
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
1.9e+00
2.4e+00
2.6e+00
1.0e+50
2.8e+00
2.7e+00
2.1e+00
cases:0.73%
controls:0.11%
cases:0.50%
controls:0.05%
cases:0.21%
controls:0.02%
cases:0.21%
controls:0.00%
cases:0.23%
controls:0.01%
cases:0.49%
controls:0.03%
cases:0.95%
controls:0.11%
38
58
5159
51884
26
24
5171
51918
11
8
5186
51934
11
0
5186
51942
12
7
5145
51704
24
17
4828
48754
35
43
3642
37494
Recurrent depressive disorder, unspecified
F33.9 [45581458]
1.8e+00
2.4e+00
2.9e+00
—
3.0e+00
2.5e+00
1.9e+00
cases:1.33%
controls:0.22%
cases:1.04%
controls:0.09%
cases:0.37%
controls:0.02%
—
—
cases:0.41%
controls:0.02%
cases:1.28%
controls:0.10%
cases:1.77%
controls:0.26%
69
115
5128
51827
54
49
5143
51893
19
11
5178
51931
—
21
11
5136
51700
62
50
4790
48721
65
97
3612
37440
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.7e+00
2.5e+00
3.1e+00
—
2.7e+00
2.5e+00
1.9e+00
cases:3.02%
controls:0.57%
cases:2.33%
controls:0.19%
cases:0.94%
controls:0.04%
—
—
cases:0.72%
controls:0.05%
cases:2.39%
controls:0.20%
cases:3.64%
controls:0.57%
157
296
5040
51646
121
99
5076
51843
49
23
5148
51919
—
37
25
5120
51686
116
96
4736
48675
134
213
3543
37324
quetiapine; oral
N05AH04 [21604544]
1.5e+00
1.8e+00
2.1e+00
3.0e+00
2.0e+00
2.0e+00
2.0e+00
cases:9.45%
controls:2.30%
cases:9.04%
controls:1.69%
cases:3.98%
controls:0.52%
cases:0.63%
controls:0.03%
cases:4.03%
controls:0.56%
cases:12.14%
controls:1.78%
cases:19.50%
controls:3.04%
491
1193
4706
50749
470
876
4727
51066
207
268
4990
51674
33
17
5164
51925
208
291
4949
51420
589
868
4263
47903
717
1140
2960
36397
haloperidol; oral, parenteral
N05AD01 [21604516]
2.0e+00
2.1e+00
2.7e+00
—
3.0e+00
2.3e+00
2.2e+00
cases:1.10%
controls:0.14%
cases:0.69%
controls:0.08%
cases:0.23%
controls:0.02%
—
—
cases:0.47%
controls:0.02%
cases:1.11%
controls:0.11%
cases:1.79%
controls:0.20%
57
75
5140
51867
36
43
5161
51899
12
8
5185
51934
—
24
12
5133
51699
54
56
4798
48715
66
75
3611
37462
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
2.3e+00
3.2e+00
3.4e+00
1.0e+50
—
2.8e+00
2.5e+00
cases:1.08%
controls:0.11%
cases:0.83%
controls:0.03%
cases:0.38%
controls:0.01%
cases:0.33%
controls:0.00%
—
—
cases:0.72%
controls:0.04%
cases:1.31%
controls:0.10%
56
59
5141
51883
43
17
5154
51925
20
7
5177
51935
17
0
5180
51942
—
35
21
4817
48750
48
39
3629
37498
Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]
1.4e+00
2.0e+00
2.3e+00
—
3.7e+00
2.5e+00
2.4e+00
cases:1.15%
controls:0.28%
cases:1.15%
controls:0.16%
cases:0.25%
controls:0.03%
—
—
cases:0.60%
controls:0.02%
cases:1.81%
controls:0.16%
cases:3.62%
controls:0.35%
60
145
5137
51797
60
83
5137
51859
13
13
5184
51929
—
31
8
5126
51703
88
76
4764
48695
133
133
3544
37404
lithium; oral
N05AN01 [21604556]
2.1e+00
2.3e+00
2.1e+00
—
2.8e+00
2.3e+00
2.4e+00
cases:1.37%
controls:0.16%
cases:1.19%
controls:0.12%
cases:0.40%
controls:0.05%
—
—
cases:0.48%
controls:0.03%
cases:1.32%
controls:0.13%
cases:1.79%
controls:0.16%
71
85
5126
51857
62
61
5135
51881
21
26
5176
51916
—
25
15
5132
51696
64
65
4788
48706
66
61
3611
37476
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
1.7e+00
3.2e+00
3.8e+00
1.0e+50
—
3.5e+00
1.7e+00
cases:1.54%
controls:0.29%
cases:1.89%
controls:0.08%
cases:0.42%
controls:0.01%
cases:0.38%
controls:0.00%
—
—
cases:2.72%
controls:0.08%
cases:1.88%
controls:0.33%
80
150
5117
51792
98
40
5099
51902
22
5
5175
51937
20
0
5177
51942
—
132
40
4720
48731
69
125
3608
37412
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
1.7e+00
3.2e+00
3.8e+00
1.0e+50
—
3.5e+00
1.7e+00
cases:1.54%
controls:0.29%
cases:1.87%
controls:0.08%
cases:0.42%
controls:0.01%
cases:0.40%
controls:0.00%
—
—
cases:2.76%
controls:0.08%
cases:1.88%
controls:0.34%
80
150
5117
51792
97
41
5100
51901
22
5
5175
51937
21
0
5176
51942
—
134
40
4718
48731
69
127
3608
37410
Dementia
P70 [2002000864]
1.8e+00
1.7e+00
—
—
2.3e+00
4.2e+00
3.8e+00
cases:0.35%
controls:0.06%
cases:0.17%
controls:0.03%
—
—
—
—
cases:0.12%
controls:0.01%
cases:1.32%
controls:0.02%
cases:5.85%
controls:0.13%
18
29
5179
51913
9
16
5188
51926
—
—
6
6
5151
51705
64
10
4788
48761
215
50
3462
37487
Office Visit
OMOP4822458 [581477]
5.4e-01
1.0e+00
2.2e+00
5.9e+00
2.2e+00
1.2e+00
7.0e-01
cases:14.97%
controls:9.33%
cases:6.81%
controls:2.50%
cases:3.06%
controls:0.36%
cases:3.54%
controls:0.01%
cases:2.83%
controls:0.31%
cases:7.38%
controls:2.30%
cases:12.27%
controls:6.47%
778
4846
4419
47096
354
1300
4843
50642
159
186
5038
51756
184
5
5013
51937
146
159
5011
51552
358
1124
4494
47647
451
2427
3226
35110
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
1.8e+00
2.6e+00
2.6e+00
—
2.6e+00
2.3e+00
1.9e+00
cases:2.23%
controls:0.38%
cases:1.79%
controls:0.14%
cases:0.71%
controls:0.05%
—
—
cases:0.60%
controls:0.04%
cases:1.48%
controls:0.16%
cases:2.58%
controls:0.38%
116
197
5081
51745
93
73
5104
51869
37
27
5160
51915
—
31
23
5126
51688
72
76
4780
48695
95
142
3582
37395
Depressive episode, unspecified
F32.9 [45571760]
1.6e+00
2.5e+00
2.9e+00
—
3.1e+00
2.1e+00
1.6e+00
cases:4.75%
controls:0.98%
cases:3.96%
controls:0.34%
cases:1.39%
controls:0.08%
—
—
cases:1.47%
controls:0.07%
cases:3.42%
controls:0.43%
cases:6.17%
controls:1.33%
247
511
4950
51431
206
175
4991
51767
72
41
5125
51901
—
76
35
5081
51676
166
212
4686
48559
227
499
3450
37038
Other Alzheimer disease
G30.8 [45605532]
2.0e+00
2.2e+00
—
—
1.0e+50
4.8e+00
4.7e+00
cases:0.12%
controls:0.02%
cases:0.13%
controls:0.02%
—
—
—
—
cases:0.12%
controls:0.00%
cases:1.42%
controls:0.01%
cases:4.73%
controls:0.05%
6
8
5191
51934
7
8
5190
51934
—
—
6
0
5151
51711
69
6
4783
48765
174
17
3503
37520
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
1.7e+00
2.1e+00
2.7e+00
1.0e+50
2.4e+00
2.4e+00
2.3e+00
cases:1.29%
controls:0.23%
cases:1.08%
controls:0.13%
cases:0.50%
controls:0.03%
cases:0.50%
controls:0.00%
cases:0.41%
controls:0.04%
cases:1.38%
controls:0.13%
cases:2.61%
controls:0.27%
67
121
5130
51821
56
66
5141
51876
26
18
5171
51924
26
0
5171
51942
21
20
5136
51691
67
62
4785
48709
96
101
3581
37436
Psychiatric monitoring contact
IGY02 [2001304322]
1.7e+00
2.2e+00
2.0e+00
1.0e+50
3.2e+00
2.6e+00
1.8e+00
cases:0.54%
controls:0.09%
cases:0.79%
controls:0.09%
cases:0.29%
controls:0.04%
cases:0.25%
controls:0.00%
cases:0.52%
controls:0.02%
cases:1.34%
controls:0.10%
cases:1.36%
controls:0.23%
28
49
5169
51893
41
48
5156
51894
15
20
5182
51922
13
0
5184
51942
27
11
5130
51700
65
47
4787
48724
50
85
3627
37452
clobazam; oral
N05BA09 [21604574]
2.6e+00
2.5e+00
—
—
2.7e+00
2.7e+00
3.1e+00
cases:0.42%
controls:0.03%
cases:0.40%
controls:0.03%
—
—
—
—
cases:0.19%
controls:0.01%
cases:0.52%
controls:0.03%
cases:0.82%
controls:0.04%
22
17
5175
51925
21
18
5176
51924
—
—
10
7
5147
51704
25
17
4827
48754
30
14
3647
37523
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
1.6e+00
1.8e+00
2.7e+00
—
2.6e+00
2.6e+00
2.1e+00
cases:0.58%
controls:0.12%
cases:0.21%
controls:0.04%
cases:0.17%
controls:0.01%
—
—
cases:0.21%
controls:0.02%
cases:0.37%
controls:0.03%
cases:0.41%
controls:0.05%
30
60
5167
51882
11
19
5186
51923
9
6
5188
51936
—
11
8
5146
51703
18
14
4834
48757
15
18
3662
37519
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
1.6e+00
2.1e+00
2.0e+00
—
3.0e+00
2.8e+00
2.0e+00
cases:0.67%
controls:0.14%
cases:0.83%
controls:0.10%
cases:0.31%
controls:0.04%
—
—
cases:0.56%
controls:0.03%
cases:1.40%
controls:0.09%
cases:1.71%
controls:0.25%
35
72
5162
51870
43
53
5154
51889
16
22
5181
51920
—
29
15
5128
51696
68
44
4784
48727
63
92
3614
37445
Neuropsychological investigation
XA800 [2001300412]
2.4e+00
3.8e+00
—
—
—
4.1e+00
2.8e+00
cases:2.64%
controls:0.24%
cases:2.98%
controls:0.07%
—
—
—
—
—
—
cases:4.04%
controls:0.07%
cases:3.29%
controls:0.20%
137
123
5060
51819
155
34
5042
51908
—
—
—
196
33
4656
48738
121
75
3556
37462
Severe psychotic and other severe mental disorders
112 [2001600112]
2.4e+00
3.7e+00
—
—
—
4.1e+00
2.9e+00
cases:1.67%
controls:0.15%
cases:0.96%
controls:0.03%
—
—
—
—
—
—
cases:1.90%
controls:0.03%
cases:2.34%
controls:0.13%
87
80
5110
51862
50
13
5147
51929
—
—
—
92
15
4760
48756
86
47
3591
37490
lacosamide; oral, parenteral
N03AX18 [21604440]
2.3e+00
2.5e+00
1.8e+00
—
2.1e+00
2.2e+00
2.1e+00
cases:0.38%
controls:0.04%
cases:0.48%
controls:0.04%
cases:0.13%
controls:0.02%
—
—
cases:0.19%
controls:0.02%
cases:0.54%
controls:0.06%
cases:0.76%
controls:0.10%
20
20
5177
51922
25
21
5172
51921
7
12
5190
51930
—
10
12
5147
51699
26
28
4826
48743
28
36
3649
37501
Hospital outpatient
ZY010 [2001311599]
9.4e-01
2.0e+00
2.7e+00
—
3.2e+00
2.2e+00
1.7e+00
cases:0.98%
controls:0.39%
cases:1.10%
controls:0.14%
cases:0.54%
controls:0.03%
—
—
cases:0.80%
controls:0.03%
cases:1.50%
controls:0.17%
cases:2.42%
controls:0.44%
51
200
5146
51742
57
75
5140
51867
28
18
5169
51924
—
41
17
5116
51694
73
85
4779
48686
89
167
3588
37370
olanzapine; oral, parenteral
N05AH03 [21604543]
1.7e+00
2.1e+00
1.9e+00
—
2.3e+00
2.4e+00
2.4e+00
cases:3.41%
controls:0.63%
cases:3.48%
controls:0.46%
cases:1.44%
controls:0.21%
—
—
cases:2.02%
controls:0.21%
cases:5.21%
controls:0.49%
cases:7.51%
controls:0.75%
177
326
5020
51616
181
240
5016
51702
75
108
5122
51834
—
104
110
5053
51601
253
237
4599
48534
276
282
3401
37255
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 [2000502142]
1.7e+00
1.9e+00
2.4e+00
—
2.8e+00
1.9e+00
2.0e+00
cases:0.96%
controls:0.18%
cases:0.79%
controls:0.12%
cases:0.27%
controls:0.03%
—
—
cases:0.21%
controls:0.01%
cases:0.93%
controls:0.13%
cases:1.77%
controls:0.23%
50
96
5147
51846
41
60
5156
51882
14
13
5183
51929
—
11
7
5146
51704
45
65
4807
48706
65
87
3612
37450
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
F00.20*G30.8 [2000501580]
—
2.9e+00
—
1.0e+50
1.0e+50
5.0e+00
4.7e+00
—
—
cases:0.17%
controls:0.01%
—
—
cases:0.13%
controls:0.00%
cases:0.21%
controls:0.00%
cases:2.35%
controls:0.02%
cases:5.77%
controls:0.05%
—
9
5
5188
51937
—
7
0
5190
51942
11
0
5146
51711
114
8
4738
48763
212
20
3465
37517
lamotrigine; oral
N03AX09 [21604431]
1.7e+00
1.9e+00
2.2e+00
—
2.4e+00
2.2e+00
2.2e+00
cases:1.73%
controls:0.31%
cases:1.33%
controls:0.21%
cases:0.46%
controls:0.05%
—
—
cases:0.60%
controls:0.05%
cases:1.65%
controls:0.19%
cases:2.96%
controls:0.35%
90
161
5107
51781
69
109
5128
51833
24
27
5173
51915
—
31
28
5126
51683
80
93
4772
48678
109
130
3568
37407
Normal-pressure hydrocephalus
G91.2 [45547765]
1.4e+00
2.0e+00
2.0e+00
1.0e+50
2.3e+00
2.4e+00
2.4e+00
cases:0.87%
controls:0.22%
cases:0.94%
controls:0.13%
cases:0.21%
controls:0.03%
cases:0.69%
controls:0.00%
cases:0.31%
controls:0.03%
cases:1.38%
controls:0.13%
cases:2.20%
controls:0.20%
45
114
5152
51828
49
68
5148
51874
11
15
5186
51927
36
0
5161
51942
16
16
5141
51695
67
62
4785
48709
81
76
3596
37461
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
1.7e+00
1.9e+00
2.1e+00
—
2.1e+00
2.2e+00
2.4e+00
cases:3.68%
controls:0.70%
cases:3.58%
controls:0.55%
cases:1.62%
controls:0.20%
—
—
cases:1.47%
controls:0.17%
cases:4.84%
controls:0.55%
cases:7.51%
controls:0.74%
191
362
5006
51580
186
285
5011
51657
84
103
5113
51839
—
76
90
5081
51621
235
269
4617
48502
276
279
3401
37258
Poisoning by systemic antibiotics
T36 [45756588]
1.8e+00
2.7e+00
3.4e+00
—
—
2.4e+00
2.2e+00
cases:1.21%
controls:0.21%
cases:0.79%
controls:0.06%
cases:0.35%
controls:0.01%
—
—
—
—
cases:0.64%
controls:0.06%
cases:1.99%
controls:0.21%
63
110
5134
51832
41
29
5156
51913
18
6
5179
51936
—
—
31
29
4821
48742
73
80
3604
37457
Sequelae of cerebral infarction
I69.3 [45533476]
5.7e-01
1.2e+00
1.5e+00
5.0e+00
1.7e+00
1.4e+00
1.0e+00
cases:2.94%
controls:1.68%
cases:3.02%
controls:0.89%
cases:0.87%
controls:0.19%
cases:2.67%
controls:0.02%
cases:1.03%
controls:0.20%
cases:4.00%
controls:1.06%
cases:6.69%
controls:2.57%
153
875
5044
51067
157
464
5040
51478
45
100
5152
51842
139
10
5058
51932
53
101
5104
51610
194
519
4658
48252
246
963
3431
36574
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
1.8e+00
2.1e+00
2.3e+00
—
2.2e+00
2.2e+00
1.6e+00
cases:2.41%
controls:0.41%
cases:1.48%
controls:0.18%
cases:0.50%
controls:0.05%
—
—
cases:0.50%
controls:0.06%
cases:1.55%
controls:0.18%
cases:2.37%
controls:0.48%
125
214
5072
51728
77
95
5120
51847
26
26
5171
51916
—
26
29
5131
51682
75
86
4777
48685
87
181
3590
37356
Epilepsy, unspecified
G40.9 [45562083]
1.4e+00
2.1e+00
2.6e+00
—
2.3e+00
1.9e+00
1.8e+00
cases:1.58%
controls:0.38%
cases:1.27%
controls:0.15%
cases:0.40%
controls:0.03%
—
—
cases:0.43%
controls:0.04%
cases:1.24%
controls:0.18%
cases:2.77%
controls:0.45%
82
197
5115
51745
66
78
5131
51864
21
16
5176
51926
—
22
23
5135
51688
60
90
4792
48681
102
168
3575
37369
Other bipolar affective disorders
F31.8 [45586237]
1.9e+00
1.9e+00
2.0e+00
—
2.2e+00
2.0e+00
2.2e+00
cases:0.63%
controls:0.10%
cases:0.37%
controls:0.06%
cases:0.17%
controls:0.02%
—
—
cases:0.19%
controls:0.02%
cases:0.41%
controls:0.06%
cases:0.98%
controls:0.11%
33
51
5164
51891
19
29
5178
51913
9
12
5188
51930
—
10
11
5147
51700
20
28
4832
48743
36
41
3641
37496
Lithium [Moles/volume] in Serum or Plasma
14334-7 [3024666]
2.1e+00
2.4e+00
2.5e+00
—
—
2.3e+00
2.8e+00
cases:0.65%
controls:0.08%
cases:0.63%
controls:0.06%
cases:0.27%
controls:0.02%
—
—
—
—
cases:0.80%
controls:0.08%
cases:1.41%
controls:0.09%
34
42
5163
51900
33
30
5164
51912
14
12
5183
51930
—
—
39
38
4813
48733
52
33
3625
37504
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
1.2e+00
2.2e+00
2.6e+00
—
3.0e+00
1.8e+00
1.3e+00
cases:2.60%
controls:0.81%
cases:2.10%
controls:0.23%
cases:0.54%
controls:0.04%
—
—
cases:0.41%
controls:0.02%
cases:1.44%
controls:0.24%
cases:2.88%
controls:0.80%
135
423
5062
51519
109
122
5088
51820
28
20
5169
51922
—
21
11
5136
51700
70
118
4782
48653
106
301
3571
37236
Schizophrenia, unspecified
F20.9 [45576533]
1.3e+00
2.0e+00
2.7e+00
1.0e+50
2.5e+00
2.0e+00
1.5e+00
cases:0.62%
controls:0.17%
cases:0.46%
controls:0.06%
cases:0.17%
controls:0.01%
cases:0.13%
controls:0.00%
cases:0.14%
controls:0.01%
cases:0.52%
controls:0.07%
cases:0.76%
controls:0.17%
32
89
5165
51853
24
32
5173
51910
9
6
5188
51936
7
0
5190
51942
7
6
5150
51705
25
33
4827
48738
28
63
3649
37474
clozapine; oral, parenteral
N05AH02 [21604542]
1.8e+00
1.9e+00
1.7e+00
—
1.7e+00
2.3e+00
2.5e+00
cases:0.90%
controls:0.15%
cases:0.90%
controls:0.13%
cases:0.62%
controls:0.11%
—
—
cases:0.60%
controls:0.11%
cases:1.42%
controls:0.14%
cases:1.82%
controls:0.15%
47
77
5150
51865
47
70
5150
51872
32
58
5165
51884
—
31
57
5126
51654
69
68
4783
48703
67
58
3610
37479
Personality disorder, unspecified
F60.9 [45538076]
2.4e+00
3.3e+00
—
1.0e+50
—
3.4e+00
2.9e+00
cases:0.29%
controls:0.03%
cases:0.25%
controls:0.01%
—
—
cases:0.12%
controls:0.00%
—
—
cases:0.35%
controls:0.01%
cases:0.54%
controls:0.03%
15
14
5182
51928
13
5
5184
51937
—
6
0
5191
51942
—
17
6
4835
48765
20
11
3657
37526
Progressive vascular leukoencephalopathy
I67.3 [45538402]
1.2e+00
1.5e+00
2.3e+00
1.0e+50
2.5e+00
2.7e+00
1.7e+00
cases:0.37%
controls:0.11%
cases:0.31%
controls:0.07%
cases:0.15%
controls:0.02%
cases:0.73%
controls:0.00%
cases:0.33%
controls:0.03%
cases:1.22%
controls:0.08%
cases:1.50%
controls:0.29%
19
56
5178
51886
16
37
5181
51905
8
8
5189
51934
38
0
5159
51942
17
14
5140
51697
59
40
4793
48731
55
108
3622
37429
escitalopram; oral
N06AB10 [21604718]
1.1e+00
1.4e+00
1.3e+00
3.6e+00
1.7e+00
1.4e+00
1.4e+00
cases:7.14%
controls:2.58%
cases:5.95%
controls:1.60%
cases:1.69%
controls:0.49%
cases:0.58%
controls:0.02%
cases:2.19%
controls:0.40%
cases:6.70%
controls:1.69%
cases:11.12%
controls:2.96%
371
1338
4826
50604
309
832
4888
51110
88
254
5109
51688
30
8
5167
51934
113
209
5044
51502
325
824
4527
47947
409
1110
3268
36427
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
1.6e+00
2.1e+00
2.1e+00
—
2.2e+00
2.0e+00
1.9e+00
cases:1.39%
controls:0.29%
cases:1.02%
controls:0.13%
cases:0.31%
controls:0.04%
—
—
cases:0.29%
controls:0.03%
cases:0.89%
controls:0.12%
cases:2.09%
controls:0.33%
72
153
5125
51789
53
65
5144
51877
16
19
5181
51923
—
15
17
5142
51694
43
59
4809
48712
77
124
3600
37413
Lumbar puncture
TAB00 [2001300538]
1.8e+00
3.8e+00
—
1.0e+50
1.0e+50
4.1e+00
2.2e+00
cases:1.60%
controls:0.27%
cases:2.27%
controls:0.05%
—
—
cases:0.73%
controls:0.00%
cases:1.55%
controls:0.00%
cases:3.15%
controls:0.06%
cases:1.28%
controls:0.15%
83
142
5114
51800
118
27
5079
51915
—
38
0
5159
51942
80
0
5077
51711
153
27
4699
48744
47
55
3630
37482
Social worker
Z2446 [2001311559]
7.9e-01
1.9e+00
2.9e+00
1.0e+50
2.8e+00
2.1e+00
1.3e+00
cases:1.37%
controls:0.62%
cases:1.12%
controls:0.16%
cases:0.25%
controls:0.01%
cases:0.54%
controls:0.00%
cases:0.37%
controls:0.02%
cases:1.07%
controls:0.14%
cases:1.55%
controls:0.42%
71
324
5126
51618
58
85
5139
51857
13
7
5184
51935
28
0
5169
51942
19
12
5138
51699
52
67
4800
48704
57
158
3620
37379
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
1.1e+00
2.0e+00
3.2e+00
—
2.7e+00
1.5e+00
1.1e+00
cases:0.83%
controls:0.26%
cases:0.75%
controls:0.10%
cases:0.38%
controls:0.02%
—
—
cases:0.33%
controls:0.02%
cases:0.70%
controls:0.15%
cases:1.69%
controls:0.55%
43
137
5154
51805
39
53
5158
51889
20
8
5177
51934
—
17
11
5140
51700
34
73
4818
48698
62
208
3615
37329
Diffuse brain injury
S06.2 [45592516]
2.3e+00
3.8e+00
—
1.0e+50
1.0e+50
3.0e+00
2.6e+00
cases:0.42%
controls:0.04%
cases:0.52%
controls:0.01%
—
—
cases:0.17%
controls:0.00%
cases:0.19%
controls:0.00%
cases:0.56%
controls:0.03%
cases:0.54%
controls:0.04%
22
22
5175
51920
27
6
5170
51936
—
9
0
5188
51942
10
0
5147
51711
27
13
4825
48758
20
16
3657
37521
Functional capacity evaluation
443351003 [40481051]
5.7e-01
1.3e+00
1.5e+00
3.8e+00
1.5e+00
1.5e+00
1.4e+00
cases:5.89%
controls:3.43%
cases:5.60%
controls:1.52%
cases:1.75%
controls:0.38%
cases:2.60%
controls:0.06%
cases:1.75%
controls:0.40%
cases:7.50%
controls:1.72%
cases:16.02%
controls:4.50%
306
1783
4891
50159
291
792
4906
51150
91
197
5106
51745
135
30
5062
51912
90
207
5067
51504
364
840
4488
47931
589
1689
3088
35848
Inpatient Hospital
21 [8717]
6.0e-01
9.5e-01
1.6e+00
5.0e+00
1.5e+00
9.8e-01
8.4e-01
cases:48.66%
controls:34.27%
cases:24.90%
controls:11.38%
cases:8.31%
controls:1.75%
cases:11.89%
controls:0.09%
cases:7.21%
controls:1.67%
cases:24.32%
controls:10.73%
cases:42.07%
controls:23.88%
2529
17799
2668
34143
1294
5913
3903
46029
432
908
4765
51034
618
45
4579
51897
372
862
4785
50849
1180
5231
3672
43540
1547
8963
2130
28574
Complex partial seizures with only alteration of consciousness
G40.20 [2000502139]
1.7e+00
2.4e+00
—
1.0e+50
2.5e+00
2.4e+00
2.5e+00
cases:0.54%
controls:0.10%
cases:0.38%
controls:0.04%
—
—
cases:0.17%
controls:0.00%
cases:0.12%
controls:0.01%
cases:0.39%
controls:0.03%
cases:0.87%
controls:0.07%
28
51
5169
51891
20
19
5177
51923
—
9
0
5188
51942
6
5
5151
51706
19
17
4833
48754
32
26
3645
37511
Bipolar affective disorder, currently in remission
F31.7 [45581457]
1.6e+00
1.5e+00
1.8e+00
—
2.2e+00
2.1e+00
2.2e+00
cases:0.75%
controls:0.15%
cases:0.38%
controls:0.08%
cases:0.19%
controls:0.03%
—
—
cases:0.17%
controls:0.02%
cases:0.58%
controls:0.07%
cases:1.31%
controls:0.14%
39
76
5158
51866
20
43
5177
51899
10
17
5187
51925
—
9
10
5148
51701
28
35
4824
48736
48
54
3629
37483
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
1.1e+00
2.1e+00
3.2e+00
—
1.9e+00
1.8e+00
1.5e+00
cases:2.33%
controls:0.82%
cases:1.96%
controls:0.25%
cases:0.50%
controls:0.02%
—
—
cases:0.25%
controls:0.04%
cases:1.17%
controls:0.20%
cases:2.96%
controls:0.69%
121
424
5076
51518
102
131
5095
51811
26
11
5171
51931
—
13
20
5144
51691
57
96
4795
48675
109
259
3568
37278
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
2.3e+00
2.9e+00
—
1.0e+50
—
3.7e+00
2.5e+00
cases:0.42%
controls:0.04%
cases:0.46%
controls:0.03%
—
—
cases:0.21%
controls:0.00%
—
—
cases:0.49%
controls:0.01%
cases:0.71%
controls:0.06%
22
22
5175
51920
24
13
5173
51929
—
11
0
5186
51942
—
24
6
4828
48765
26
22
3651
37515
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
1.4e+00
1.9e+00
2.6e+00
1.0e+50
2.2e+00
1.7e+00
1.6e+00
cases:2.60%
controls:0.63%
cases:1.31%
controls:0.21%
cases:0.42%
controls:0.03%
cases:0.58%
controls:0.00%
cases:0.37%
controls:0.04%
cases:1.28%
controls:0.24%
cases:3.10%
controls:0.62%
135
326
5062
51616
68
107
5129
51835
22
17
5175
51925
30
0
5167
51942
19
22
5138
51689
62
118
4790
48653
114
233
3563
37304
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
F00.10*G30.1 [2000501573]
—
—
—
1.0e+50
—
5.7e+00
5.6e+00
—
—
—
—
—
—
cases:0.12%
controls:0.00%
—
—
cases:3.01%
controls:0.01%
cases:8.89%
controls:0.04%
—
—
—
6
0
5191
51942
—
146
5
4706
48766
327
14
3350
37523
Psychologist
Z2445 [2001311558]
1.8e+00
3.0e+00
—
—
—
3.8e+00
2.6e+00
cases:1.10%
controls:0.19%
cases:0.94%
controls:0.05%
—
—
—
—
—
—
cases:1.61%
controls:0.04%
cases:1.63%
controls:0.13%
57
98
5140
51844
49
25
5148
51917
—
—
—
78
18
4774
48753
60
47
3617
37490
Communicating hydrocephalus
G91.0 [45533173]
1.8e+00
3.0e+00
—
1.0e+50
1.0e+50
3.4e+00
3.0e+00
cases:0.29%
controls:0.05%
cases:0.23%
controls:0.01%
—
—
cases:0.13%
controls:0.00%
cases:0.16%
controls:0.00%
cases:0.35%
controls:0.01%
cases:0.57%
controls:0.03%
15
25
5182
51917
12
6
5185
51936
—
7
0
5190
51942
8
0
5149
51711
17
6
4835
48765
21
11
3656
37526
Psychological sympt/compl other
P29 [2002000823]
1.4e+00
1.6e+00
2.6e+00
—
2.2e+00
1.9e+00
1.4e+00
cases:1.67%
controls:0.43%
cases:0.90%
controls:0.18%
cases:0.42%
controls:0.03%
—
—
cases:0.35%
controls:0.04%
cases:1.28%
controls:0.19%
cases:2.69%
controls:0.66%
87
221
5110
51721
47
91
5150
51851
22
17
5175
51925
—
18
21
5139
51690
62
91
4790
48680
99
248
3578
37289
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
7.8e-01
1.8e+00
2.1e+00
2.8e+00
2.3e+00
6.6e-01
7.0e-01
cases:10.20%
controls:4.96%
cases:16.07%
controls:3.17%
cases:3.08%
controls:0.40%
cases:0.23%
controls:0.01%
cases:3.41%
controls:0.36%
cases:7.11%
controls:3.80%
cases:21.68%
controls:12.09%
530
2575
4667
49367
835
1644
4362
50298
160
210
5037
51732
12
7
5185
51935
176
188
4981
51523
345
1853
4507
46918
797
4539
2880
32998
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
6.3e-01
1.5e+00
2.5e+00
1.0e+50
2.7e+00
2.0e+00
1.7e+00
cases:0.98%
controls:0.53%
cases:0.79%
controls:0.18%
cases:0.29%
controls:0.02%
cases:0.40%
controls:0.00%
cases:0.39%
controls:0.03%
cases:0.95%
controls:0.13%
cases:1.44%
controls:0.26%
51
274
5146
51668
41
94
5156
51848
15
12
5182
51930
21
0
5176
51942
20
14
5137
51697
46
61
4806
48710
53
96
3624
37441
disulfiram; oral
N07BB01 [21604821]
1.5e+00
2.4e+00
—
—
3.0e+00
2.3e+00
1.8e+00
cases:1.33%
controls:0.30%
cases:0.87%
controls:0.08%
—
—
—
—
cases:0.27%
controls:0.01%
cases:0.91%
controls:0.09%
cases:1.58%
controls:0.25%
69
155
5128
51787
45
41
5152
51901
—
—
14
7
5143
51704
44
45
4808
48726
58
95
3619
37442
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
1.1e+00
2.2e+00
2.8e+00
1.0e+50
1.8e+00
1.9e+00
1.2e+00
cases:2.96%
controls:0.96%
cases:2.75%
controls:0.33%
cases:0.75%
controls:0.05%
cases:2.79%
controls:0.00%
cases:0.19%
controls:0.03%
cases:1.83%
controls:0.29%
cases:3.15%
controls:0.97%
154
500
5043
51442
143
170
5054
51772
39
25
5158
51917
145
0
5052
51942
10
16
5147
51695
89
139
4763
48632
116
363
3561
37174
Memory test
SPAT1053 [2001700154]
1.2e+00
2.9e+00
2.1e+00
—
1.3e+00
1.7e+00
1.7e+00
cases:12.43%
controls:3.92%
cases:17.20%
controls:1.13%
cases:0.98%
controls:0.12%
—
—
cases:0.37%
controls:0.10%
cases:5.42%
controls:1.04%
cases:16.05%
controls:3.51%
646
2038
4551
49904
894
589
4303
51353
51
63
5146
51879
—
19
51
5138
51660
263
508
4589
48263
590
1316
3087
36221
Other depressive episodes
F32.8 [45571759]
1.8e+00
2.3e+00
—
1.0e+50
2.6e+00
2.5e+00
1.7e+00
cases:0.40%
controls:0.07%
cases:0.35%
controls:0.03%
—
—
cases:0.12%
controls:0.00%
cases:0.14%
controls:0.01%
cases:0.31%
controls:0.03%
cases:0.44%
controls:0.08%
21
35
5176
51907
18
18
5179
51924
—
6
0
5191
51942
7
5
5150
51706
15
13
4837
48758
16
30
3661
37507
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
7.6e-01
1.8e+00
1.9e+00
3.1e+00
1.9e+00
6.3e-01
7.2e-01
cases:24.05%
controls:12.89%
cases:29.04%
controls:6.33%
cases:4.62%
controls:0.70%
cases:0.31%
controls:0.01%
cases:4.46%
controls:0.68%
cases:12.26%
controls:6.92%
cases:33.02%
controls:19.41%
1250
6695
3947
45247
1509
3286
3688
48656
240
361
4957
51581
16
7
5181
51935
230
353
4927
51358
595
3377
4257
45394
1214
7285
2463
30252
Hallucinations, unspecified
R44.3 [45563307]
2.0e+00
3.4e+00
—
1.0e+50
—
3.4e+00
2.1e+00
cases:0.19%
controls:0.03%
cases:0.38%
controls:0.01%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.31%
controls:0.01%
cases:0.30%
controls:0.04%
10
14
5187
51928
20
7
5177
51935
—
10
0
5187
51942
—
15
5
4837
48766
11
14
3666
37523
Profession-specific psychiatric evaluation
IBZ01 [2001304075]
1.9e+00
3.1e+00
—
1.0e+50
—
3.5e+00
2.3e+00
cases:0.29%
controls:0.04%
cases:0.56%
controls:0.03%
—
—
cases:0.44%
controls:0.00%
—
—
cases:0.52%
controls:0.02%
cases:0.76%
controls:0.08%
15
22
5182
51920
29
13
5168
51929
—
23
0
5174
51942
—
25
8
4827
48763
28
30
3649
37507
aripiprazole; oral, parenteral
N05AX12 [21604562]
1.5e+00
1.6e+00
1.5e+00
—
1.9e+00
2.0e+00
2.2e+00
cases:1.12%
controls:0.25%
cases:0.96%
controls:0.19%
cases:0.40%
controls:0.09%
—
—
cases:0.50%
controls:0.08%
cases:1.32%
controls:0.19%
cases:2.58%
controls:0.28%
58
129
5139
51813
50
99
5147
51843
21
46
5176
51896
—
26
40
5131
51671
64
92
4788
48679
95
105
3582
37432
citalopram; oral, parenteral
N06AB04 [21604712]
1.2e+00
1.3e+00
1.1e+00
2.8e+00
1.6e+00
1.4e+00
1.3e+00
cases:8.49%
controls:2.74%
cases:5.95%
controls:1.66%
cases:1.40%
controls:0.47%
cases:0.35%
controls:0.02%
cases:1.92%
controls:0.39%
cases:6.10%
controls:1.61%
cases:8.46%
controls:2.43%
441
1422
4756
50520
309
863
4888
51079
73
245
5124
51697
18
11
5179
51931
99
204
5058
51507
296
787
4556
47984
311
913
3366
36624
Hospital inpatient
ZY000 [2001311598]
1.9e+00
3.0e+00
1.0e+50
1.0e+50
—
3.5e+00
2.3e+00
cases:0.33%
controls:0.05%
cases:0.27%
controls:0.01%
cases:0.17%
controls:0.00%
cases:0.48%
controls:0.00%
—
—
cases:0.39%
controls:0.01%
cases:0.41%
controls:0.04%
17
25
5180
51917
14
7
5183
51935
9
0
5188
51942
25
0
5172
51942
—
19
6
4833
48765
15
16
3662
37521
vortioxetine; oral
N06AX26 [44819158]
1.2e+00
1.6e+00
1.7e+00
—
2.3e+00
1.9e+00
1.8e+00
cases:1.71%
controls:0.51%
cases:1.87%
controls:0.39%
cases:0.87%
controls:0.15%
—
—
cases:1.26%
controls:0.12%
cases:2.80%
controls:0.42%
cases:5.44%
controls:0.92%
89
264
5108
51678
97
204
5100
51738
45
80
5152
51862
—
65
64
5092
51647
136
207
4716
48564
200
344
3477
37193
Anxiety disorder, unspecified
F41.9 [45542849]
1.4e+00
1.8e+00
2.5e+00
—
2.2e+00
1.6e+00
1.1e+00
cases:2.37%
controls:0.61%
cases:1.65%
controls:0.28%
cases:0.60%
controls:0.05%
—
—
cases:0.48%
controls:0.05%
cases:1.36%
controls:0.27%
cases:2.37%
controls:0.84%
123
316
5074
51626
86
145
5111
51797
31
25
5166
51917
—
25
27
5132
51684
66
132
4786
48639
87
314
3590
37223
Mixed personality disorders
F61.0 [2000502024]
2.5e+00
3.1e+00
—
1.0e+50
—
2.6e+00
2.4e+00
cases:0.48%
controls:0.04%
cases:0.38%
controls:0.02%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.31%
controls:0.02%
cases:0.54%
controls:0.05%
25
21
5172
51921
20
9
5177
51933
—
9
0
5188
51942
—
15
11
4837
48760
20
19
3657
37518
Appearance of Cerebral spinal fluid
10333-3 [3023410]
1.8e+00
3.4e+00
—
—
1.0e+50
3.9e+00
1.4e+00
cases:0.73%
controls:0.12%
cases:0.89%
controls:0.03%
—
—
—
—
cases:0.54%
controls:0.00%
cases:1.20%
controls:0.02%
cases:0.52%
controls:0.13%
38
61
5159
51881
46
15
5151
51927
—
—
28
0
5129
51711
58
12
4794
48759
19
47
3658
37490
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
5.5e-01
9.3e-01
1.5e+00
4.0e+00
1.8e+00
8.7e-01
8.8e-01
cases:13.72%
controls:8.41%
cases:7.93%
controls:3.28%
cases:1.87%
controls:0.40%
cases:0.73%
controls:0.01%
cases:1.98%
controls:0.33%
cases:7.50%
controls:3.27%
cases:22.44%
controls:10.76%
713
4368
4484
47574
412
1705
4785
50237
97
210
5100
51732
38
7
5159
51935
102
172
5055
51539
364
1597
4488
47174
825
4038
2852
33499
Occupational Medicine Clinic/Center
261QX0100X [38004267]
6.7e-01
1.7e+00
2.6e+00
—
2.8e+00
1.8e+00
9.9e-01
cases:0.63%
controls:0.33%
cases:0.35%
controls:0.06%
cases:0.15%
controls:0.01%
—
—
cases:0.25%
controls:0.02%
cases:0.64%
controls:0.11%
cases:0.76%
controls:0.29%
33
169
5164
51773
18
33
5179
51909
8
6
5189
51936
—
13
8
5144
51703
31
53
4821
48718
28
107
3649
37430
General Practice
1 [38004446]
5.3e-01
9.0e-01
1.3e+00
4.5e+00
1.4e+00
9.2e-01
8.9e-01
cases:26.86%
controls:17.84%
cases:16.91%
controls:7.63%
cases:4.54%
controls:1.26%
cases:5.66%
controls:0.07%
cases:5.00%
controls:1.24%
cases:19.21%
controls:8.69%
cases:41.39%
controls:22.53%
1396
9265
3801
42677
879
3961
4318
47981
236
654
4961
51288
294
34
4903
51908
258
641
4899
51070
932
4238
3920
44533
1522
8457
2155
29080
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
2.2e+00
3.0e+00
—
1.0e+50
—
2.5e+00
2.8e+00
cases:0.37%
controls:0.04%
cases:0.31%
controls:0.02%
—
—
cases:0.12%
controls:0.00%
—
—
cases:0.31%
controls:0.02%
cases:0.71%
controls:0.05%
19
21
5178
51921
16
8
5181
51934
—
6
0
5191
51942
—
15
12
4837
48759
26
17
3651
37520
Partial epileptic seizure with cloudiness and automatism
G40.21 [2000502140]
2.6e+00
2.7e+00
—
—
—
2.3e+00
2.9e+00
cases:0.54%
controls:0.04%
cases:0.38%
controls:0.03%
—
—
—
—
—
—
cases:0.33%
controls:0.03%
cases:0.65%
controls:0.04%
28
20
5169
51922
20
14
5177
51928
—
—
—
16
16
4836
48755
24
14
3653
37523
topiramate; oral
N03AX11 [21604433]
1.7e+00
2.0e+00
1.8e+00
—
1.7e+00
1.9e+00
1.5e+00
cases:0.89%
controls:0.17%
cases:0.71%
controls:0.09%
cases:0.19%
controls:0.03%
—
—
cases:0.17%
controls:0.03%
cases:0.66%
controls:0.10%
cases:0.87%
controls:0.21%
46
88
5151
51854
37
49
5160
51893
10
17
5187
51925
—
9
17
5148
51694
32
49
4820
48722
32
77
3645
37460
chlorpromazine; oral, parenteral, rectal
N05AA01 [21604492]
2.1e+00
2.0e+00
—
—
—
3.0e+00
3.2e+00
cases:0.19%
controls:0.02%
cases:0.12%
controls:0.02%
—
—
—
—
—
—
cases:0.21%
controls:0.01%
cases:0.41%
controls:0.02%
10
12
5187
51930
6
8
5191
51934
—
—
—
10
5
4842
48766
15
6
3662
37531
Extensive initial psychiatric evaluation
IBA04 [2001304046]
2.2e+00
3.1e+00
1.0e+50
1.0e+50
—
3.2e+00
1.9e+00
cases:0.33%
controls:0.04%
cases:0.42%
controls:0.02%
cases:0.12%
controls:0.00%
cases:0.35%
controls:0.00%
—
—
cases:0.49%
controls:0.02%
cases:0.54%
controls:0.08%
17
19
5180
51923
22
10
5175
51932
6
0
5191
51942
18
0
5179
51942
—
24
10
4828
48761
20
31
3657
37506
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
6.1e-01
1.4e+00
2.3e+00
1.0e+50
2.6e+00
1.7e+00
1.8e+00
cases:1.00%
controls:0.55%
cases:0.71%
controls:0.17%
cases:0.19%
controls:0.02%
cases:0.23%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.64%
controls:0.12%
cases:1.25%
controls:0.22%
52
285
5145
51657
37
89
5160
51853
10
10
5187
51932
12
0
5185
51942
9
7
5148
51704
31
58
4821
48713
46
82
3631
37455
Recurrent depression, moderate episode of somatic syndrome
F33.11 [2000501985]
1.7e+00
2.0e+00
2.6e+00
1.0e+50
1.6e+00
2.2e+00
1.9e+00
cases:0.62%
controls:0.11%
cases:0.38%
controls:0.05%
cases:0.17%
controls:0.01%
cases:0.19%
controls:0.00%
cases:0.10%
controls:0.02%
cases:0.47%
controls:0.06%
cases:0.90%
controls:0.13%
32
59
5165
51883
20
28
5177
51914
9
7
5188
51935
10
0
5187
51942
5
10
5152
51701
23
27
4829
48744
33
50
3644
37487
Schizophrenia
P72 [2002000866]
1.3e+00
1.7e+00
1.9e+00
—
1.6e+00
1.8e+00
1.9e+00
cases:0.50%
controls:0.13%
cases:0.37%
controls:0.07%
cases:0.21%
controls:0.03%
—
—
cases:0.16%
controls:0.03%
cases:0.37%
controls:0.06%
cases:1.03%
controls:0.16%
26
70
5171
51872
19
35
5178
51907
11
16
5186
51926
—
8
16
5149
51695
18
29
4834
48742
38
59
3639
37478
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
1.7e+00
3.3e+00
—
—
—
3.4e+00
1.8e+00
cases:1.56%
controls:0.30%
cases:1.92%
controls:0.07%
—
—
—
—
—
—
cases:2.76%
controls:0.09%
cases:1.96%
controls:0.33%
81
156
5116
51786
100
36
5097
51906
—
—
—
134
44
4718
48727
72
122
3605
37415
Other and unspecified abnormalities of gait and mobility
R26.8 [45597174]
7.7e-01
1.8e+00
2.3e+00
1.0e+50
2.3e+00
2.0e+00
1.1e+00
cases:0.56%
controls:0.26%
cases:0.58%
controls:0.10%
cases:0.13%
controls:0.01%
cases:0.21%
controls:0.00%
cases:0.14%
controls:0.01%
cases:0.54%
controls:0.08%
cases:0.95%
controls:0.32%
29
134
5168
51808
30
50
5167
51892
7
7
5190
51935
11
0
5186
51942
7
7
5150
51704
26
37
4826
48734
35
119
3642
37418
Outpatient Visit
OP [9202]
6.4e-01
7.6e-01
8.7e-01
5.0e+00
9.8e-01
1.0e+00
9.3e-01
cases:88.63%
controls:80.39%
cases:77.72%
controls:61.88%
cases:25.48%
controls:12.58%
cases:49.80%
controls:0.66%
cases:27.30%
controls:12.38%
cases:81.16%
controls:60.20%
cases:93.28%
controls:84.52%
4606
41757
591
10185
4039
32143
1158
19799
1324
6534
3873
45408
2588
345
2609
51597
1408
6402
3749
45309
3938
29359
914
19412
3430
31728
247
5809
Emergency Room Visit
ER [9203]
6.1e-01
9.6e-01
1.6e+00
4.2e+00
1.2e+00
8.0e-01
7.8e-01
cases:52.45%
controls:37.54%
cases:28.17%
controls:13.11%
cases:8.54%
controls:1.82%
cases:6.56%
controls:0.10%
cases:5.37%
controls:1.68%
cases:25.23%
controls:13.22%
cases:52.35%
controls:33.58%
2726
19497
2471
32445
1464
6807
3733
45135
444
947
4753
50995
341
53
4856
51889
277
869
4880
50842
1224
6447
3628
42324
1925
12605
1752
24932
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
1.1e+00
1.8e+00
2.3e+00
—
2.8e+00
1.2e+00
9.9e-01
cases:0.81%
controls:0.27%
cases:1.17%
controls:0.20%
cases:0.23%
controls:0.02%
—
—
cases:0.35%
controls:0.02%
cases:0.85%
controls:0.25%
cases:2.20%
controls:0.83%
42
139
5155
51803
61
106
5136
51836
12
12
5185
51930
—
18
11
5139
51700
41
124
4811
48647
81
313
3596
37224
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
7.1e-01
1.7e+00
2.4e+00
1.0e+50
2.9e+00
1.5e+00
9.6e-01
cases:3.60%
controls:1.79%
cases:3.00%
controls:0.59%
cases:0.71%
controls:0.06%
cases:0.12%
controls:0.00%
cases:0.95%
controls:0.05%
cases:2.25%
controls:0.54%
cases:5.00%
controls:1.98%
187
932
5010
51010
156
305
5041
51637
37
33
5160
51909
6
0
5191
51942
49
26
5108
51685
109
261
4743
48510
184
742
3493
36795
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
8.3e-01
1.9e+00
1.8e+00
2.3e+00
1.3e+00
9.0e-01
1.1e+00
cases:10.81%
controls:5.04%
cases:14.55%
controls:2.44%
cases:2.41%
controls:0.42%
cases:0.12%
controls:0.01%
cases:1.53%
controls:0.41%
cases:5.85%
controls:2.47%
cases:18.36%
controls:7.11%
562
2616
4635
49326
756
1266
4441
50676
125
217
5072
51725
6
6
5191
51936
79
213
5078
51498
284
1207
4568
47564
675
2668
3002
34869
Moderate depressive episode with somatic syndrome
F32.11 [2000501981]
1.8e+00
2.2e+00
2.1e+00
1.0e+50
—
2.1e+00
1.9e+00
cases:0.79%
controls:0.14%
cases:0.46%
controls:0.05%
cases:0.12%
controls:0.01%
cases:0.10%
controls:0.00%
—
—
cases:0.45%
controls:0.06%
cases:0.92%
controls:0.14%
41
71
5156
51871
24
27
5173
51915
6
7
5191
51935
5
0
5192
51942
—
22
27
4830
48744
34
52
3643
37485
Undifferentiated schizophrenia continuous
F20.30 [2000501944]
1.6e+00
2.2e+00
—
1.0e+50
2.4e+00
1.9e+00
2.1e+00
cases:0.42%
controls:0.09%
cases:0.35%
controls:0.04%
—
—
cases:0.27%
controls:0.00%
cases:0.19%
controls:0.02%
cases:0.25%
controls:0.04%
cases:0.60%
controls:0.08%
22
46
5175
51896
18
20
5179
51922
—
14
0
5183
51942
10
9
5147
51702
12
19
4840
48752
22
29
3655
37508
bupropion; oral
N06AX12 [21604741]
1.4e+00
1.8e+00
1.6e+00
—
2.1e+00
1.7e+00
1.4e+00
cases:1.71%
controls:0.42%
cases:1.56%
controls:0.27%
cases:0.40%
controls:0.08%
—
—
cases:0.64%
controls:0.08%
cases:1.53%
controls:0.27%
cases:2.42%
controls:0.59%
89
220
5108
51722
81
140
5116
51802
21
42
5176
51900
—
33
41
5124
51670
74
132
4778
48639
89
223
3588
37314
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
6.7e-01
1.3e+00
1.3e+00
3.0e+00
1.3e+00
1.2e+00
1.2e+00
cases:9.93%
controls:5.33%
cases:7.62%
controls:2.30%
cases:1.42%
controls:0.38%
cases:0.38%
controls:0.02%
cases:1.49%
controls:0.39%
cases:6.47%
controls:2.02%
cases:13.22%
controls:4.22%
516
2768
4681
49174
396
1196
4801
50746
74
199
5123
51743
20
10
5177
51932
77
203
5080
51508
314
984
4538
47787
486
1585
3191
35952
Examination and observation for unspecified reason
Z04.9 [45605102]
3.1e-01
1.9e+00
3.4e+00
—
2.8e+00
1.4e+00
6.2e-01
cases:0.73%
controls:0.54%
cases:0.63%
controls:0.10%
cases:0.38%
controls:0.01%
—
—
cases:0.21%
controls:0.01%
cases:0.66%
controls:0.16%
cases:1.03%
controls:0.56%
38
278
5159
51664
33
52
5164
51890
20
7
5177
51935
—
11
7
5146
51704
32
78
4820
48693
38
210
3639
37327
chlordiazepoxide; oral, parenteral
N05BA02 [21604567]
1.6e+00
2.1e+00
1.7e+00
—
2.0e+00
2.3e+00
2.1e+00
cases:0.75%
controls:0.16%
cases:0.50%
controls:0.06%
cases:0.10%
controls:0.02%
—
—
cases:0.12%
controls:0.02%
cases:0.47%
controls:0.05%
cases:0.60%
controls:0.08%
39
82
5158
51860
26
32
5171
51910
5
9
5192
51933
—
6
8
5151
51703
23
24
4829
48747
22
29
3655
37508
cloZAPine [Moles/volume] in Serum or Plasma
14656-3 [3000081]
1.7e+00
1.7e+00
2.1e+00
—
—
2.3e+00
2.2e+00
cases:0.44%
controls:0.08%
cases:0.38%
controls:0.07%
cases:0.15%
controls:0.02%
—
—
—
—
cases:0.68%
controls:0.07%
cases:0.95%
controls:0.11%
23
44
5174
51898
20
35
5177
51907
8
10
5189
51932
—
—
33
32
4819
48739
35
41
3642
37496
Other and unspecified convulsions
R56.8 [45602033]
1.3e+00
2.0e+00
2.8e+00
1.0e+50
—
2.2e+00
1.5e+00
cases:1.27%
controls:0.34%
cases:0.87%
controls:0.11%
cases:0.19%
controls:0.01%
cases:0.12%
controls:0.00%
—
—
cases:0.89%
controls:0.09%
cases:1.79%
controls:0.39%
66
175
5131
51767
45
59
5152
51883
10
6
5187
51936
6
0
5191
51942
—
43
46
4809
48725
66
146
3611
37391
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
9.2e-01
2.2e+00
2.5e+00
—
2.3e+00
9.2e-01
1.2e+00
cases:14.35%
controls:6.27%
cases:13.64%
controls:1.80%
cases:2.23%
controls:0.18%
—
—
cases:1.78%
controls:0.18%
cases:4.16%
controls:1.70%
cases:13.54%
controls:4.72%
746
3256
4451
48686
709
933
4488
51009
116
95
5081
51847
—
92
94
5065
51617
202
828
4650
47943
498
1773
3179
35764
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
N04BA03 [21604466]
1.8e+00
1.6e+00
1.6e+00
—
1.9e+00
1.6e+00
1.6e+00
cases:0.71%
controls:0.12%
cases:0.62%
controls:0.13%
cases:0.23%
controls:0.05%
—
—
cases:0.25%
controls:0.04%
cases:0.62%
controls:0.13%
cases:0.82%
controls:0.17%
37
64
5160
51878
32
66
5165
51876
12
25
5185
51917
—
13
19
5144
51692
30
64
4822
48707
30
65
3647
37472
oxcarbazepine; oral
N03AF02 [21604418]
1.5e+00
1.7e+00
1.5e+00
—
1.6e+00
1.8e+00
2.0e+00
cases:1.85%
controls:0.44%
cases:1.69%
controls:0.33%
cases:0.50%
controls:0.12%
—
—
cases:0.52%
controls:0.11%
cases:2.00%
controls:0.32%
cases:2.96%
controls:0.43%
96
228
5101
51714
88
170
5109
51772
26
60
5171
51882
—
27
57
5130
51654
97
158
4755
48613
109
162
3568
37375
Mixed anxiety and depressive disorder
F41.2 [45566845]
1.4e+00
1.7e+00
2.2e+00
1.0e+50
2.1e+00
1.5e+00
1.1e+00
cases:1.85%
controls:0.47%
cases:1.00%
controls:0.19%
cases:0.38%
controls:0.04%
cases:0.33%
controls:0.00%
cases:0.37%
controls:0.05%
cases:0.95%
controls:0.21%
cases:1.99%
controls:0.67%
96
244
5101
51698
52
99
5145
51843
20
23
5177
51919
17
0
5180
51942
19
24
5138
51687
46
100
4806
48671
73
252
3604
37285
Recurrent depression, severe episode without somatic syndrome
F33.30 [2000501986]
2.1e+00
2.6e+00
—
—
—
2.5e+00
2.8e+00
cases:0.52%
controls:0.07%
cases:0.29%
controls:0.02%
—
—
—
—
—
—
cases:0.31%
controls:0.03%
cases:0.68%
controls:0.04%
27
34
5170
51908
15
11
5182
51931
—
—
—
15
13
4837
48758
25
16
3652
37521
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
1.6e+00
3.2e+00
—
—
—
3.4e+00
1.8e+00
cases:1.62%
controls:0.34%
cases:2.10%
controls:0.09%
—
—
—
—
—
—
cases:2.82%
controls:0.10%
cases:2.12%
controls:0.36%
84
179
5113
51763
109
45
5088
51897
—
—
—
137
49
4715
48722
78
136
3599
37401
methylphenidate; oral
N06BA04 [21604757]
1.6e+00
2.0e+00
2.1e+00
—
2.0e+00
2.4e+00
1.7e+00
cases:0.31%
controls:0.06%
cases:0.33%
controls:0.04%
cases:0.12%
controls:0.01%
—
—
cases:0.10%
controls:0.01%
cases:0.45%
controls:0.04%
cases:0.65%
controls:0.12%
16
32
5181
51910
17
23
5180
51919
6
7
5191
51935
—
5
7
5152
51704
22
20
4830
48751
24
45
3653
37492
olanzapine and samidorphan
N05AH53 [955100]
1.9e+00
3.0e+00
—
—
—
2.6e+00
2.3e+00
cases:0.52%
controls:0.08%
cases:0.52%
controls:0.03%
—
—
—
—
—
—
cases:0.58%
controls:0.04%
cases:1.03%
controls:0.10%
27
41
5170
51901
27
14
5170
51928
—
—
—
28
21
4824
48750
38
39
3639
37498
Norclozapine [Moles/volume] in Serum or Plasma
14851-0 [3008832]
1.6e+00
1.8e+00
2.0e+00
—
—
2.3e+00
2.0e+00
cases:0.40%
controls:0.08%
cases:0.37%
controls:0.06%
cases:0.12%
controls:0.02%
—
—
—
—
cases:0.62%
controls:0.06%
cases:0.76%
controls:0.10%
21
41
5176
51901
19
33
5178
51909
6
8
5191
51934
—
—
30
29
4822
48742
28
39
3649
37498
Orthostatic test
SPAT1101 [2001700202]
1.1e+00
1.7e+00
1.9e+00
—
1.8e+00
1.5e+00
1.6e+00
cases:2.54%
controls:0.87%
cases:1.62%
controls:0.28%
cases:0.25%
controls:0.04%
—
—
cases:0.23%
controls:0.04%
cases:1.36%
controls:0.32%
cases:4.49%
controls:0.91%
132
451
5065
51491
84
148
5113
51794
13
19
5184
51923
—
12
19
5145
51692
66
156
4786
48615
165
343
3512
37194
Alzheimer disease
G30 [45538101]
3.7e+00
—
1.0e+50
—
1.0e+50
1.0e+50
6.0e+00
cases:0.38%
controls:0.01%
—
—
cases:0.13%
controls:0.00%
—
—
cases:0.12%
controls:0.00%
cases:2.58%
controls:0.00%
cases:5.09%
controls:0.01%
20
5
5177
51937
—
7
0
5190
51942
—
6
0
5151
51711
125
0
4727
48771
187
5
3490
37532
Mild depressive episode without somatic syndrome
F32.00 [2000501978]
1.7e+00
2.1e+00
2.0e+00
1.0e+50
—
2.5e+00
1.3e+00
cases:1.23%
controls:0.23%
cases:0.62%
controls:0.07%
cases:0.12%
controls:0.02%
cases:0.37%
controls:0.00%
—
—
cases:0.87%
controls:0.07%
cases:0.92%
controls:0.25%
64
120
5133
51822
32
38
5165
51904
6
8
5191
51934
19
0
5178
51942
—
42
35
4810
48736
34
93
3643
37444
Assessment of need for services (elderly/care support)
SPAT1217 [2001700318]
1.1e+00
1.6e+00
1.8e+00
—
2.1e+00
1.7e+00
1.3e+00
cases:3.64%
controls:1.23%
cases:3.17%
controls:0.68%
cases:0.60%
controls:0.10%
—
—
cases:0.83%
controls:0.10%
cases:4.02%
controls:0.76%
cases:8.32%
controls:2.36%
189
637
5008
51305
165
354
5032
51588
31
51
5166
51891
—
43
51
5114
51660
195
372
4657
48399
306
884
3371
36653
Extensive MRI examination of brain with 3 Tesla magnet
AA1CM [2001300117]
1.6e+00
3.1e+00
—
1.0e+50
—
2.5e+00
2.4e+00
cases:0.63%
controls:0.13%
cases:0.31%
controls:0.01%
—
—
cases:0.10%
controls:0.00%
—
—
cases:0.21%
controls:0.02%
cases:0.63%
controls:0.06%
33
67
5164
51875
16
7
5181
51935
—
5
0
5192
51942
—
10
8
4842
48763
23
22
3654
37515
Bipolar affective disorder, current episode hypomanic
F31.0 [45542840]
1.9e+00
2.3e+00
—
—
—
2.5e+00
2.9e+00
cases:0.40%
controls:0.06%
cases:0.21%
controls:0.02%
—
—
—
—
—
—
cases:0.33%
controls:0.03%
cases:0.87%
controls:0.05%
21
30
5176
51912
11
11
5186
51931
—
—
—
16
13
4836
48758
32
19
3645
37518
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
6.5e-01
8.9e-01
1.3e+00
3.8e+00
1.2e+00
9.7e-01
8.2e-01
cases:10.14%
controls:5.54%
cases:5.18%
controls:2.19%
cases:1.37%
controls:0.39%
cases:1.21%
controls:0.03%
cases:1.26%
controls:0.38%
cases:6.16%
controls:2.43%
cases:17.11%
controls:8.33%
527
2879
4670
49063
269
1138
4928
50804
71
205
5126
51737
63
14
5134
51928
65
194
5092
51517
299
1187
4553
47584
629
3128
3048
34409
fluvoxamine; oral
N06AB08 [21604716]
1.5e+00
1.5e+00
2.1e+00
—
2.5e+00
2.2e+00
1.9e+00
cases:0.37%
controls:0.08%
cases:0.17%
controls:0.04%
cases:0.10%
controls:0.01%
—
—
cases:0.12%
controls:0.01%
cases:0.31%
controls:0.03%
cases:0.41%
controls:0.06%
19
44
5178
51898
9
20
5188
51922
5
6
5192
51936
—
6
5
5151
51706
15
17
4837
48754
15
22
3662
37515
Unspecified mood [affective] disorder
F39 [45591137]
2.0e+00
2.6e+00
—
—
—
2.7e+00
2.2e+00
cases:0.44%
controls:0.06%
cases:0.27%
controls:0.02%
—
—
—
—
—
—
cases:0.35%
controls:0.02%
cases:0.63%
controls:0.07%
23
31
5174
51911
14
10
5183
51932
—
—
—
17
12
4835
48759
23
25
3654
37512
Epilepsy
G40 [45595935]
1.6e+00
1.8e+00
—
—
2.1e+00
2.0e+00
2.1e+00
cases:1.19%
controls:0.24%
cases:0.56%
controls:0.09%
—
—
—
—
cases:0.14%
controls:0.02%
cases:0.56%
controls:0.08%
cases:1.52%
controls:0.20%
62
125
5135
51817
29
48
5168
51894
—
—
7
9
5150
51702
27
37
4825
48734
56
74
3621
37463
Psychosocial counselling and guidance
SPAT1307 [2001700408]
1.3e+00
1.7e+00
2.9e+00
—
1.5e+00
1.8e+00
1.8e+00
cases:1.25%
controls:0.35%
cases:0.62%
controls:0.12%
cases:0.25%
controls:0.01%
—
—
cases:0.14%
controls:0.03%
cases:0.74%
controls:0.12%
cases:2.09%
controls:0.36%
65
180
5132
51762
32
61
5165
51881
13
7
5184
51935
—
7
15
5150
51696
36
58
4816
48713
77
137
3600
37400
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
1.6e+00
3.1e+00
—
—
—
3.4e+00
1.4e+00
cases:1.27%
controls:0.26%
cases:1.52%
controls:0.07%
—
—
—
—
—
—
cases:2.21%
controls:0.07%
cases:1.31%
controls:0.33%
66
137
5131
51805
79
37
5118
51905
—
—
—
107
36
4745
48735
48
122
3629
37415
Outpatient Hospital
22 [8756]
4.4e-01
8.1e-01
1.4e+00
3.9e+00
1.3e+00
8.3e-01
6.8e-01
cases:37.48%
controls:27.92%
cases:16.22%
controls:7.90%
cases:4.16%
controls:1.04%
cases:2.89%
controls:0.06%
cases:3.68%
controls:0.98%
cases:14.84%
controls:7.07%
cases:30.13%
controls:17.91%
1948
14502
3249
37440
843
4102
4354
47840
216
542
4981
51400
150
30
5047
51912
190
509
4967
51202
720
3449
4132
45322
1108
6721
2569
30816
Provision of support and information to patient’s family members
SPAT1245 [2001700346]
7.9e-01
1.3e+00
1.5e+00
—
2.1e+00
1.8e+00
2.0e+00
cases:0.94%
controls:0.43%
cases:0.94%
controls:0.25%
cases:0.19%
controls:0.04%
—
—
cases:0.39%
controls:0.05%
cases:1.88%
controls:0.32%
cases:5.55%
controls:0.83%
49
224
5148
51718
49
128
5148
51814
10
22
5187
51920
—
20
25
5137
51686
91
158
4761
48613
204
311
3473
37226
Generalized anxiety disorder
F41.1 [45571764]
1.2e+00
1.3e+00
2.1e+00
1.0e+50
2.0e+00
1.6e+00
1.2e+00
cases:0.83%
controls:0.25%
cases:0.50%
controls:0.14%
cases:0.21%
controls:0.03%
cases:0.17%
controls:0.00%
cases:0.19%
controls:0.03%
cases:0.68%
controls:0.14%
cases:1.17%
controls:0.34%
43
130
5154
51812
26
71
5171
51871
11
13
5186
51929
9
0
5188
51942
10
14
5147
51697
33
68
4819
48703
43
128
3634
37409
pH of Serum or Plasma
2753-2 [3018418]
7.1e-01
1.4e+00
1.5e+00
2.8e+00
1.6e+00
7.4e-01
6.3e-01
cases:16.16%
controls:8.63%
cases:17.05%
controls:4.69%
cases:3.56%
controls:0.80%
cases:0.46%
controls:0.03%
cases:3.88%
controls:0.79%
cases:9.81%
controls:4.94%
cases:20.78%
controls:12.29%
840
4481
4357
47461
886
2434
4311
49508
185
417
5012
51525
24
15
5173
51927
200
410
4957
51301
476
2411
4376
46360
764
4615
2913
32922
mirtazapine; oral
N06AX11 [21604740]
9.7e-01
1.1e+00
1.1e+00
2.6e+00
1.3e+00
1.2e+00
1.1e+00
cases:16.88%
controls:7.17%
cases:12.64%
controls:4.46%
cases:3.94%
controls:1.34%
cases:0.81%
controls:0.06%
cases:4.81%
controls:1.40%
cases:13.56%
controls:4.62%
cases:23.69%
controls:9.18%
877
3726
4320
48216
657
2315
4540
49627
205
696
4992
51246
42
30
5155
51912
248
725
4909
50986
658
2254
4194
46517
871
3446
2806
34091
Differential panel - Cerebral spinal fluid
29584-0 [3016018]
1.7e+00
2.9e+00
—
—
1.0e+50
3.4e+00
1.3e+00
cases:0.73%
controls:0.13%
cases:0.81%
controls:0.04%
—
—
—
—
cases:0.27%
controls:0.00%
cases:0.95%
controls:0.03%
cases:0.68%
controls:0.18%
38
69
5159
51873
42
23
5155
51919
—
—
14
0
5143
51711
46
15
4806
48756
25
67
3652
37470
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
1.8e+00
2.7e+00
—
1.0e+50
—
2.4e+00
2.5e+00
cases:0.89%
controls:0.14%
cases:0.62%
controls:0.04%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.49%
controls:0.05%
cases:1.44%
controls:0.13%
46
73
5151
51869
32
22
5165
51920
—
9
0
5188
51942
—
24
22
4828
48749
53
47
3624
37490
Internal Medicine
11 [38004456]
4.7e-01
7.6e-01
1.3e+00
4.3e+00
9.7e-01
7.7e-01
6.9e-01
cases:37.10%
controls:26.90%
cases:20.38%
controls:10.72%
cases:6.79%
controls:1.86%
cases:6.48%
controls:0.09%
cases:4.46%
controls:1.74%
cases:19.99%
controls:10.38%
cases:39.14%
controls:24.31%
1928
13973
3269
37969
1059
5566
4138
46376
353
967
4844
50975
337
48
4860
51894
230
899
4927
50812
970
5062
3882
43709
1439
9127
2238
28410
levetiracetam; oral, parenteral
N03AX14 [21604436]
1.4e+00
1.5e+00
1.5e+00
—
1.4e+00
1.7e+00
1.7e+00
cases:1.31%
controls:0.31%
cases:1.39%
controls:0.30%
cases:0.54%
controls:0.12%
—
—
cases:0.50%
controls:0.12%
cases:1.69%
controls:0.30%
cases:2.18%
controls:0.40%
68
162
5129
51780
72
157
5125
51785
28
64
5169
51878
—
26
64
5131
51647
82
146
4770
48625
80
152
3597
37385
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
1.2e+00
1.7e+00
2.0e+00
1.0e+50
2.9e+00
1.5e+00
7.0e-01
cases:0.67%
controls:0.21%
cases:0.33%
controls:0.06%
cases:0.12%
controls:0.02%
cases:0.12%
controls:0.00%
cases:0.21%
controls:0.01%
cases:0.37%
controls:0.08%
cases:0.44%
controls:0.22%
35
110
5162
51832
17
32
5180
51910
6
8
5191
51934
6
0
5191
51942
11
6
5146
51705
18
39
4834
48732
16
81
3661
37456
Procedure duration 150 to 179 minutes
ZXE17 [2001311407]
1.7e+00
2.4e+00
—
—
—
2.9e+00
2.2e+00
cases:0.29%
controls:0.05%
cases:0.17%
controls:0.02%
—
—
—
—
—
—
cases:0.23%
controls:0.01%
cases:0.30%
controls:0.03%
15
27
5182
51915
9
8
5188
51934
—
—
—
11
6
4841
48765
11
12
3666
37525
Alcohol dependence currently independent
F10.20 [2000501677]
1.9e+00
2.4e+00
—
1.0e+50
—
2.8e+00
2.2e+00
cases:0.63%
controls:0.10%
cases:0.33%
controls:0.03%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.47%
controls:0.03%
cases:0.68%
controls:0.07%
33
50
5164
51892
17
16
5180
51926
—
9
0
5188
51942
—
23
14
4829
48757
25
28
3652
37509
Schizoaffective disorder, unspecified
F25.9 [45605490]
1.7e+00
2.5e+00
—
—
—
2.6e+00
2.5e+00
cases:0.40%
controls:0.08%
cases:0.46%
controls:0.04%
—
—
—
—
—
—
cases:0.47%
controls:0.04%
cases:0.79%
controls:0.07%
21
39
5176
51903
24
20
5173
51922
—
—
—
23
18
4829
48753
29
25
3648
37512
Psychiatric treatment plan, monitoring
ICB03 [2001304100]
1.9e+00
2.4e+00
—
1.0e+50
—
2.7e+00
2.2e+00
cases:0.44%
controls:0.07%
cases:0.58%
controls:0.05%
—
—
cases:0.37%
controls:0.00%
—
—
cases:0.95%
controls:0.06%
cases:1.31%
controls:0.14%
23
35
5174
51907
30
28
5167
51914
—
19
0
5178
51942
—
46
31
4806
48740
48
54
3629
37483
Observation for suspected mental and behavioural disorders
Z03.2 [45552060]
1.6e+00
3.2e+00
—
—
—
2.0e+00
2.3e+00
cases:0.31%
controls:0.06%
cases:0.29%
controls:0.01%
—
—
—
—
—
—
cases:0.14%
controls:0.02%
cases:0.49%
controls:0.05%
16
31
5181
51911
15
6
5182
51936
—
—
—
7
10
4845
48761
18
19
3659
37518
Traumatic subdural haemorrhage
S06.5 [45563422]
6.8e-01
1.7e+00
2.3e+00
1.0e+50
2.4e+00
1.4e+00
6.5e-01
cases:0.79%
controls:0.40%
cases:0.94%
controls:0.17%
cases:0.42%
controls:0.04%
cases:0.33%
controls:0.00%
cases:0.35%
controls:0.03%
cases:0.74%
controls:0.19%
cases:1.25%
controls:0.66%
41
209
5156
51733
49
89
5148
51853
22
23
5175
51919
17
0
5180
51942
18
16
5139
51695
36
94
4816
48677
46
246
3631
37291
Multiple sclerosis
G35 [45571794]
9.5e-01
1.4e+00
2.0e+00
—
2.1e+00
1.3e+00
1.3e+00
cases:0.44%
controls:0.17%
cases:0.46%
controls:0.12%
cases:0.29%
controls:0.04%
—
—
cases:0.31%
controls:0.04%
cases:0.47%
controls:0.13%
cases:0.68%
controls:0.18%
23
89
5174
51853
24
60
5173
51882
15
21
5182
51921
—
16
20
5141
51691
23
62
4829
48709
25
68
3652
37469
Depressive disorder
P76 [2002000870]
1.3e+00
1.5e+00
2.1e+00
—
1.6e+00
1.3e+00
1.1e+00
cases:1.73%
controls:0.47%
cases:0.89%
controls:0.21%
cases:0.40%
controls:0.05%
—
—
cases:0.25%
controls:0.05%
cases:0.82%
controls:0.22%
cases:1.79%
controls:0.58%
90
244
5107
51698
46
108
5151
51834
21
25
5176
51917
—
13
26
5144
51685
40
106
4812
48665
66
216
3611
37321
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
5.9e-01
1.3e+00
1.3e+00
2.9e+00
1.5e+00
7.0e-01
7.2e-01
cases:22.28%
controls:13.76%
cases:21.78%
controls:7.38%
cases:4.68%
controls:1.30%
cases:0.94%
controls:0.05%
cases:5.24%
controls:1.24%
cases:14.20%
controls:7.63%
cases:31.55%
controls:18.31%
1158
7145
4039
44797
1132
3834
4065
48108
243
674
4954
51268
49
26
5148
51916
270
640
4887
51071
689
3719
4163
45052
1160
6872
2517
30665
Emergency Room and Inpatient Visit
ERIP [262]
3.6e-01
7.6e-01
1.2e+00
4.4e+00
1.1e+00
5.7e-01
5.4e-01
cases:10.28%
controls:7.37%
cases:8.93%
controls:4.39%
cases:2.52%
controls:0.77%
cases:3.87%
controls:0.05%
cases:2.11%
controls:0.69%
cases:8.97%
controls:5.30%
cases:24.91%
controls:16.19%
534
3826
4663
48116
464
2281
4733
49661
131
400
5066
51542
201
25
4996
51917
109
355
5048
51356
435
2585
4417
46186
916
6077
2761
31460
venlafaxine; oral
N06AX16 [21604745]
1.2e+00
1.6e+00
1.6e+00
—
1.6e+00
1.5e+00
1.4e+00
cases:4.96%
controls:1.50%
cases:4.10%
controls:0.85%
cases:1.39%
controls:0.29%
—
—
cases:1.43%
controls:0.28%
cases:4.06%
controls:0.95%
cases:6.55%
controls:1.70%
258
780
4939
51162
213
439
4984
51503
72
150
5125
51792
—
74
145
5083
51566
197
463
4655
48308
241
639
3436
36898
Dysthymia
F34.1 [45586238]
1.2e+00
2.0e+00
1.6e+00
1.0e+50
2.2e+00
1.7e+00
1.8e+00
cases:0.79%
controls:0.23%
cases:0.67%
controls:0.10%
cases:0.10%
controls:0.02%
cases:0.40%
controls:0.00%
cases:0.17%
controls:0.02%
cases:0.47%
controls:0.09%
cases:1.39%
controls:0.23%
41
121
5156
51821
35
50
5162
51892
5
10
5192
51932
21
0
5176
51942
9
10
5148
51701
23
42
4829
48729
51
85
3626
37452
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
1.1e+00
1.3e+00
1.3e+00
1.0e+50
1.7e+00
1.7e+00
1.8e+00
cases:2.66%
controls:0.86%
cases:2.02%
controls:0.58%
cases:0.79%
controls:0.22%
cases:0.13%
controls:0.00%
cases:1.09%
controls:0.20%
cases:3.44%
controls:0.63%
cases:5.82%
controls:1.03%
138
446
5059
51496
105
300
5092
51642
41
112
5156
51830
7
0
5190
51942
56
105
5101
51606
167
309
4685
48462
214
385
3463
37152
sertraline; oral
N06AB06 [21604714]
1.3e+00
1.4e+00
1.6e+00
—
1.7e+00
1.5e+00
1.4e+00
cases:3.17%
controls:0.92%
cases:2.35%
controls:0.60%
cases:0.83%
controls:0.17%
—
—
cases:0.91%
controls:0.17%
cases:2.80%
controls:0.61%
cases:4.43%
controls:1.09%
165
480
5032
51462
122
313
5075
51629
43
89
5154
51853
—
47
87
5110
51624
136
299
4716
48472
163
409
3514
37128
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
7.0e-01
1.7e+00
1.5e+00
2.1e+00
1.3e+00
7.0e-01
9.2e-01
cases:16.55%
controls:8.93%
cases:19.40%
controls:4.35%
cases:3.39%
controls:0.77%
cases:0.23%
controls:0.03%
cases:2.66%
controls:0.76%
cases:8.68%
controls:4.49%
cases:24.67%
controls:11.58%
860
4641
4337
47301
1008
2260
4189
49682
176
402
5021
51540
12
15
5185
51927
137
392
5020
51319
421
2189
4431
46582
907
4346
2770
33191
Mental disorder, not otherwise specified
F99 [45605525]
1.7e+00
2.2e+00
2.9e+00
—
—
2.0e+00
1.2e+00
cases:0.37%
controls:0.07%
cases:0.29%
controls:0.03%
cases:0.21%
controls:0.01%
—
—
—
—
cases:0.23%
controls:0.03%
cases:0.27%
controls:0.08%
19
35
5178
51907
15
17
5182
51925
11
6
5186
51936
—
—
11
15
4841
48756
10
30
3667
37507
Parkinson disease
G20 [45538098]
1.1e+00
1.3e+00
2.0e+00
—
1.8e+00
1.3e+00
1.2e+00
cases:2.04%
controls:0.67%
cases:2.00%
controls:0.58%
cases:0.98%
controls:0.13%
—
—
cases:0.95%
controls:0.15%
cases:2.25%
controls:0.64%
cases:3.07%
controls:0.92%
106
346
5091
51596
104
301
5093
51641
51
68
5146
51874
—
49
78
5108
51633
109
310
4743
48461
113
345
3564
37192
Circumscribed brain atrophy
G31.0 [45591166]
1.5e+00
2.5e+00
—
—
—
3.2e+00
3.1e+00
cases:0.12%
controls:0.03%
cases:0.13%
controls:0.01%
—
—
—
—
—
—
cases:0.62%
controls:0.02%
cases:1.41%
controls:0.07%
6
13
5191
51929
7
6
5190
51936
—
—
—
30
12
4822
48759
52
25
3625
37512
UNS Panic Syndrome
F41.09 [2000501997]
1.7e+00
1.9e+00
2.3e+00
—
—
1.4e+00
1.4e+00
cases:0.67%
controls:0.12%
cases:0.35%
controls:0.05%
cases:0.15%
controls:0.02%
—
—
—
—
cases:0.29%
controls:0.07%
cases:0.57%
controls:0.15%
35
63
5162
51879
18
26
5179
51916
8
8
5189
51934
—
—
14
35
4838
48736
21
55
3656
37482
Bipolar affective disorder
F31 [45595902]
2.2e+00
1.9e+00
—
—
—
2.4e+00
2.3e+00
cases:0.65%
controls:0.08%
cases:0.21%
controls:0.03%
—
—
—
—
—
—
cases:0.35%
controls:0.03%
cases:1.01%
controls:0.10%
34
39
5163
51903
11
17
5186
51925
—
—
—
17
16
4835
48755
37
38
3640
37499
Epilepsy
N88 [2002000788]
2.1e+00
2.2e+00
—
—
—
2.0e+00
2.4e+00
cases:0.25%
controls:0.03%
cases:0.17%
controls:0.02%
—
—
—
—
—
—
cases:0.12%
controls:0.02%
cases:0.41%
controls:0.04%
13
16
5184
51926
9
10
5188
51932
—
—
—
6
8
4846
48763
15
14
3662
37523
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
1.1e+00
1.8e+00
2.3e+00
1.0e+50
—
2.2e+00
1.3e+00
cases:0.56%
controls:0.18%
cases:0.44%
controls:0.08%
cases:0.12%
controls:0.01%
cases:0.23%
controls:0.00%
—
—
cases:0.33%
controls:0.04%
cases:0.71%
controls:0.19%
29
93
5168
51849
23
40
5174
51902
6
6
5191
51936
12
0
5185
51942
—
16
18
4836
48753
26
72
3651
37465
buspirone; oral
N05BE01 [21604601]
1.5e+00
1.4e+00
—
—
2.4e+00
2.0e+00
1.5e+00
cases:0.62%
controls:0.14%
cases:0.25%
controls:0.06%
—
—
—
—
cases:0.23%
controls:0.02%
cases:0.49%
controls:0.07%
cases:0.54%
controls:0.13%
32
75
5165
51867
13
32
5184
51910
—
—
12
11
5145
51700
24
33
4828
48738
20
48
3657
37489
melatonin; oral
N05CH01 [21604659]
6.2e-01
8.7e-01
1.1e+00
2.8e+00
1.2e+00
1.1e+00
1.1e+00
cases:5.68%
controls:3.15%
cases:4.71%
controls:2.04%
cases:1.60%
controls:0.56%
cases:0.25%
controls:0.02%
cases:2.04%
controls:0.61%
cases:6.04%
controls:2.18%
cases:13.33%
controls:5.04%
295
1634
4902
50308
245
1058
4952
50884
83
291
5114
51651
13
8
5184
51934
105
316
5052
51395
293
1061
4559
47710
490
1893
3187
35644
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
1.4e+00
1.3e+00
1.4e+00
—
1.5e+00
1.4e+00
1.6e+00
cases:1.19%
controls:0.28%
cases:0.71%
controls:0.20%
cases:0.25%
controls:0.06%
—
—
cases:0.31%
controls:0.07%
cases:0.80%
controls:0.19%
cases:1.03%
controls:0.21%
62
148
5135
51794
37
102
5160
51840
13
32
5184
51910
—
16
36
5141
51675
39
94
4813
48677
38
79
3639
37458
2-person team, doctor-nurse
ZXY51 [2001311525]
1.4e+00
2.2e+00
—
1.0e+50
—
3.1e+00
2.0e+00
cases:0.21%
controls:0.05%
cases:0.25%
controls:0.03%
—
—
cases:0.13%
controls:0.00%
—
—
cases:0.35%
controls:0.02%
cases:0.54%
controls:0.07%
11
26
5186
51916
13
15
5184
51927
—
7
0
5190
51942
—
17
8
4835
48763
20
28
3657
37509
Limited function/disability (P)
P28 [2002000822]
1.5e+00
2.6e+00
—
—
—
2.5e+00
2.0e+00
cases:0.27%
controls:0.06%
cases:0.21%
controls:0.02%
—
—
—
—
—
—
cases:0.29%
controls:0.02%
cases:0.46%
controls:0.06%
14
30
5183
51912
11
8
5186
51934
—
—
—
14
12
4838
48759
17
23
3660
37514
agomelatine; oral
N06AX22 [21604750]
1.4e+00
1.6e+00
—
—
2.3e+00
1.8e+00
1.6e+00
cases:0.62%
controls:0.15%
cases:0.44%
controls:0.09%
—
—
—
—
cases:0.21%
controls:0.02%
cases:0.56%
controls:0.09%
cases:0.95%
controls:0.20%
32
79
5165
51863
23
48
5174
51894
—
—
11
11
5146
51700
27
46
4825
48725
35
74
3642
37463
levomepromazine; oral, parenteral
N05AA02 [21604493]
1.5e+00
1.7e+00
1.0e+00
—
1.6e+00
1.9e+00
2.0e+00
cases:1.65%
controls:0.37%
cases:1.10%
controls:0.21%
cases:0.19%
controls:0.07%
—
—
cases:0.35%
controls:0.07%
cases:1.34%
controls:0.21%
cases:2.18%
controls:0.31%
86
191
5111
51751
57
107
5140
51835
10
36
5187
51906
—
18
38
5139
51673
65
100
4787
48671
80
116
3597
37421
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
5.6e-01
1.2e+00
1.3e+00
2.9e+00
1.4e+00
6.1e-01
5.9e-01
cases:24.19%
controls:15.35%
cases:24.15%
controls:8.53%
cases:5.29%
controls:1.54%
cases:0.98%
controls:0.06%
cases:5.82%
controls:1.46%
cases:15.27%
controls:8.93%
cases:33.48%
controls:21.84%
1257
7974
3940
43968
1255
4433
3942
47509
275
800
4922
51142
51
29
5146
51913
300
754
4857
50957
741
4355
4111
44416
1231
8198
2446
29339
moclobemide; oral
N06AG02 [21604727]
1.9e+00
2.2e+00
1.7e+00
—
1.4e+00
1.7e+00
1.1e+00
cases:0.92%
controls:0.14%
cases:0.60%
controls:0.07%
cases:0.15%
controls:0.03%
—
—
cases:0.10%
controls:0.02%
cases:0.33%
controls:0.06%
cases:0.38%
controls:0.13%
48
71
5149
51871
31
35
5166
51907
8
15
5189
51927
—
5
12
5152
51699
16
30
4836
48741
14
48
3663
37489
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
4.7e-01
1.2e+00
1.3e+00
2.5e+00
1.9e+00
6.5e-01
5.3e-01
cases:16.28%
controls:10.86%
cases:15.99%
controls:5.68%
cases:2.69%
controls:0.75%
cases:0.21%
controls:0.02%
cases:4.03%
controls:0.60%
cases:10.82%
controls:5.97%
cases:25.54%
controls:16.82%
846
5642
4351
46300
831
2948
4366
48994
140
392
5057
51550
11
9
5186
51933
208
308
4949
51403
525
2911
4327
45860
939
6315
2738
31222
oxazepam; oral
N05BA04 [21604569]
8.2e-01
9.8e-01
1.3e+00
2.0e+00
1.2e+00
1.0e+00
1.1e+00
cases:11.01%
controls:5.17%
cases:7.39%
controls:2.92%
cases:2.87%
controls:0.76%
cases:0.31%
controls:0.04%
cases:2.68%
controls:0.84%
cases:7.93%
controls:2.93%
cases:15.26%
controls:5.44%
572
2686
4625
49256
384
1516
4813
50426
149
395
5048
51547
16
22
5181
51920
138
435
5019
51276
385
1430
4467
47341
561
2043
3116
35494
Visual hallucinations
R44.1 [45602029]
2.1e+00
2.2e+00
—
1.0e+50
—
2.5e+00
1.7e+00
cases:0.27%
controls:0.03%
cases:0.21%
controls:0.02%
—
—
cases:0.15%
controls:0.00%
—
—
cases:0.25%
controls:0.02%
cases:0.33%
controls:0.06%
14
18
5183
51924
11
12
5186
51930
—
8
0
5189
51942
—
12
10
4840
48761
12
22
3665
37515
Intracerebral haemorrhage in hemisphere, subcortical
I61.0 [45605803]
1.3e+00
1.6e+00
2.1e+00
—
2.0e+00
1.4e+00
7.6e-01
cases:0.38%
controls:0.10%
cases:0.27%
controls:0.05%
cases:0.13%
controls:0.02%
—
—
cases:0.12%
controls:0.02%
cases:0.23%
controls:0.05%
cases:0.49%
controls:0.23%
20
54
5177
51888
14
27
5183
51915
7
9
5190
51933
—
6
8
5151
51703
11
26
4841
48745
18
86
3659
37451
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
1.4e-03
3.2e-01
1.5e+00
4.3e+00
1.6e+00
5.5e-01
4.8e-01
cases:3.12%
controls:3.11%
cases:1.94%
controls:1.42%
cases:0.81%
controls:0.17%
cases:0.67%
controls:0.01%
cases:0.99%
controls:0.20%
cases:2.41%
controls:1.40%
cases:5.68%
controls:3.58%
162
1617
5035
50325
101
739
5096
51203
42
90
5155
51852
35
5
5162
51937
51
101
5106
51610
117
684
4735
48087
209
1345
3468
36192
Persistent delusional disorder, unspecified
F22.9 [45542837]
1.5e+00
2.3e+00
1.0e+50
1.0e+50
—
3.6e+00
2.5e+00
cases:0.15%
controls:0.03%
cases:0.15%
controls:0.02%
cases:0.15%
controls:0.00%
cases:0.17%
controls:0.00%
—
—
cases:0.45%
controls:0.01%
cases:0.63%
controls:0.05%
8
17
5189
51925
8
8
5189
51934
8
0
5189
51942
9
0
5188
51942
—
22
6
4830
48765
23
19
3654
37518
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
5.5e-01
8.5e-01
8.0e-01
3.3e+00
1.5e+00
6.8e-01
7.4e-01
cases:5.41%
controls:3.20%
cases:3.83%
controls:1.67%
cases:0.52%
controls:0.23%
cases:0.31%
controls:0.01%
cases:1.01%
controls:0.22%
cases:3.85%
controls:1.98%
cases:12.92%
controls:6.62%
281
1662
4916
50280
199
866
4998
51076
27
122
5170
51820
16
6
5181
51936
52
115
5105
51596
187
966
4665
47805
475
2486
3202
35051
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.2 [45591172]
1.6e+00
2.9e+00
—
—
1.0e+50
2.0e+00
1.9e+00
cases:0.60%
controls:0.12%
cases:0.54%
controls:0.03%
—
—
—
—
cases:0.12%
controls:0.00%
cases:0.31%
controls:0.04%
cases:0.95%
controls:0.14%
31
60
5166
51882
28
16
5169
51926
—
—
6
0
5151
51711
15
21
4837
48750
35
54
3642
37483
mianserin; oral
N06AX03 [21604732]
1.3e+00
1.4e+00
1.6e+00
—
1.6e+00
1.3e+00
1.1e+00
cases:1.27%
controls:0.34%
cases:0.79%
controls:0.19%
cases:0.23%
controls:0.05%
—
—
cases:0.23%
controls:0.05%
cases:0.68%
controls:0.18%
cases:0.95%
controls:0.31%
66
178
5131
51764
41
99
5156
51843
12
25
5185
51917
—
12
24
5145
51687
33
90
4819
48681
35
116
3642
37421
Other psychiatric treatment contact
IGY99 [2001304323]
1.6e+00
1.8e+00
—
—
—
2.9e+00
2.0e+00
cases:0.33%
controls:0.06%
cases:0.19%
controls:0.03%
—
—
—
—
—
—
cases:0.43%
controls:0.02%
cases:0.87%
controls:0.12%
17
33
5180
51909
10
16
5187
51926
—
—
—
21
12
4831
48759
32
44
3645
37493
Hypothyroidism, unspecified
E03.9 [45537945]
3.3e-01
6.2e-01
9.6e-01
4.1e+00
1.2e+00
6.8e-01
4.4e-01
cases:3.75%
controls:2.74%
cases:2.60%
controls:1.41%
cases:0.71%
controls:0.27%
cases:1.15%
controls:0.02%
cases:0.78%
controls:0.23%
cases:2.74%
controls:1.40%
cases:5.44%
controls:3.57%
195
1421
5002
50521
135
733
5062
51209
37
142
5160
51800
60
10
5137
51932
40
120
5117
51591
133
684
4719
48087
200
1341
3477
36196
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
8.6e-01
1.2e+00
2.4e+00
—
1.7e+00
1.4e+00
8.1e-01
cases:2.23%
controls:0.96%
cases:1.08%
controls:0.34%
cases:0.35%
controls:0.03%
—
—
cases:0.21%
controls:0.04%
cases:1.36%
controls:0.35%
cases:2.34%
controls:1.05%
116
497
5081
51445
56
178
5141
51764
18
16
5179
51926
—
11
20
5146
51691
66
170
4786
48601
86
396
3591
37141
Inpatient Visit
IP [9201]
1.9e-01
5.7e-01
8.5e-01
4.3e+00
1.4e+00
6.0e-01
4.2e-01
cases:10.45%
controls:8.82%
cases:6.72%
controls:3.90%
cases:1.19%
controls:0.51%
cases:2.52%
controls:0.03%
cases:2.13%
controls:0.55%
cases:7.25%
controls:4.13%
cases:18.85%
controls:13.26%
543
4581
4654
47361
349
2028
4848
49914
62
266
5135
51676
131
18
5066
51924
110
283
5047
51428
352
2014
4500
46757
693
4978
2984
32559
biperiden; oral, parenteral
N04AA02 [21604447]
1.6e+00
1.8e+00
1.4e+00
—
1.5e+00
1.6e+00
1.8e+00
cases:0.79%
controls:0.16%
cases:0.54%
controls:0.09%
cases:0.13%
controls:0.03%
—
—
cases:0.17%
controls:0.04%
cases:0.43%
controls:0.09%
cases:0.82%
controls:0.14%
41
84
5156
51858
28
46
5169
51896
7
17
5190
51925
—
9
20
5148
51691
21
43
4831
48728
30
51
3647
37486
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
4.1e-01
6.7e-01
1.2e+00
3.7e+00
1.0e+00
6.2e-01
6.8e-01
cases:12.51%
controls:8.65%
cases:9.26%
controls:4.94%
cases:2.56%
controls:0.78%
cases:0.60%
controls:0.02%
cases:1.98%
controls:0.71%
cases:9.15%
controls:5.12%
cases:22.79%
controls:12.99%
650
4491
4547
47451
481
2566
4716
49376
133
405
5064
51537
31
8
5166
51934
102
366
5055
51345
444
2499
4408
46272
838
4875
2839
32662
sulpiride; oral, parenteral
N05AL01 [21604548]
1.9e+00
2.0e+00
—
—
—
2.0e+00
2.4e+00
cases:0.31%
controls:0.05%
cases:0.23%
controls:0.03%
—
—
—
—
—
—
cases:0.23%
controls:0.03%
cases:0.52%
controls:0.05%
16
24
5181
51918
12
16
5185
51926
—
—
—
11
15
4841
48756
19
18
3658
37519
Mononuclear cells/Leukocytes in Cerebral spinal fluid
26492-9 [3033306]
1.8e+00
3.0e+00
—
1.0e+50
1.0e+50
3.5e+00
1.2e+00
cases:0.33%
controls:0.06%
cases:0.23%
controls:0.01%
—
—
cases:0.12%
controls:0.00%
cases:0.16%
controls:0.00%
cases:0.41%
controls:0.01%
cases:0.24%
controls:0.08%
17
29
5180
51913
12
6
5185
51936
—
6
0
5191
51942
8
0
5149
51711
20
6
4832
48765
9
29
3668
37508
Emergency Medicine
93 [38004510]
4.3e-01
7.2e-01
1.3e+00
3.8e+00
8.6e-01
6.5e-01
5.3e-01
cases:25.90%
controls:18.59%
cases:18.74%
controls:10.08%
cases:5.64%
controls:1.59%
cases:3.87%
controls:0.09%
cases:3.57%
controls:1.54%
cases:19.52%
controls:11.24%
cases:40.66%
controls:28.66%
1346
9654
3851
42288
974
5234
4223
46708
293
827
4904
51115
201
48
4996
51894
184
796
4973
50915
947
5483
3905
43288
1495
10758
2182
26779
Neurosurgery
14 [38004459]
8.8e-01
1.3e+00
1.7e+00
—
1.8e+00
1.4e+00
1.1e+00
cases:6.81%
controls:2.93%
cases:4.43%
controls:1.19%
cases:1.14%
controls:0.21%
—
—
cases:1.05%
controls:0.18%
cases:4.16%
controls:1.02%
cases:7.32%
controls:2.50%
354
1522
4843
50420
230
618
4967
51324
59
109
5138
51833
—
54
92
5103
51619
202
498
4650
48273
269
939
3408
36598
Feeling depressed
P03 [2002000800]
9.7e-01
1.2e+00
2.1e+00
—
1.4e+00
1.4e+00
1.2e+00
cases:2.10%
controls:0.80%
cases:1.04%
controls:0.31%
cases:0.35%
controls:0.04%
—
—
cases:0.25%
controls:0.06%
cases:0.99%
controls:0.25%
cases:2.83%
controls:0.91%
109
417
5088
51525
54
161
5143
51781
18
22
5179
51920
—
13
31
5144
51680
48
124
4804
48647
104
342
3573
37195
Emergency Room - Hospital
23 [8870]
9.3e-01
1.9e+00
2.1e+00
—
—
1.6e+00
1.7e+00
cases:0.92%
controls:0.37%
cases:0.63%
controls:0.10%
cases:0.12%
controls:0.01%
—
—
—
—
cases:0.49%
controls:0.10%
cases:1.74%
controls:0.34%
48
190
5149
51752
33
52
5164
51890
6
7
5191
51935
—
—
24
47
4828
48724
64
126
3613
37411
Counselling and guidance related to ageing
SPAT1304 [2001700405]
4.5e-01
1.0e+00
1.3e+00
1.9e+00
1.6e+00
9.9e-01
1.0e+00
cases:2.39%
controls:1.53%
cases:1.64%
controls:0.59%
cases:0.60%
controls:0.17%
cases:0.23%
controls:0.03%
cases:0.78%
controls:0.16%
cases:1.85%
controls:0.70%
cases:5.28%
controls:2.01%
124
797
5073
51145
85
307
5112
51635
31
87
5166
51855
12
18
5185
51924
40
82
5117
51629
90
341
4762
48430
194
755
3483
36782
Pure hypercholesterolaemia
E78.01 [2000501514]
3.1e-01
6.7e-01
7.5e-01
4.7e+00
1.1e+00
6.5e-01
1.6e-01
cases:7.54%
controls:5.65%
cases:5.29%
controls:2.77%
cases:1.25%
controls:0.60%
cases:3.08%
controls:0.03%
cases:1.49%
controls:0.48%
cases:5.19%
controls:2.78%
cases:9.30%
controls:8.02%
392
2935
4805
49007
275
1437
4922
50505
65
310
5132
51632
160
15
5037
51927
77
247
5080
51464
252
1358
4600
47413
342
3010
3335
34527
Participation in compiling a psychiatric treatment plan
ICZ03 [2001304119]
1.6e+00
2.1e+00
—
—
—
2.6e+00
1.9e+00
cases:0.48%
controls:0.09%
cases:0.44%
controls:0.05%
—
—
—
—
—
—
cases:0.56%
controls:0.04%
cases:0.82%
controls:0.13%
25
49
5172
51893
23
28
5174
51914
—
—
—
27
21
4825
48750
30
47
3647
37490
Specific gravity of Urine by Refractometry
5810-7 [3019150]
6.8e-01
9.1e-01
1.1e+00
2.8e+00
1.1e+00
7.3e-01
7.8e-01
cases:12.93%
controls:7.00%
cases:9.29%
controls:3.95%
cases:1.96%
controls:0.65%
cases:0.33%
controls:0.02%
cases:1.78%
controls:0.58%
cases:8.45%
controls:4.25%
cases:21.59%
controls:11.25%
672
3635
4525
48307
483
2054
4714
49888
102
338
5095
51604
17
10
5180
51932
92
301
5065
51410
410
2073
4442
46698
794
4224
2883
33313
Voluntary or Charitable Agency
251V00000X [38004202]
6.1e-01
1.1e+00
1.8e+00
—
2.2e+00
1.1e+00
1.4e+00
cases:0.94%
controls:0.52%
cases:0.85%
controls:0.29%
cases:0.23%
controls:0.04%
—
—
cases:0.31%
controls:0.03%
cases:0.99%
controls:0.35%
cases:4.38%
controls:1.12%
49
268
5148
51674
44
150
5153
51792
12
20
5185
51922
—
16
17
5141
51694
48
169
4804
48602
161
421
3516
37116
colecalciferol; oral
A11CC05 [21600820]
7.3e-01
1.3e+00
1.4e+00
—
1.5e+00
1.6e+00
1.7e+00
cases:0.75%
controls:0.36%
cases:1.39%
controls:0.39%
cases:0.85%
controls:0.21%
—
—
cases:0.95%
controls:0.22%
cases:2.43%
controls:0.48%
cases:5.66%
controls:1.11%
39
188
5158
51754
72
204
5125
51738
44
111
5153
51831
—
49
112
5108
51599
118
236
4734
48535
208
418
3469
37119
Sleep apnoea
G47.3 [45562094]
4.0e-01
5.8e-01
8.8e-01
4.3e+00
8.6e-01
6.7e-01
5.2e-01
cases:7.60%
controls:5.23%
cases:5.60%
controls:3.22%
cases:1.52%
controls:0.63%
cases:1.87%
controls:0.03%
cases:1.49%
controls:0.64%
cases:6.24%
controls:3.31%
cases:9.52%
controls:5.91%
395
2719
4802
49223
291
1671
4906
50271
79
329
5118
51613
97
14
5100
51928
77
331
5080
51380
303
1615
4549
47156
350
2219
3327
35318
clonazepam; oral, parenteral
N03AE01 [21604415]
1.2e+00
1.3e+00
1.7e+00
—
1.3e+00
1.2e+00
1.4e+00
cases:2.66%
controls:0.85%
cases:1.87%
controls:0.50%
cases:0.65%
controls:0.12%
—
—
cases:0.50%
controls:0.14%
cases:1.75%
controls:0.52%
cases:2.69%
controls:0.67%
138
444
5059
51498
97
262
5100
51680
34
63
5163
51879
—
26
72
5131
51639
85
252
4767
48519
99
253
3578
37284
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22126-7 [3010380]
1.1e+00
3.0e+00
—
—
—
2.6e+00
1.4e+00
cases:0.44%
controls:0.14%
cases:0.42%
controls:0.02%
—
—
—
—
—
—
cases:0.47%
controls:0.04%
cases:0.52%
controls:0.13%
23
74
5174
51868
22
11
5175
51931
—
—
—
23
18
4829
48753
19
49
3658
37488
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
6.4e-01
1.4e+00
1.3e+00
1.8e+00
1.3e+00
7.8e-01
8.5e-01
cases:22.11%
controls:13.04%
cases:22.88%
controls:7.03%
cases:4.64%
controls:1.25%
cases:0.37%
controls:0.06%
cases:4.23%
controls:1.24%
cases:14.41%
controls:7.14%
cases:33.51%
controls:17.77%
1149
6771
4048
45171
1189
3651
4008
48291
241
650
4956
51292
19
31
5178
51911
218
642
4939
51069
699
3481
4153
45290
1232
6670
2445
30867
Parkinsonism
N87 [2002000787]
1.3e+00
1.4e+00
2.1e+00
—
1.4e+00
1.6e+00
1.6e+00
cases:0.56%
controls:0.15%
cases:0.42%
controls:0.10%
cases:0.17%
controls:0.02%
—
—
cases:0.14%
controls:0.03%
cases:0.60%
controls:0.13%
cases:1.39%
controls:0.27%
29
79
5168
51863
22
52
5175
51890
9
11
5188
51931
—
7
18
5150
51693
29
62
4823
48709
51
102
3626
37435
Delirium, unspecified
F05.9 [45591078]
4.0e+00
—
—
1.0e+50
—
—
4.1e+00
cases:0.90%
controls:0.02%
—
—
—
—
cases:0.77%
controls:0.00%
—
—
—
—
cases:1.99%
controls:0.03%
47
9
5150
51933
—
—
40
0
5157
51942
—
—
73
13
3604
37524
Rehabilitation Hospital
283X00000X [38004285]
1.1e+00
1.8e+00
—
—
1.9e+00
2.0e+00
1.3e+00
cases:1.12%
controls:0.38%
cases:0.63%
controls:0.11%
—
—
—
—
cases:0.14%
controls:0.02%
cases:0.78%
controls:0.11%
cases:1.03%
controls:0.27%
58
198
5139
51744
33
57
5164
51885
—
—
7
11
5150
51700
38
53
4814
48718
38
103
3639
37434
Chronic alcohol abuse
P15 [2002000811]
1.3e+00
1.7e+00
2.4e+00
—
1.5e+00
1.4e+00
1.2e+00
cases:0.81%
controls:0.23%
cases:0.50%
controls:0.09%
cases:0.15%
controls:0.01%
—
—
cases:0.10%
controls:0.02%
cases:0.41%
controls:0.10%
cases:0.98%
controls:0.29%
42
120
5155
51822
26
48
5171
51894
8
7
5189
51935
—
5
11
5152
51700
20
51
4832
48720
36
108
3641
37429
Orthostatic hypotension
I95.1 [45605872]
7.8e-01
1.2e+00
1.5e+00
—
2.0e+00
1.3e+00
1.1e+00
cases:1.31%
controls:0.60%
cases:0.96%
controls:0.28%
cases:0.19%
controls:0.04%
—
—
cases:0.33%
controls:0.05%
cases:1.11%
controls:0.29%
cases:2.80%
controls:0.91%
68
314
5129
51628
50
146
5147
51796
10
22
5187
51920
—
17
24
5140
51687
54
143
4798
48628
103
342
3574
37195
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
5.3e-01
9.9e-01
2.1e+00
—
2.4e+00
1.0e+00
9.1e-01
cases:1.29%
controls:0.76%
cases:0.89%
controls:0.33%
cases:0.27%
controls:0.03%
—
—
cases:0.21%
controls:0.02%
cases:0.95%
controls:0.34%
cases:2.83%
controls:1.16%
67
395
5130
51547
46
172
5151
51770
14
17
5183
51925
—
11
10
5146
51701
46
165
4806
48606
104
436
3573
37101
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
3.0e-01
6.9e-01
1.3e+00
3.6e+00
9.6e-01
5.7e-01
5.4e-01
cases:15.61%
controls:12.01%
cases:10.58%
controls:5.59%
cases:2.89%
controls:0.81%
cases:1.64%
controls:0.05%
cases:2.21%
controls:0.86%
cases:10.43%
controls:6.16%
cases:26.22%
controls:17.18%
811
6237
4386
45705
550
2902
4647
49040
150
419
5047
51523
85
24
5112
51918
114
445
5043
51266
506
3006
4346
45765
964
6450
2713
31087
Accelerated psychiatric treatment contact
IGY01 [2001304321]
1.4e+00
2.0e+00
—
—
—
2.7e+00
1.8e+00
cases:0.27%
controls:0.07%
cases:0.46%
controls:0.06%
—
—
—
—
—
—
cases:0.70%
controls:0.05%
cases:0.90%
controls:0.14%
14
34
5183
51908
24
32
5173
51910
—
—
—
34
24
4818
48747
33
54
3644
37483
Sequelae of subarachnoid haemorrhage
I69.0 [45543193]
7.4e-01
1.8e+00
—
1.0e+50
2.5e+00
1.9e+00
1.8e+00
cases:0.27%
controls:0.13%
cases:0.29%
controls:0.05%
—
—
cases:0.31%
controls:0.00%
cases:0.12%
controls:0.01%
cases:0.47%
controls:0.07%
cases:0.90%
controls:0.15%
14
67
5183
51875
15
25
5182
51917
—
16
0
5181
51942
6
5
5151
51706
23
36
4829
48735
33
57
3644
37480
Treponema pallidum Ab [Presence] in Serum
22587-0 [3019832]
5.4e-01
1.5e+00
1.9e+00
—
2.9e+00
1.1e+00
4.6e-01
cases:1.12%
controls:0.65%
cases:1.08%
controls:0.25%
cases:0.17%
controls:0.03%
—
—
cases:0.39%
controls:0.02%
cases:0.68%
controls:0.22%
cases:1.60%
controls:1.02%
58
340
5139
51602
56
129
5141
51813
9
14
5188
51928
—
20
11
5137
51700
33
106
4819
48665
59
382
3618
37155
Procedure duration 120 to 149 minutes
ZXE15 [2001311406]
9.7e-01
2.8e+00
—
1.0e+50
—
2.7e+00
2.5e+00
cases:0.27%
controls:0.10%
cases:0.37%
controls:0.02%
—
—
cases:0.13%
controls:0.00%
—
—
cases:0.49%
controls:0.03%
cases:0.71%
controls:0.06%
14
53
5183
51889
19
12
5178
51930
—
7
0
5190
51942
—
24
17
4828
48754
26
22
3651
37515
Addiction caused by alcohol UNS
F10.29 [2000501684]
1.8e+00
2.8e+00
—
1.0e+50
—
1.7e+00
1.6e+00
cases:0.75%
controls:0.13%
cases:0.50%
controls:0.03%
—
—
cases:0.25%
controls:0.00%
—
—
cases:0.27%
controls:0.05%
cases:0.65%
controls:0.13%
39
68
5158
51874
26
16
5171
51926
—
13
0
5184
51942
—
13
23
4839
48748
24
49
3653
37488
Assessment of need for psychiatric treatment
IAA01 [2001304011]
2.0e+00
2.4e+00
—
1.0e+50
—
1.9e+00
1.6e+00
cases:0.71%
controls:0.10%
cases:0.60%
controls:0.05%
—
—
cases:0.44%
controls:0.00%
—
—
cases:0.35%
controls:0.05%
cases:0.95%
controls:0.19%
37
52
5160
51890
31
27
5166
51915
—
23
0
5174
51942
—
17
26
4835
48745
35
73
3642
37464
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
3.1e-01
8.0e-01
9.8e-01
2.8e+00
1.7e+00
6.4e-01
6.1e-01
cases:5.06%
controls:3.75%
cases:3.50%
controls:1.60%
cases:0.75%
controls:0.28%
cases:0.19%
controls:0.01%
cases:1.49%
controls:0.27%
cases:3.38%
controls:1.81%
cases:8.68%
controls:4.89%
263
1946
4934
49996
182
830
5015
51112
39
147
5158
51795
10
6
5187
51936
77
141
5080
51570
164
881
4688
47890
319
1836
3358
35701
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22133-3 [3014973]
1.1e+00
2.9e+00
—
—
—
2.4e+00
1.5e+00
cases:0.44%
controls:0.15%
cases:0.44%
controls:0.03%
—
—
—
—
—
—
cases:0.49%
controls:0.04%
cases:0.60%
controls:0.14%
23
78
5174
51864
23
13
5174
51929
—
—
—
24
21
4828
48750
22
52
3655
37485
Vascular dementia, unspecified
F01.9 [45533058]
2.1e+00
2.7e+00
—
1.0e+50
—
—
3.1e+00
cases:0.15%
controls:0.02%
cases:0.19%
controls:0.01%
—
—
cases:0.13%
controls:0.00%
—
—
—
—
cases:1.74%
controls:0.08%
8
10
5189
51932
10
7
5187
51935
—
7
0
5190
51942
—
—
64
29
3613
37508
Implementation of occupational therapy rehabilitation plan
SPAT1226 [2001700327]
7.7e-01
1.9e+00
—
—
2.1e+00
1.8e+00
1.3e+00
cases:0.67%
controls:0.31%
cases:0.48%
controls:0.07%
—
—
—
—
cases:0.14%
controls:0.02%
cases:0.76%
controls:0.13%
cases:1.50%
controls:0.39%
35
163
5162
51779
25
37
5172
51905
—
—
7
9
5150
51702
37
63
4815
48708
55
148
3622
37389
Subarachnoid haemorrhage from middle cerebral artery
I60.1 [45552798]
1.0e+00
2.3e+00
1.0e+50
—
1.0e+50
3.0e+00
2.5e+00
cases:0.12%
controls:0.04%
cases:0.13%
controls:0.01%
cases:0.12%
controls:0.00%
—
—
cases:0.10%
controls:0.00%
cases:0.25%
controls:0.01%
cases:0.27%
controls:0.02%
6
21
5191
51921
7
7
5190
51935
6
0
5191
51942
—
5
0
5152
51711
12
6
4840
48765
10
8
3667
37529
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22118-4 [3011166]
1.1e+00
3.2e+00
—
—
—
2.4e+00
1.1e+00
cases:0.38%
controls:0.12%
cases:0.40%
controls:0.02%
—
—
—
—
—
—
cases:0.43%
controls:0.04%
cases:0.41%
controls:0.13%
20
64
5177
51878
21
9
5176
51933
—
—
—
21
20
4831
48751
15
49
3662
37488
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
6.9e-01
1.2e+00
1.9e+00
—
1.6e+00
1.3e+00
1.1e+00
cases:5.37%
controls:2.76%
cases:3.08%
controls:0.98%
cases:0.67%
controls:0.10%
—
—
cases:0.66%
controls:0.13%
cases:3.42%
controls:0.97%
cases:8.78%
controls:3.02%
279
1436
4918
50506
160
510
5037
51432
35
53
5162
51889
—
34
67
5123
51644
166
475
4686
48296
323
1135
3354
36402
Sequelae of intracerebral haemorrhage
I69.1 [45538404]
1.3e+00
1.3e+00
2.1e+00
1.0e+50
2.0e+00
1.5e+00
1.6e+00
cases:0.44%
controls:0.12%
cases:0.25%
controls:0.07%
cases:0.12%
controls:0.01%
cases:0.29%
controls:0.00%
cases:0.10%
controls:0.01%
cases:0.37%
controls:0.08%
cases:0.95%
controls:0.20%
23
64
5174
51878
13
35
5184
51907
6
7
5191
51935
15
0
5182
51942
5
7
5152
51704
18
41
4834
48730
35
76
3642
37461
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
F25.10 [2000501966]
2.2e+00
2.3e+00
—
—
—
2.6e+00
3.0e+00
cases:0.15%
controls:0.02%
cases:0.10%
controls:0.01%
—
—
—
—
—
—
cases:0.14%
controls:0.01%
cases:0.41%
controls:0.02%
8
9
5189
51933
5
5
5192
51937
—
—
—
7
5
4845
48766
15
8
3662
37529
Focal brain injury
S06.3 [45606905]
1.6e+00
2.3e+00
—
1.0e+50
—
1.9e+00
1.9e+00
cases:0.42%
controls:0.08%
cases:0.37%
controls:0.04%
—
—
cases:0.10%
controls:0.00%
—
—
cases:0.35%
controls:0.05%
cases:0.73%
controls:0.11%
22
44
5175
51898
19
19
5178
51923
—
5
0
5192
51942
—
17
25
4835
48746
27
40
3650
37497
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
3.6e-01
7.1e-01
1.1e+00
3.7e+00
8.7e-01
4.9e-01
5.3e-01
cases:24.03%
controls:18.10%
cases:16.43%
controls:8.85%
cases:3.83%
controls:1.30%
cases:2.04%
controls:0.05%
cases:2.87%
controls:1.23%
cases:14.06%
controls:9.12%
cases:35.33%
controls:24.38%
1249
9399
3948
42543
854
4599
4343
47343
199
677
4998
51265
106
26
5091
51916
148
635
5009
51076
682
4448
4170
44323
1299
9153
2378
28384
IgG [Mass/volume] in Cerebral spinal fluid
2464-6 [3007368]
1.2e+00
2.9e+00
—
—
1.0e+50
2.4e+00
1.4e+00
cases:0.27%
controls:0.08%
cases:0.37%
controls:0.02%
—
—
—
—
cases:0.14%
controls:0.00%
cases:0.35%
controls:0.03%
cases:0.27%
controls:0.07%
14
43
5183
51899
19
11
5178
51931
—
—
7
0
5150
51711
17
16
4835
48755
10
26
3667
37511
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
1.3e+00
1.4e+00
1.2e+00
—
2.2e+00
1.7e+00
1.2e+00
cases:1.73%
controls:0.47%
cases:0.73%
controls:0.19%
cases:0.10%
controls:0.03%
—
—
cases:0.16%
controls:0.02%
cases:1.09%
controls:0.20%
cases:1.88%
controls:0.59%
90
242
5107
51700
38
97
5159
51845
5
15
5192
51927
—
8
9
5149
51702
53
97
4799
48674
69
220
3608
37317
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
6.9e-01
1.0e+00
6.5e-01
2.9e+00
1.6e+00
7.5e-01
7.6e-01
cases:4.29%
controls:2.20%
cases:3.02%
controls:1.13%
cases:0.31%
controls:0.16%
cases:0.17%
controls:0.01%
cases:0.80%
controls:0.15%
cases:2.84%
controls:1.36%
cases:9.71%
controls:4.81%
223
1142
4974
50800
157
588
5040
51354
16
84
5181
51858
9
5
5188
51937
41
80
5116
51631
138
665
4714
48106
357
1805
3320
35732
Degeneration of nervous system due to alcohol
G31.2 [45591167]
8.4e-01
1.9e+00
—
1.0e+50
—
2.8e+00
3.1e+00
cases:0.12%
controls:0.05%
cases:0.13%
controls:0.02%
—
—
cases:0.23%
controls:0.00%
—
—
cases:0.29%
controls:0.02%
cases:0.54%
controls:0.02%
6
26
5191
51916
7
11
5190
51931
—
12
0
5185
51942
—
14
9
4838
48762
20
9
3657
37528
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
5.2e-01
1.0e+00
1.2e+00
1.0e+00
1.4e+00
1.3e+00
1.2e+00
cases:5.35%
controls:3.25%
cases:4.39%
controls:1.60%
cases:1.85%
controls:0.57%
cases:0.52%
controls:0.18%
cases:2.23%
controls:0.59%
cases:6.62%
controls:1.80%
cases:13.16%
controls:4.24%
278
1687
4919
50255
228
833
4969
51109
96
295
5101
51647
27
96
5170
51846
115
303
5042
51408
321
880
4531
47891
484
1590
3193
35947
Support of social functional capacity
SPAT1234 [2001700335]
6.6e-01
1.2e+00
9.4e-01
3.6e-01
1.2e+00
1.8e+00
2.0e+00
cases:1.35%
controls:0.70%
cases:1.48%
controls:0.44%
cases:0.62%
controls:0.24%
cases:0.10%
controls:0.07%
cases:0.74%
controls:0.23%
cases:2.93%
controls:0.51%
cases:7.89%
controls:1.19%
70
364
5127
51578
77
231
5120
51711
32
125
5165
51817
5
35
5192
51907
38
119
5119
51592
142
251
4710
48520
290
445
3387
37092
phenytoin; oral, parenteral
N03AB02 [21604399]
1.3e+00
1.4e+00
—
—
2.2e+00
1.4e+00
1.4e+00
cases:0.38%
controls:0.10%
cases:0.29%
controls:0.07%
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.27%
controls:0.06%
cases:0.33%
controls:0.08%
20
54
5177
51888
15
36
5182
51906
—
—
6
7
5151
51704
13
31
4839
48740
12
31
3665
37506
Lamotrigin and topiramate
183 [2001600182]
2.2e+00
2.5e+00
—
—
—
—
3.0e+00
cases:0.29%
controls:0.03%
cases:0.12%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.02%
15
17
5182
51925
6
5
5191
51937
—
—
—
—
16
8
3661
37529
Psychiatric treatment plan, standard
ICB01 [2001304098]
1.5e+00
1.7e+00
—
—
—
2.5e+00
1.9e+00
cases:0.42%
controls:0.10%
cases:0.40%
controls:0.07%
—
—
—
—
—
—
cases:0.54%
controls:0.04%
cases:1.14%
controls:0.17%
22
50
5175
51892
21
37
5176
51905
—
—
—
26
21
4826
48750
42
63
3635
37474
Fear of neurological disease other
N27 [2002000732]
1.5e+00
2.6e+00
—
—
2.2e+00
1.4e+00
5.2e-01
cases:0.69%
controls:0.16%
cases:0.73%
controls:0.06%
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.37%
controls:0.09%
cases:0.33%
controls:0.19%
36
82
5161
51860
38
29
5159
51913
—
—
6
7
5151
51704
18
43
4834
48728
12
73
3665
37464
Psychiatric consultation in another specialty
IAZ97 [2001304038]
1.5e+00
1.5e+00
—
1.0e+50
2.6e+00
1.9e+00
1.6e+00
cases:0.31%
controls:0.07%
cases:0.15%
controls:0.03%
—
—
cases:0.29%
controls:0.00%
cases:0.16%
controls:0.01%
cases:0.21%
controls:0.03%
cases:0.38%
controls:0.07%
16
35
5181
51907
8
18
5189
51924
—
15
0
5182
51942
8
6
5149
51705
10
15
4842
48756
14
28
3663
37509
Depressive episode
F32 [45595904]
1.4e+00
1.8e+00
1.8e+00
—
—
1.5e+00
1.1e+00
cases:1.50%
controls:0.37%
cases:0.67%
controls:0.11%
cases:0.15%
controls:0.03%
—
—
—
—
cases:0.41%
controls:0.09%
cases:1.25%
controls:0.44%
78
194
5119
51748
35
56
5162
51886
8
13
5189
51929
—
—
20
44
4832
48727
46
165
3631
37372
12 lead EKG panel
34534-8 [3044889]
4.3e-01
9.4e-01
1.2e+00
3.0e+00
1.1e+00
5.8e-01
3.8e-01
cases:35.85%
controls:26.66%
cases:29.75%
controls:14.16%
cases:5.29%
controls:1.70%
cases:1.00%
controls:0.05%
cases:4.58%
controls:1.65%
cases:21.99%
controls:13.69%
cases:41.23%
controls:32.37%
1863
13847
3334
38095
1546
7357
3651
44585
275
881
4922
51061
52
25
5145
51917
236
851
4921
50860
1067
6677
3785
42094
1516
12150
2161
25387
Bipolar affective disorder, current episode manic without psychotic symptoms
F31.1 [45576537]
2.3e+00
2.3e+00
—
—
—
—
3.0e+00
cases:0.33%
controls:0.03%
cases:0.13%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.52%
controls:0.03%
17
17
5180
51925
7
7
5190
51935
—
—
—
—
19
10
3658
37527
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
182 [2001600181]
1.4e+00
2.5e+00
—
—
—
2.0e+00
1.7e+00
cases:0.52%
controls:0.13%
cases:0.40%
controls:0.03%
—
—
—
—
—
—
cases:0.31%
controls:0.04%
cases:0.76%
controls:0.14%
27
70
5170
51872
21
18
5176
51924
—
—
—
15
20
4837
48751
28
51
3649
37486
Cells panel - Urine sediment
58434-2 [40761535]
7.5e-01
1.3e+00
1.4e+00
—
1.6e+00
1.3e+00
1.2e+00
cases:5.83%
controls:2.84%
cases:3.91%
controls:1.11%
cases:0.73%
controls:0.18%
—
—
cases:0.83%
controls:0.17%
cases:3.96%
controls:1.11%
cases:9.19%
controls:2.97%
303
1476
4894
50466
203
575
4994
51367
38
94
5159
51848
—
43
86
5114
51625
192
539
4660
48232
338
1113
3339
36424
Dedicated profession-specific psychiatric intervention, group
IER02 [2001304206]
1.4e+00
2.9e+00
—
1.0e+50
—
2.4e+00
2.2e+00
cases:0.12%
controls:0.03%
cases:0.17%
controls:0.01%
—
—
cases:0.27%
controls:0.00%
—
—
cases:0.21%
controls:0.02%
cases:0.30%
controls:0.03%
6
15
5191
51927
9
5
5188
51937
—
14
0
5183
51942
—
10
9
4842
48762
11
12
3666
37525
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
1.8e+00
2.2e+00
—
—
—
1.8e+00
1.7e+00
cases:0.46%
controls:0.08%
cases:0.37%
controls:0.04%
—
—
—
—
—
—
cases:0.23%
controls:0.04%
cases:0.79%
controls:0.14%
24
41
5173
51901
19
21
5178
51921
—
—
—
11
18
4841
48753
29
52
3648
37485
ropinirole; oral
N04BC04 [21604476]
1.7e+00
1.6e+00
1.2e+00
—
2.0e+00
1.2e+00
1.0e+00
cases:0.87%
controls:0.15%
cases:0.54%
controls:0.11%
cases:0.17%
controls:0.05%
—
—
cases:0.27%
controls:0.04%
cases:0.45%
controls:0.13%
cases:0.41%
controls:0.15%
45
79
5152
51863
28
59
5169
51883
9
26
5188
51916
—
14
20
5143
51691
22
64
4830
48707
15
55
3662
37482
Bacteria identified in Urine by Culture
630-4 [3026008]
4.8e-01
7.1e-01
1.1e+00
3.0e+00
9.2e-01
6.5e-01
6.6e-01
cases:14.37%
controls:9.40%
cases:9.58%
controls:4.94%
cases:2.08%
controls:0.73%
cases:0.56%
controls:0.03%
cases:2.04%
controls:0.82%
cases:9.40%
controls:5.14%
cases:24.20%
controls:14.15%
747
4880
4450
47062
498
2568
4699
49374
108
380
5089
51562
29
14
5168
51928
105
424
5052
51287
456
2509
4396
46262
890
5310
2787
32227
Limited function/disability NOS
A28 [2002000162]
7.0e-01
1.0e+00
1.2e+00
1.2e+00
1.2e+00
1.3e+00
9.1e-01
cases:7.31%
controls:3.78%
cases:6.72%
controls:2.54%
cases:3.12%
controls:0.98%
cases:0.98%
controls:0.30%
cases:3.28%
controls:0.98%
cases:9.62%
controls:2.95%
cases:16.45%
controls:7.35%
380
1963
4817
49979
349
1319
4848
50623
162
507
5035
51435
51
155
5146
51787
169
508
4988
51203
467
1439
4385
47332
605
2759
3072
34778
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
4.7e-01
6.8e-01
9.5e-01
3.2e+00
9.7e-01
5.9e-01
6.4e-01
cases:31.61%
controls:22.50%
cases:20.61%
controls:11.65%
cases:4.93%
controls:1.96%
cases:1.46%
controls:0.06%
cases:4.87%
controls:1.90%
cases:19.58%
controls:11.88%
cases:43.32%
controls:28.69%
1643
11686
3554
40256
1071
6050
4126
45892
256
1016
4941
50926
76
32
5121
51910
251
982
4906
50729
950
5794
3902
42977
1593
10770
2084
26767
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
8.2e-01
2.1e+00
—
1.0e+50
—
2.4e+00
2.2e+00
cases:0.54%
controls:0.24%
cases:0.60%
controls:0.08%
—
—
cases:0.21%
controls:0.00%
—
—
cases:0.64%
controls:0.06%
cases:0.87%
controls:0.10%
28
124
5169
51818
31
40
5166
51902
—
11
0
5186
51942
—
31
28
4821
48743
32
38
3645
37499
Post-traumatic stress disorder
F43.1 [45595909]
1.6e+00
2.0e+00
—
1.0e+50
—
2.3e+00
1.5e+00
cases:0.42%
controls:0.09%
cases:0.25%
controls:0.03%
—
—
cases:0.23%
controls:0.00%
—
—
cases:0.37%
controls:0.04%
cases:0.44%
controls:0.09%
22
45
5175
51897
13
18
5184
51924
—
12
0
5185
51942
—
18
18
4834
48753
16
35
3661
37502
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
6.9e-01
9.6e-01
6.1e-01
2.7e+00
1.6e+00
7.5e-01
7.4e-01
cases:4.19%
controls:2.15%
cases:3.16%
controls:1.23%
cases:0.33%
controls:0.18%
cases:0.17%
controls:0.01%
cases:0.76%
controls:0.16%
cases:3.01%
controls:1.44%
cases:10.09%
controls:5.07%
218
1119
4979
50823
164
639
5033
51303
17
92
5180
51850
9
6
5188
51936
39
82
5118
51629
146
704
4706
48067
371
1904
3306
35633
Specialised imaging for glaucoma
CS5Z4 [2001301479]
1.3e+00
1.6e+00
—
—
2.1e+00
1.1e+00
1.3e+00
cases:1.46%
controls:0.39%
cases:1.00%
controls:0.21%
—
—
—
—
cases:0.25%
controls:0.03%
cases:0.74%
controls:0.24%
cases:1.90%
controls:0.54%
76
202
5121
51740
52
108
5145
51834
—
—
13
16
5144
51695
36
119
4816
48652
70
203
3607
37334
Epilepsy and comparable convulsive disorders
111 [2001600111]
1.4e+00
2.2e+00
—
—
—
2.1e+00
1.7e+00
cases:1.10%
controls:0.28%
cases:0.67%
controls:0.08%
—
—
—
—
—
—
cases:0.58%
controls:0.07%
cases:1.36%
controls:0.25%
57
147
5140
51795
35
40
5162
51902
—
—
—
28
33
4824
48738
50
94
3627
37443
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5.0e-01
6.9e-01
9.9e-01
2.7e+00
1.1e+00
7.2e-01
6.7e-01
cases:10.28%
controls:6.47%
cases:7.64%
controls:3.99%
cases:1.75%
controls:0.66%
cases:0.23%
controls:0.02%
cases:1.80%
controls:0.61%
cases:8.12%
controls:4.11%
cases:19.28%
controls:10.94%
534
3363
4663
48579
397
2070
4800
49872
91
342
5106
51600
12
8
5185
51934
93
314
5064
51397
394
2004
4458
46767
709
4106
2968
33431
Ventriculoperitoneal shunt
AAF05 [2001300295]
1.1e+00
2.8e+00
—
—
—
—
3.4e+00
cases:0.37%
controls:0.12%
cases:0.33%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.87%
controls:0.03%
19
61
5178
51881
17
10
5180
51932
—
—
—
—
32
11
3645
37526
Psychological disorders other
P99 [2002000880]
1.6e+00
2.0e+00
1.7e+00
—
1.7e+00
1.9e+00
1.9e+00
cases:0.81%
controls:0.17%
cases:0.56%
controls:0.08%
cases:0.12%
controls:0.02%
—
—
cases:0.10%
controls:0.02%
cases:0.54%
controls:0.08%
cases:1.41%
controls:0.21%
42
89
5155
51853
29
41
5168
51901
6
11
5191
51931
—
5
9
5152
51702
26
39
4826
48732
52
78
3625
37459
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
3.3e-01
6.7e-01
1.1e+00
2.9e+00
1.1e+00
6.8e-01
5.3e-01
cases:4.10%
controls:2.98%
cases:2.87%
controls:1.49%
cases:0.60%
controls:0.20%
cases:0.37%
controls:0.02%
cases:0.62%
controls:0.21%
cases:3.11%
controls:1.61%
cases:9.14%
controls:5.56%
213
1550
4984
50392
149
773
5048
51169
31
105
5166
51837
19
10
5178
51932
32
108
5125
51603
151
783
4701
47988
336
2088
3341
35449
Bipolar affective disorder, current episode mixed
F31.6 [45571757]
2.4e+00
2.4e+00
—
—
—
—
2.6e+00
cases:0.42%
controls:0.04%
cases:0.19%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.05%
22
21
5175
51921
10
9
5187
51933
—
—
—
—
23
18
3654
37519
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
6.1e-01
6.9e-01
7.6e-01
3.3e+00
1.0e+00
6.6e-01
3.2e-01
cases:10.35%
controls:5.93%
cases:5.52%
controls:2.85%
cases:1.00%
controls:0.47%
cases:0.60%
controls:0.02%
cases:1.12%
controls:0.40%
cases:5.69%
controls:3.01%
cases:10.91%
controls:8.20%
538
3079
4659
48863
287
1478
4910
50464
52
244
5145
51698
31
12
5166
51930
58
209
5099
51502
276
1468
4576
47303
401
3078
3276
34459
levodopa and decarboxylase inhibitor; oral
N04BA02 [21604465]
1.1e+00
1.1e+00
1.2e+00
—
1.3e+00
1.3e+00
1.3e+00
cases:1.89%
controls:0.66%
cases:1.83%
controls:0.64%
cases:0.81%
controls:0.24%
—
—
cases:0.89%
controls:0.24%
cases:2.51%
controls:0.69%
cases:3.43%
controls:0.92%
98
344
5099
51598
95
335
5102
51607
42
125
5155
51817
—
46
123
5111
51588
122
335
4730
48436
126
347
3551
37190
Pneumonia, unspecified
J18.9 [45601123]
3.6e-01
5.9e-01
1.0e+00
3.3e+00
9.2e-01
5.9e-01
5.2e-01
cases:6.45%
controls:4.60%
cases:3.43%
controls:1.93%
cases:0.83%
controls:0.29%
cases:0.52%
controls:0.02%
cases:0.68%
controls:0.27%
cases:3.87%
controls:2.19%
cases:11.04%
controls:6.88%
335
2389
4862
49553
178
1000
5019
50942
43
153
5154
51789
27
10
5170
51932
35
141
5122
51570
188
1068
4664
47703
406
2583
3271
34954
fluoxetine; oral
N06AB03 [21604711]
1.2e+00
1.2e+00
1.0e+00
2.0e+00
1.5e+00
1.2e+00
1.2e+00
cases:2.46%
controls:0.77%
cases:1.37%
controls:0.42%
cases:0.29%
controls:0.11%
cases:0.10%
controls:0.01%
cases:0.41%
controls:0.09%
cases:1.32%
controls:0.42%
cases:2.04%
controls:0.61%
128
401
5069
51541
71
217
5126
51725
15
55
5182
51887
5
7
5192
51935
21
45
5136
51666
64
204
4788
48567
75
229
3602
37308
Thorax X-ray examination
GD1AA [2001303617]
4.6e-01
7.5e-01
8.8e-01
3.2e+00
8.1e-01
6.7e-01
5.4e-01
cases:19.28%
controls:13.14%
cases:10.31%
controls:5.14%
cases:1.71%
controls:0.71%
cases:0.96%
controls:0.04%
cases:1.34%
controls:0.60%
cases:9.05%
controls:4.84%
cases:21.65%
controls:13.87%
1002
6826
4195
45116
536
2669
4661
49273
89
371
5108
51571
50
21
5147
51921
69
311
5088
51400
439
2360
4413
46411
796
5205
2881
32332
Home Visit
OMOP4822459 [581476]
5.2e-01
9.8e-01
1.1e+00
1.1e+00
1.2e+00
1.2e+00
1.2e+00
cases:13.26%
controls:8.34%
cases:13.05%
controls:5.34%
cases:5.81%
controls:2.06%
cases:2.16%
controls:0.73%
cases:6.71%
controls:2.07%
cases:18.18%
controls:6.20%
cases:36.01%
controls:14.74%
689
4334
4508
47608
678
2772
4519
49170
302
1070
4895
50872
112
379
5085
51563
346
1073
4811
50638
882
3024
3970
45747
1324
5533
2353
32004
Alzheimer disease, unspecified
G30.9 [45591165]
3.1e+00
—
—
—
—
—
4.1e+00
cases:0.31%
controls:0.01%
—
—
—
—
—
—
—
—
—
—
cases:4.35%
controls:0.07%
16
7
5181
51935
—
—
—
—
—
160
27
3517
37510
Electroconvulsive Therapy (ECT)
IFB01 [2001304301]
2.1e+00
2.1e+00
—
—
—
2.7e+00
2.5e+00
cases:0.23%
controls:0.03%
cases:0.10%
controls:0.01%
—
—
—
—
—
—
cases:0.19%
controls:0.01%
cases:0.57%
controls:0.05%
12
15
5185
51927
5
6
5192
51936
—
—
—
9
6
4843
48765
21
18
3656
37519
Recurrent depressive disorder, current episode severe with psychotic symptoms
F33.3 [45562042]
2.2e+00
2.3e+00
—
—
—
—
2.7e+00
cases:0.25%
controls:0.03%
cases:0.12%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.02%
13
14
5184
51928
6
6
5191
51936
—
—
—
—
12
8
3665
37529
Alcohol dependence continuous use
F10.25 [2000501682]
1.6e+00
2.2e+00
—
1.0e+50
—
1.7e+00
1.7e+00
cases:0.44%
controls:0.09%
cases:0.25%
controls:0.03%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.23%
controls:0.04%
cases:0.68%
controls:0.12%
23
48
5174
51894
13
14
5184
51928
—
10
0
5187
51942
—
11
20
4841
48751
25
45
3652
37492
Anankastic personality disorder
F60.5 [45591150]
7.8e-01
2.2e+00
—
—
—
2.6e+00
2.4e+00
cases:0.10%
controls:0.04%
cases:0.13%
controls:0.02%
—
—
—
—
—
—
cases:0.14%
controls:0.01%
cases:0.38%
controls:0.03%
5
23
5192
51919
7
8
5190
51934
—
—
—
7
5
4845
48766
14
13
3663
37524
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2.8e-01
7.0e-01
1.2e+00
2.4e+00
1.7e+00
4.9e-01
4.1e-01
cases:20.65%
controls:16.39%
cases:13.55%
controls:7.20%
cases:3.16%
controls:0.95%
cases:0.62%
controls:0.06%
cases:4.63%
controls:0.90%
cases:11.62%
controls:7.44%
cases:28.28%
controls:20.76%
1073
8512
4124
43430
704
3739
4493
48203
164
495
5033
51447
32
29
5165
51913
239
464
4918
51247
564
3627
4288
45144
1040
7793
2637
29744
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
2.6e-01
5.1e-01
1.1e+00
3.3e+00
1.1e+00
4.1e-01
5.7e-01
cases:13.74%
controls:10.90%
cases:9.01%
controls:5.59%
cases:2.37%
controls:0.80%
cases:0.75%
controls:0.03%
cases:2.27%
controls:0.79%
cases:8.47%
controls:5.76%
cases:23.99%
controls:15.17%
714
5660
4483
46282
468
2906
4729
49036
123
416
5074
51526
39
15
5158
51927
117
411
5040
51300
411
2810
4441
45961
882
5696
2795
31841
Psychiatric network contact
IGV01 [2001304319]
2.1e+00
—
—
1.0e+50
1.0e+50
2.6e+00
2.4e+00
cases:0.12%
controls:0.01%
—
—
—
—
cases:0.13%
controls:0.00%
cases:0.10%
controls:0.00%
cases:0.14%
controls:0.01%
cases:0.46%
controls:0.04%
6
7
5191
51935
—
—
7
0
5190
51942
5
0
5152
51711
7
5
4845
48766
17
16
3660
37521
Structured mapping of problematic alcohol use
IHA10 [2001304335]
—
2.9e+00
—
1.0e+50
—
2.3e+00
1.9e+00
—
—
cases:0.25%
controls:0.01%
—
—
cases:0.58%
controls:0.00%
—
—
cases:0.19%
controls:0.02%
cases:0.38%
controls:0.06%
—
13
7
5184
51935
—
30
0
5167
51942
—
9
9
4843
48762
14
21
3663
37516
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
3.3e-01
6.4e-01
1.1e+00
3.2e+00
8.7e-01
4.7e-01
5.4e-01
cases:15.95%
controls:12.00%
cases:11.56%
controls:6.43%
cases:2.98%
controls:1.02%
cases:0.60%
controls:0.03%
cases:2.29%
controls:0.97%
cases:10.59%
controls:6.87%
cases:27.33%
controls:17.95%
829
6233
4368
45709
601
3339
4596
48603
155
528
5042
51414
31
13
5166
51929
118
501
5039
51210
514
3350
4338
45421
1005
6738
2672
30799
Sensorineural hearing loss, bilateral
H90.3 [45576850]
5.0e-01
5.9e-01
8.4e-01
3.6e+00
7.0e-01
5.8e-01
3.2e-01
cases:9.31%
controls:5.88%
cases:4.77%
controls:2.69%
cases:0.89%
controls:0.39%
cases:0.67%
controls:0.02%
cases:0.85%
controls:0.43%
cases:4.70%
controls:2.68%
cases:9.63%
controls:7.19%
484
3052
4713
48890
248
1399
4949
50543
46
200
5151
51742
35
10
5162
51932
44
221
5113
51490
228
1305
4624
47466
354
2698
3323
34839
Alcohol dependence periodic alcoholism
F10.26 [2000501683]
1.4e+00
1.7e+00
—
1.0e+50
—
2.4e+00
1.6e+00
cases:0.46%
controls:0.11%
cases:0.17%
controls:0.03%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.25%
controls:0.02%
cases:0.41%
controls:0.08%
24
58
5173
51884
9
17
5188
51925
—
10
0
5187
51942
—
12
11
4840
48760
15
31
3662
37506
Moderate depressive episode
F32.1 [45552478]
1.2e+00
1.4e+00
1.9e+00
—
1.9e+00
1.4e+00
1.2e+00
cases:0.85%
controls:0.26%
cases:0.38%
controls:0.09%
cases:0.13%
controls:0.02%
—
—
cases:0.12%
controls:0.02%
cases:0.37%
controls:0.09%
cases:0.87%
controls:0.27%
44
135
5153
51807
20
49
5177
51893
7
10
5190
51932
—
6
9
5151
51702
18
46
4834
48725
32
103
3645
37434
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.5e-01
6.3e-01
1.0e+00
3.1e+00
9.9e-01
5.0e-01
5.0e-01
cases:19.22%
controls:14.38%
cases:15.09%
controls:8.68%
cases:3.71%
controls:1.40%
cases:0.77%
controls:0.03%
cases:3.39%
controls:1.29%
cases:14.37%
controls:9.24%
cases:34.35%
controls:24.08%
999
7468
4198
44474
784
4507
4413
47435
193
729
5004
51213
40
18
5157
51924
175
669
4982
51042
697
4508
4155
44263
1263
9038
2414
28499
Therapeutic discussion
SPAT1240 [2001700341]
1.0e+00
1.2e+00
1.6e+00
—
1.0e+00
1.2e+00
1.1e+00
cases:3.00%
controls:1.12%
cases:1.29%
controls:0.41%
cases:0.54%
controls:0.11%
—
—
cases:0.33%
controls:0.12%
cases:1.34%
controls:0.41%
cases:3.13%
controls:1.08%
156
582
5041
51360
67
213
5130
51729
28
57
5169
51885
—
17
61
5140
51650
65
201
4787
48570
115
405
3562
37132
Sodium [Moles/volume] in Urine
2955-3 [3003181]
8.1e-01
1.3e+00
2.1e+00
—
2.1e+00
7.6e-01
7.7e-01
cases:0.89%
controls:0.39%
cases:0.54%
controls:0.15%
cases:0.21%
controls:0.03%
—
—
cases:0.17%
controls:0.02%
cases:0.45%
controls:0.21%
cases:1.44%
controls:0.67%
46
205
5151
51737
28
77
5169
51865
11
14
5186
51928
—
9
11
5148
51700
22
104
4830
48667
53
252
3624
37285
pH of Urine
2756-5 [3015736]
4.1e-01
7.3e-01
9.9e-01
2.6e+00
1.1e+00
5.9e-01
5.9e-01
cases:16.07%
controls:11.30%
cases:11.95%
controls:6.16%
cases:2.64%
controls:1.00%
cases:0.42%
controls:0.03%
cases:2.77%
controls:0.93%
cases:11.27%
controls:6.61%
cases:28.39%
controls:17.97%
835
5871
4362
46071
621
3201
4576
48741
137
519
5060
51423
22
16
5175
51926
143
481
5014
51230
547
3223
4305
45548
1044
6746
2633
30791
temazepam; oral
N05CD07 [21604642]
7.4e-01
7.5e-01
8.0e-01
2.1e+00
8.7e-01
8.4e-01
9.1e-01
cases:8.64%
controls:4.33%
cases:5.62%
controls:2.75%
cases:1.62%
controls:0.73%
cases:0.19%
controls:0.02%
cases:1.73%
controls:0.73%
cases:6.10%
controls:2.74%
cases:9.52%
controls:4.05%
449
2250
4748
49692
292
1427
4905
50515
84
381
5113
51561
10
12
5187
51930
89
377
5068
51334
296
1335
4556
47436
350
1522
3327
36015
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
4.1e-01
1.1e+00
1.1e+00
2.3e+00
1.2e+00
4.0e-01
5.1e-01
cases:43.97%
controls:34.19%
cases:44.33%
controls:20.29%
cases:7.45%
controls:2.65%
cases:0.85%
controls:0.09%
cases:7.95%
controls:2.50%
cases:27.95%
controls:20.68%
cases:57.00%
controls:44.37%
2285
17760
2912
34182
2304
10538
2893
41404
387
1377
4810
50565
44
46
5153
51896
410
1295
4747
50416
1356
10085
3496
38686
2096
16657
1581
20880
Psychiatric treatment plan, permanent discontinuation
ICC04 [2001304105]
1.1e+00
1.8e+00
—
1.0e+50
—
3.0e+00
2.3e+00
cases:0.21%
controls:0.07%
cases:0.19%
controls:0.03%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.76%
controls:0.04%
cases:1.01%
controls:0.11%
11
38
5186
51904
10
17
5187
51925
—
9
0
5188
51942
—
37
19
4815
48752
37
40
3640
37497

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
462
145
34.77
307.65
1.0
1.0
779.58
836.02
ng/l
0.72
332
99
529
745
7.77
307.65
1.4
1.4
768.22
1146.57
e6/l
0.47
416
584
571
872
7.21
307.65
1.3
1.3
491.83
606.23
mg/l
5.18
547
843
528
738
7.83
307.65
1.3
1.4
3.55
38.00
e6/l
2.35
400
544
538
769
7.66
307.65
1.3
1.2
3.90
3.79
mmol/l
1.23
517
726
2347
9133
3.79
307.65
1.9
1.7
1321.15
1153.92
nmol/l
13.57
1846
6773
458
147
33.97
307.65
1.0
1.0
304.25
222.41
ng/l
5.66
334
103
3651
22356
2.98
300.19
2.9
2.2
93.09
94.87
pmol/l
1.56
2061
11642
2780
14973
2.78
289.09
2.1
1.7
21.73
20.19
nmol/l
4.37
2520
12515
344
432
8.44
257.26
6.1
4.8
353.04
347.11
umol/l
0.27
300
371
3581
22885
2.69
249.67
5.7
5.1
35.26
34.76
g/l
6.39
3330
21352
431
719
6.43
249.19
1.3
1.4
—
—
—
0
0
2040
10253
2.60
231.01
3.3
3.2
2.45
2.47
mmol/l
4.26
1878
9099
2860
17080
2.44
219.52
3.3
3.6
2.35
2.35
mmol/l
0.20
2634
15323
3523
23205
2.51
215.90
7.2
6.8
1.21
1.21
mmol/l
0.71
3301
21361
3720
25857
2.43
190.51
8.4
7.5
1.21
1.21
mmol/l
0.71
3284
22245
2004
10750
2.38
188.73
6.1
4.6
1.02
1.15
kg/l
0.50
1376
7316
2594
15592
2.28
186.07
4.4
4.4
7.40
7.40
ph
3.58
2003
11270
2606
15824
2.26
180.77
3.0
2.2
263.43
208.81
u/l
1.58
2450
14891
4130
31230
2.39
156.41
7.2
5.4
2476.47
1689.68
e6/l
0.33
100
440
229
327
7.27
152.59
1.3
1.5
—
—
—
0
0
4227
33074
2.30
134.83
5.3
4.4
14.97
15.05
pmol/l
1.20
3891
29831
2971
20659
1.98
126.77
2.8
2.4
77.75
79.93
nmol/l
4.22
2705
18260
2867
19808
1.96
123.36
5.1
3.8
6.47
6.27
ph
15.08
1490
10703
3782
28987
2.03
117.38
6.6
5.2
6.87
6.83
mmol/l
0.52
3627
27607
1762
10460
2.02
116.12
1.9
1.8
23109116.66
33688889.18
pmol/l
0.33
1454
8448
3352
24823
1.93
112.73
5.6
4.3
2.03
3.98
estimate
0.41
533
5553
3366
24994
1.93
111.88
5.6
4.3
0.01
0.21
estimate
0.52
495
5181
801
3504
2.51
111.64
7.6
6.5
24.46
24.58
mmol/l
0.41
786
3353
2311
15400
1.88
105.37
4.7
4.5
—
—
—
0
0
3289
24554
1.88
103.78
5.6
4.3
0.00
0.00
estimate
1.34
527
5357
977
4858
2.24
100.83
3.4
2.4
4.75
7.01
ug/l
6.63
807
4251
4673
39672
2.37
99.02
7.1
5.5
2.00
2.03
mu/l
0.63
4375
36055
4360
36097
2.10
97.09
8.7
8.7
79.28
82.21
u/l
2.50
4157
34192
203
414
5.06
93.66
1.3
1.4
—
—
—
0
0
1820
11614
1.86
92.00
5.8
4.1
0.87
0.40
—
8
161
2097
14094
1.80
88.60
2.8
2.4
2.90
2.97
mg/l
0.65
1827
12130
2554
18183
1.77
88.59
5.8
4.4
0.00
0.58
estimate
1.80
422
4381
3943
31939
1.88
87.73
6.2
5.1
2.71
2.11
—
10
51
4102
33674
1.92
87.26
5.0
4.6
13.26
14.25
mm/h
4.23
3812
31228
3245
24954
1.76
84.03
23.0
19.3
1.38
1.34
inr
2.20
2826
20962
2055
14004
1.76
80.81
6.2
4.5
0.00
0.00
estimate
1.74
466
4853
1167
6708
1.95
79.53
6.9
7.2
7.42
7.42
ph
2.36
792
3628
1161
6675
1.94
79.01
6.7
7.1
1.40
0.96
mmol/l
3.35
938
5470
1008
5521
2.02
78.90
7.3
7.9
121.26
119.73
g/l
1.60
997
5389
2225
15645
1.72
77.24
2.9
2.7
92.26
62.13
u/l
0.40
2055
14453
1158
6714
1.92
76.55
6.8
7.1
11.67
12.02
kpa
1.65
1129
6433
1158
6715
1.92
76.51
6.8
7.1
5.03
5.09
kpa
1.21
1131
6437
104
133
7.95
76.13
15.6
11.0
0.65
0.62
mmol/l
0.43
99
125
151
293
5.27
73.69
3.2
2.6
—
—
—
0
0
3311
26224
1.68
70.94
6.1
6.7
11.83
12.43
umol/l
1.49
3129
25030
1046
6004
1.92
70.62
6.7
7.3
95.55
95.30
%
0.57
1020
5781
2650
19837
1.66
70.44
5.6
4.4
147.06
83.37
ng/l
0.63
2116
15424
4825
42945
2.21
67.97
25.6
19.3
28.02
26.96
mg/l
1.35
4267
36374
1317
8254
1.79
66.62
1.9
2.0
29.05
29.99
s
7.85
1269
8022
293
988
3.08
66.31
2.7
2.5
30.36
35.38
umol/l
2.41
253
885
4926
44475
2.30
62.55
32.6
23.7
139.48
139.51
mmol/l
0.35
4851
43583
3827
31991
1.68
61.90
6.0
4.7
0.36
5351.48
0.68
11
77
4926
44540
2.28
61.22
32.6
23.9
3.99
4.00
mmol/l
3.08
4848
43589
3987
34117
1.65
54.30
36.4
25.2
331.13
331.32
g/l
0.67
3944
33875
358
1493
2.50
53.76
2.0
1.6
0.30
0.31
mg/l
0.09
176
676
365
1584
2.40
50.19
6.1
5.7
1.36
1.35
mmol/l
0.04
334
1409
65
78
8.42
50.13
2.8
1.9
—
—
—
0
0
1939
14273
1.56
49.50
6.7
6.5
—
—
—
0
0
3273
27058
1.54
48.50
10.6
9.5
4.42
4.30
e9/l
1.88
2820
23233
91
165
5.59
47.85
1.3
1.2
—
69.04
%
—
0
27
49
44
11.23
46.64
1.9
1.6
24.04
17.19
umol/l
2.41
49
44
4936
45416
2.07
46.49
34.0
26.0
82.16
83.45
umol/l
1.50
4865
44775
164
483
3.47
46.25
4.7
2.7
—
—
—
0
0
69
98
7.12
46.11
2.9
2.6
141.13
139.56
nmol/l
0.04
62
87
1313
8951
1.62
45.85
3.1
3.2
0.81
0.82
mmol/l
0.06
1216
8361
1485
10474
1.58
44.73
5.3
4.4
159.06
473.17
ng/l
2.92
1284
8980
4623
41801
1.76
43.94
6.6
5.7
6.17
6.07
mmol/l
4.37
4241
37677
272
1108
2.53
42.82
6.7
6.5
104.54
104.89
mmol/l
0.50
256
984
272
1108
2.53
42.82
6.7
6.5
11.33
11.29
mmol/l
0.06
256
983
2593
20726
1.49
42.81
3.6
3.2
124.08
149.59
ug/l
7.14
2379
19042
3270
27419
1.49
42.21
4.4
3.4
54.01
55.19
u/l
0.27
3016
25270
398
1928
2.15
41.94
2.3
2.2
763.86
562.31
ug/l
0.49
371
1842
711
4234
1.78
40.72
2.1
2.3
383.52
384.63
nmol/l
0.05
650
3898
793
4885
1.73
40.32
3.7
3.3
178.90
244.71
ng/l
4.42
747
4483
115
292
4.00
40.27
1.7
1.3
1.30
1.10
promille
0.57
89
224
4940
45862
1.96
39.24
40.1
29.2
239.25
242.71
e9/l
3.23
4850
44777
4940
45866
1.96
39.17
39.9
29.1
30.46
30.41
pg
1.00
4875
45237
4940
45868
1.96
39.14
39.9
29.1
91.80
91.66
fl
1.47
4878
45239
4940
45869
1.96
39.12
40.0
29.2
4.34
4.41
e12/l
16.78
4839
44605
4940
45870
1.96
39.10
40.7
29.7
39.37
39.73
%
5.73
4876
45219
4940
45878
1.95
38.96
40.3
29.4
130.92
132.95
g/l
17.79
4879
45281
4939
45875
1.95
38.79
40.0
29.2
7.03
6.92
e9/l
1.64
4840
44603
167
555
3.07
38.70
3.2
2.0
—
—
—
0
0
77
147
5.30
38.32
2.7
2.4
55.90
50.22
umol/l
0.64
62
127
2978
24760
1.45
38.32
7.5
6.3
0.19
0.20
e9/l
1.94
2558
21205
2908
24087
1.45
38.05
7.0
6.1
0.04
0.04
e9/l
0.87
2483
20309
2892
23987
1.45
37.19
6.9
6.1
0.60
0.62
e9/l
2.58
2470
20204
2148
16914
1.45
36.18
4.2
3.6
61.88
81.29
e6/l
0.39
1692
13061
1074
7338
1.58
35.93
5.2
5.9
1.01
1.05
mmol/l
3.78
979
6796
4839
44890
1.79
34.85
15.4
13.3
24.53
25.42
u/l
1.27
4681
43346
2925
24482
1.43
34.71
7.2
6.2
1.82
1.87
e9/l
0.79
2514
21145
891
5875
1.62
34.46
4.2
3.7
5.84
5.82
kpa
0.27
866
5723
872
5735
1.62
34.04
4.4
3.7
1.98
1.79
mmol/l
0.79
772
4968
2273
18238
1.43
33.83
3.6
3.5
1656.73
1812.89
ng/l
0.83
1988
16030
77
164
4.75
33.81
3.8
1.8
133.90
121.42
umol/l
0.09
40
90
178
662
2.75
33.64
3.3
2.0
—
—
—
0
0
897
5956
1.61
33.63
4.3
3.7
7.38
7.38
ph
1.49
538
3501
1579
11877
1.47
33.09
3.2
2.8
5.45
5.11
e6/l
0.56
1446
10790
1895
14900
1.42
30.72
3.8
3.3
35.83
36.60
u/l
0.10
1786
13951
2296
18686
1.40
30.40
5.2
4.2
76.89
119.34
e6/l
2.58
1708
13492
4491
41215
1.55
29.71
8.4
7.2
40.56
40.15
mmol/mol
2.12
4181
37983
179
713
2.56
29.54
3.3
2.0
—
—
—
0
0
70
155
4.56
29.36
1.2
1.2
0.51
0.52
ratio
0.21
44
90
179
716
2.55
29.28
3.3
2.0
—
—
—
0
0
179
720
2.54
28.95
3.3
1.9
—
—
—
0
0
739
4861
1.60
28.43
3.8
3.1
4.40
4.46
kpa
0.30
714
4727
536
3247
1.72
28.39
8.4
9.4
16.17
15.79
%
2.58
524
3136
241
1119
2.21
28.16
1.5
1.3
60.91
59.95
mmol/l
0.13
185
901
150
567
2.69
27.52
1.5
1.3
278.94
274.94
mosm/kgh2o
1.00
108
425
62
132
4.74
27.29
3.6
2.6
29.45
30.09
umol/l
0.12
39
103
851
5843
1.54
27.05
1.9
1.8
—
—
—
0
0
657
4250
1.62
26.99
3.6
3.9
87.23
97.90
ng/l
2.79
556
3601
1848
14713
1.39
26.91
4.0
3.5
0.38
0.49
e6/l
2.13
1401
10995
1035
13989
0.68
26.72
3.8
3.5
—
—
—
0
0
495
2989
1.72
26.46
3.7
2.7
0.66
0.62
%
2.08
495
2974
1232
9169
1.45
26.20
1.3
1.3
1.32
1.67
u/ml
0.52
314
2277
82
224
3.70
26.00
1.1
1.0
263.09
315.30
mg/l
1.98
73
192
171
709
2.46
25.95
3.2
1.9
—
—
—
0
0
84
234
3.63
25.89
1.2
1.1
36.54
45.00
mg/l
1.62
73
194
747
5035
1.56
25.70
2.2
2.1
0.20
0.20
g/l
0.20
674
4678
413
2388
1.79
25.67
6.7
5.0
0.93
0.85
%
2.88
400
2253
1740
13817
1.38
25.37
4.0
3.5
0.68
197.26
estimate
—
5
78
446
2688
1.72
23.95
3.3
3.5
25.32
25.10
mmol/l
0.65
429
2607
431
2585
1.73
23.54
6.6
4.8
1.67
1.54
%
2.40
417
2444
743
5097
1.53
23.46
6.6
7.0
1.42
1.37
mmol/l
0.71
724
4986
73
204
3.61
22.44
1.2
1.2
136.62
140.84
nmol/l
0.32
73
204
960
7000
1.45
22.32
2.4
2.5
1.83
1.80
%
0.28
831
6226
1332
10379
1.38
21.01
1.8
1.7
1.27
1.47
mg/l
1.66
1056
8162
1201
9218
1.39
20.73
3.6
3.2
1.53
1.19
e6/l
1.69
658
5037
324
1863
1.79
20.47
1.5
1.6
—
—
—
0
0
4569
42794
1.45
20.38
6.9
6.3
2.43
2.57
mmol/l
21.84
4205
39128
230
1208
1.94
19.34
1.3
1.2
—
—
—
0
0
135
581
2.36
18.96
4.5
3.1
11.49
10.67
mmol/l
1.78
135
575
535
3579
1.55
18.74
4.1
3.2
126.03
126.90
g/l
0.40
526
3467
134
2856
0.46
18.51
1.9
2.1
3.34
3.51
ratio
0.81
108
2270
99
383
2.61
17.48
1.2
1.1
31.67
35.05
mmol/l
0.67
84
324
84
300
2.83
17.30
1.3
1.2
2.09
2.24
mmol/l
0.50
78
275
689
4951
1.45
16.95
7.5
8.3
—
—
—
0
0
2559
22340
1.28
16.90
3.0
3.0
—
—
estimate
—
0
0
755
5529
1.43
16.74
2.3
2.6
68.28
68.53
e9/l
0.07
565
4061
1549
12714
1.31
16.43
3.7
3.3
0.21
0.06
1.02
24
425
1211
9606
1.34
16.37
2.7
2.7
11.57
12.12
umol/l
1.77
1109
8915
86
2059
0.41
15.99
1.7
1.8
3.14
3.43
mmol/l
1.34
63
1462
87
2060
0.41
15.75
1.2
1.4
—
—
—
0
0
393
2548
1.59
15.74
2.9
3.3
4.32
4.41
pmol/l
1.03
337
2232
759
5628
1.41
15.61
1.4
1.5
—
—
—
0
0
610
4362
1.45
15.33
2.9
2.6
0.51
0.51
e6/l
0.02
588
4207
475
3237
1.51
15.20
1.2
1.2
—
—
—
0
0
485
3321
1.51
15.17
5.1
3.7
24.24
24.18
mmol/l
0.14
474
3276
4445
41908
1.35
14.99
5.7
5.4
4.30
4.47
mmol/l
22.00
4072
38459
26
46
5.67
14.12
1.3
1.2
27.67
62.42
%
2.84
12
24
1265
10285
1.30
14.00
3.3
3.1
513.48
525.25
mosm/kgh2o
1.21
1101
8996
2522
22327
1.24
13.56
7.7
6.5
9.04
9.12
%
0.63
2373
20788
4402
41595
1.32
13.46
5.5
5.3
1.42
1.44
mmol/l
1.90
4022
37855
2513
22272
1.24
13.26
7.5
6.4
2.74
2.82
%
1.12
2367
20743
747
5672
1.37
13.17
2.7
2.7
10.83
9.64
umol/l
0.42
614
5021
1125
9072
1.30
13.13
2.7
2.7
2.27
2.27
g/l
0.20
1030
8352
2504
22268
1.23
12.52
7.7
6.5
0.64
0.66
%
0.62
2363
20743
1638
13916
1.25
12.42
5.7
5.0
21.43
22.29
%
1.50
821
7363
375
2544
1.51
12.24
1.3
1.3
45.85
58.92
au/ml
0.55
13
181
366
2476
1.51
12.11
2.0
1.9
1.42
2.09
ug/l
1.24
313
2185
147
785
1.90
11.89
1.7
1.9
4.44
4.63
mmol/24h
0.29
121
669
1495
12626
1.26
11.82
4.5
3.9
0.01
0.37
estimate
2.15
405
4181
2043
17872
1.23
11.67
3.5
3.4
6.98
7.10
mmol/l
0.69
1773
14845
2482
22153
1.22
11.66
7.4
6.3
58.68
58.52
%
0.28
2375
21070
65
251
2.61
11.65
1.8
2.3
16.07
25.95
umol/l
—
6
22
701
5373
1.35
11.56
1.8
1.7
—
—
—
0
0
933
7471
1.30
11.29
2.1
2.0
—
—
—
0
0
2525
22653
1.22
11.03
7.6
6.5
26.08
26.14
%
0.09
2394
21320
20
19
10.56
10.75
1.3
1.2
49.83
39.08
%
0.32
12
12
396
2789
1.45
10.72
2.5
2.5
21.37
21.94
au/ml
0.04
15
221
670
5157
1.34
10.71
2.2
2.2
164.40
154.84
ug/g
0.26
538
4075
121
628
1.95
10.69
1.5
1.4
—
—
—
0
0
121
628
1.95
10.69
1.5
1.4
—
—
—
0
0
121
628
1.95
10.69
1.5
1.4
—
—
—
0
0
121
628
1.95
10.69
1.5
1.4
—
—
—
0
0
667
5146
1.34
10.48
2.4
2.6
66.28
65.87
g/l
0.73
578
4656
1961
17258
1.21
10.14
5.9
6.2
2.85
3.81
ug/l
1.28
1735
15539
1462
12540
1.23
9.66
4.8
4.3
84.54
84.96
%
0.24
1418
12296
143
812
1.78
9.58
2.1
1.8
340.30
293.39
mu/l
0.72
126
752
20
40
5.01
9.56
1.5
1.2
—
—
mmol/l
—
0
0
1023
8458
1.26
9.42
2.8
2.8
20.38
21.50
%
1.86
935
7841
1021
8461
1.26
9.19
4.0
3.4
3.11
2.36
e6/l
1.21
479
4270
4194
39873
1.24
9.13
4.7
4.5
1.30
1.28
mmol/l
1.13
3753
35829
119
655
1.84
8.86
5.2
7.1
7.41
7.26
mmol/l
0.17
98
552
1831
16162
1.20
8.86
2.8
2.7
—
—
—
0
0
67
305
2.21
8.47
3.1
3.1
—
—
—
0
0
528
4059
1.33
8.46
1.8
1.6
—
—
—
0
0
30
858
0.35
8.46
1.2
1.2
1.54
1.51
g/l
0.30
30
858
203
1316
1.56
8.24
1.4
1.6
—
—
—
0
0
3675
34619
1.19
8.15
32.6
23.9
13.94
13.88
%
1.60
3647
34117
463
3516
1.35
8.06
2.9
2.8
10.58
10.66
g/l
0.14
406
3230
974
8157
1.24
7.86
1.5
1.5
2.70
2.60
g/l
0.48
553
4803
130
768
1.71
7.67
6.0
6.2
12.21
12.35
mg/l
0.12
114
714
467
6003
0.76
7.50
5.2
5.3
33.50
33.21
%
0.19
301
3808
1942
17445
1.18
7.31
3.5
3.5
39.62
50.31
mg/l
2.00
1258
11288
79
408
1.95
7.22
1.3
1.2
343.20
334.86
nmol/l
0.11
70
321
37
139
2.67
7.14
1.3
1.2
113.45
131.06
nmol/l
0.29
22
101
309
2254
1.39
6.95
1.4
1.3
—
—
—
0
0
1970
17793
1.17
6.80
4.0
4.2
6.79
9.29
mg/mmol
2.78
1266
11162
1496
13214
1.18
6.79
2.9
3.0
349.81
358.30
umol/l
2.18
1271
11424
56
262
2.15
6.70
2.8
2.6
36.70
37.62
%
0.12
36
146
351
4619
0.74
6.64
1.3
1.4
—
—
—
0
0
31
776
0.40
6.61
1.1
1.1
0.62
0.65
ratio
—
8
112
391
2992
1.33
6.49
1.5
1.7
1.54
1.55
g/l
0.08
323
2597
649
5305
1.25
6.46
6.2
6.9
10.38
11.49
mmol/l
3.24
606
5051
146
932
1.58
6.42
1.1
1.1
40.37
9.13
eliau/ml
—
6
80
60
294
2.05
6.39
1.1
1.1
10.45
12.90
nmol/l
0.12
13
69
42
178
2.37
6.36
1.1
1.1
1106.67
394.07
ng/l
—
6
54
20
56
3.58
6.30
1.3
1.2
72.10
66.05
ug/l
0.48
20
56
1118
9687
1.19
6.26
5.5
4.9
—
—
—
0
0
222
1558
1.44
6.23
4.0
3.2
0.76
0.83
nmol/l
2.48
181
1249
220
1552
1.44
6.02
1.5
1.4
250.94
264.09
ug/g
0.42
129
969
48
222
2.17
5.95
1.4
1.3
—
—
—
0
0
92
533
1.74
5.91
2.0
2.1
4840.09
3998.93
u/l
0.09
28
216
37
154
2.41
5.85
1.2
1.0
1989.76
1596.82
miu/ml
1.12
37
154
26
91
2.87
5.77
1.1
1.4
—
—
—
0
0
197
2776
0.70
5.72
4.2
3.7
1.02
1.02
ratio
1.44
177
2511
49
242
2.03
5.18
1.3
1.3
1.04
1.21
nmol/l
0.48
36
175
125
812
1.55
5.18
1.3
1.2
—
—
—
0
0
32
133
2.41
5.12
1.3
1.5
14.63
16.35
pmol/l
0.80
26
107
552
6636
0.81
5.00
1.3
1.4
—
—
—
0
0
441
3552
1.26
5.00
7.1
7.7
25.01
24.86
mmol/l
0.37
435
3530
12
20
6.01
4.90
1.2
2.1
—
—
—
0
0
46
227
2.04
4.89
1.2
4.7
67.29
65.48
mg/l
0.06
21
162
1981
18235
1.14
4.77
2.0
2.0
1.32
1.32
mmol/l
0.13
1735
14964
11
17
6.48
4.77
1.6
1.1
—
—
—
0
0
11
18
6.12
4.60
1.2
1.2
10.49
33.62
nmol/l
0.58
11
18
70
1169
0.59
4.59
1.9
1.7
—
—
—
0
0
159
1119
1.43
4.50
4.0
4.5
2.30
2.82
mmol/l
1.62
124
765
159
1120
1.43
4.48
4.0
4.6
5.14
5.01
kpa
1.56
153
1098
190
1383
1.39
4.45
5.2
2.8
63.26
59.75
%
1.32
177
1336
23
88
2.62
4.39
1.0
1.1
—
—
—
0
0
159
1125
1.43
4.38
4.0
4.6
8.47
8.44
kpa
0.08
153
1103
13
28
4.65
4.36
1.0
1.1
—
—
—
0
0
169
1213
1.41
4.31
2.1
2.3
98.04
86.89
ug/min
0.15
71
699
35
165
2.13
4.24
1.2
1.1
—
—
—
0
0
231
1752
1.33
4.18
4.0
4.0
7.41
7.41
ph
0.38
225
1735
227
1719
1.33
4.16
1.8
1.9
20.96
21.24
s
0.16
206
1562
58
329
1.77
4.12
2.1
1.9
8.78
8.14
mmol/l
0.35
58
329
174
1266
1.39
4.11
2.7
3.1
88.72
89.13
%
0.30
169
1238
157
1124
1.41
4.08
1.6
1.9
2.99
3.81
iu/l
1.15
59
398
425
3492
1.24
4.08
7.9
8.7
24.53
24.28
mmol/l
0.87
413
3401
556
4699
1.20
4.03
2.8
2.5
32.99
50.07
u/l
0.98
464
3976
38
192
1.99
3.86
1.8
1.7
1.50
10.12
nmol/l
2.05
32
161
15
400
0.37
3.85
1.9
2.6
—
—
—
0
0
49
270
1.82
3.85
1.9
1.8
488.49
309.29
mu/l
0.83
43
215
38
710
0.53
3.80
1.5
1.7
—
—
—
0
0
184
2441
0.75
3.77
1.2
1.3
—
—
—
0
0
70
430
1.64
3.76
2.9
3.1
13.46
31.60
mg/l
2.14
50
336
563
4796
1.19
3.76
1.7
1.6
—
—
—
0
0
192
1442
1.34
3.75
2.7
3.1
7.75
7.90
kpa
0.70
186
1415
187
1400
1.35
3.73
2.0
2.3
128.11
126.33
g/l
0.44
157
1066
21
84
2.51
3.70
2.3
1.8
3.07
0.85
e9/l
0.32
12
32
97
646
1.51
3.70
1.1
1.1
—
—
—
0
0
198
1503
1.33
3.61
3.3
3.6
2.66
1.81
index
1.16
97
784
25
110
2.28
3.61
1.2
1.3
0.55
2.19
mmol/l
1.27
17
74
20
456
0.44
3.57
1.3
1.6
811.38
967.09
mu/l
0.36
13
378
347
2842
1.24
3.47
2.6
2.5
—
—
—
0
0
84
1254
0.66
3.45
1.1
1.1
—
—
—
0
0
55
327
1.69
3.38
3.9
5.6
198.90
60.03
u/ml
0.54
15
105
9
18
5.01
3.36
2.3
1.6
368.58
442.08
nmol/l
—
9
18
161
1199
1.35
3.36
1.2
1.2
104.00
106.70
titre
—
10
100
295
2385
1.25
3.33
2.2
2.1
—
—
—
0
0
58
352
1.65
3.31
1.3
1.4
7.38
7.41
ph
0.40
50
242
929
10332
0.88
3.22
3.3
3.5
0.70
0.83
ug/l
5.61
683
7235
85
1246
0.68
3.21
1.2
1.2
—
—
—
0
0
167
2185
0.76
3.16
3.2
4.0
89.92
99.99
u/ml
0.12
158
2084
124
896
1.39
3.14
1.5
1.4
28.57
28.86
iu/l
0.03
99
755
494
4230
1.18
3.14
4.5
4.2
1.23
1.23
mmol/l
0.35
417
3677
533
6157
0.85
3.13
3.4
4.2
5.33
28.85
ug/l
5.02
447
5100
291
2368
1.24
3.12
1.1
1.2
80.41
125.53
u/ml
1.46
108
815
61
383
1.60
3.07
1.2
1.2
—
—
—
0
0
6
8
7.51
3.05
2.8
2.0
122.13
273.38
ug/l
—
6
8
201
1569
1.29
3.05
1.6
1.6
17.87
23.75
u/ml
0.53
23
293
338
2809
1.22
2.98
2.0
1.9
1.40
1.34
g/l
0.17
291
2551
21
94
2.24
2.96
1.1
1.3
23.67
399.73
u/l
0.59
15
66
116
839
1.39
2.95
1.5
1.4
9.95
10.05
u/l
0.03
89
677
443
3790
1.18
2.86
3.2
3.9
5.17
5.16
kpa
0.16
413
3614
325
2705
1.21
2.83
1.6
1.4
—
—
—
0
0
429
3680
1.18
2.70
3.2
4.0
7.42
7.42
ph
0.17
375
3047
49
773
0.63
2.69
3.3
3.9
105.92
44.37
u/ml
0.54
49
754
277
2283
1.22
2.68
2.3
2.9
—
—
—
0
0
50
311
1.61
2.66
1.4
1.3
30.32
30.46
u/l
0.01
45
257
166
1290
1.30
2.65
1.7
1.5
0.22
0.24
g/l
1.43
154
1219
49
304
1.62
2.64
1.5
1.5
—
—
—
0
0
657
5834
1.14
2.62
3.9
3.3
6.53
4.88
e9/l
1.42
559
4883
101
731
1.39
2.60
1.2
1.3
145.53
210.16
miu/ml
1.10
26
278
165
1287
1.29
2.57
3.6
3.9
—
—
—
0
0
57
370
1.55
2.55
1.2
1.1
—
—
—
0
0
22
108
2.04
2.51
1.9
1.5
—
0.23
—
0
23
25
460
0.54
2.50
1.4
2.0
1.41
1.47
u/field
0.04
17
230
168
1322
1.28
2.46
1.7
1.5
1.18
1.17
g/l
0.13
156
1251
31
175
1.78
2.37
3.2
2.5
0.61
0.61
mmol/l
0.05
31
175
41
251
1.64
2.36
1.3
1.6
59.11
67.69
%
0.87
35
212
102
757
1.35
2.29
2.4
2.5
—
—
—
0
0
746
6749
1.12
2.24
1.3
1.3
—
—
—
0
0
87
633
1.38
2.22
1.2
1.3
280.23
289.02
pmol/l
0.10
67
524
20
377
0.53
2.20
3.4
2.8
29.27
30.67
mg/l
0.08
15
288
9
213
0.42
2.17
1.3
1.5
—
—
—
0
0
45
290
1.56
2.13
3.2
3.6
0.58
0.87
index
2.56
45
285
360
3119
1.17
2.07
1.3
1.2
—
—
—
0
0
9
208
0.43
2.06
1.3
1.5
—
—
—
0
0
0
58
0.00
2.03
0.0
1.8
—
8.17
—
0
26
46
302
1.53
2.02
1.1
1.1
—
—
—
0
0
23
125
1.84
2.02
1.7
1.3
31.23
33.85
%
0.10
13
87
9
32
2.82
2.00
1.0
1.0
—
—
—
0
0
261
2209
1.19
1.99
3.2
3.3
77.59
84.04
mg/l
0.06
220
1898
31
502
0.62
1.99
1.3
1.2
—
—
—
0
0
260
2204
1.19
1.96
3.2
3.3
39.61
57.45
mg/l
1.07
219
1890
5
11
4.55
1.94
1.0
1.4
—
—
—
0
0
23
127
1.81
1.93
1.7
1.4
116.70
208.49
nmol/24h
0.58
23
127
74
539
1.38
1.92
3.4
3.4
14.33
12.06
index
1.00
45
286
98
1269
0.77
1.85
2.0
3.3
320.51
983.32
u/ml
1.14
89
1164
36
230
1.57
1.81
5.0
7.0
12.44
227.99
ug/l
0.91
21
145
31
489
0.63
1.81
1.2
1.1
—
—
—
0
0
234
1982
1.19
1.80
3.2
3.2
3.11
4.09
ratio
0.36
149
1189
7
23
3.05
1.80
1.4
1.5
—
—
—
0
0
20
109
1.84
1.77
1.1
1.1
0.77
0.69
umol/24h
—
9
54
130
1041
1.25
1.75
1.2
1.2
—
—
—
0
0
91
697
1.31
1.73
1.0
1.1
—
—
—
0
0
23
132
1.75
1.73
1.2
1.2
1.61
1.51
mmol/l
0.17
17
81
89
680
1.31
1.72
1.7
1.4
62.27
66.43
mu/l
0.05
80
598
1785
18703
0.93
1.69
2.1
2.3
—
—
—
0
0
58
416
1.40
1.68
1.4
1.4
55.00
67.04
titre
—
6
27
35
528
0.66
1.68
1.1
1.2
—
—
—
0
0
107
844
1.27
1.65
1.4
1.5
2840.34
2808.66
e6/l
0.01
85
601
48
335
1.44
1.62
3.2
2.0
38.85
38.68
%
0.03
48
329
38
253
1.51
1.62
2.3
2.2
256.21
229.39
e6/l
0.40
33
222
53
377
1.41
1.62
1.4
1.2
106.25
105.87
pmol/l
0.02
53
377
32
487
0.66
1.61
1.2
1.1
—
—
—
0
0
10
42
2.38
1.61
1.0
1.1
—
—
—
0
0
23
136
1.69
1.58
1.2
1.1
—
—
—
0
0
59
430
1.38
1.58
1.4
1.4
952.86
189.73
titre
—
7
37
49
346
1.42
1.57
2.0
2.1
16.58
15.87
%
0.83
49
346
174
1459
1.20
1.54
1.1
1.1
—
—
—
0
0
639
5859
1.10
1.54
1.3
1.3
444.11
496.60
titre
0.55
146
1313
18
100
1.80
1.52
1.2
1.1
—
—
—
0
0
22
130
1.70
1.52
1.8
2.5
96.27
323.61
ug/l
0.47
22
130
33
217
1.52
1.51
1.4
1.5
1.69
2.54
%
0.67
28
184
67
505
1.33
1.47
1.3
1.3
19.45
11.65
u/l
0.72
60
459
82
637
1.29
1.45
1.8
2.0
—
—
—
0
0
41
285
1.44
1.45
2.0
1.6
94.56
90.56
umol/l
0.12
41
285
1871
17943
1.07
1.45
4.3
4.1
1.00
0.75
—
5
48
37
253
1.47
1.42
2.3
2.1
545.17
503.26
e6/l
0.27
29
208
9
40
2.25
1.40
1.0
1.1
0.03
0.02
u/ml
—
9
40
10
46
2.18
1.39
1.3
1.4
—
—
—
0
0
20
119
1.68
1.37
1.2
1.4
—
—
—
0
0
18
104
1.73
1.36
1.1
1.0
—
—
—
0
0
120
989
1.22
1.31
3.2
3.4
60.37
59.07
%
0.53
120
989
7
148
0.47
1.31
1.6
1.4
5.29
11.22
mm/h
—
7
148
533
4889
1.10
1.30
2.0
2.2
0.00
0.01
estimate
1.02
84
935
10
48
2.09
1.27
1.1
2.1
—
—
—
0
0
113
930
1.22
1.26
1.4
1.4
—
—
—
0
0
123
1024
1.21
1.23
1.4
1.5
—
—
—
0
0
56
732
0.76
1.23
1.5
1.5
—
—
—
0
0
18
108
1.67
1.22
4.5
4.6
—
—
—
0
0
76
602
1.27
1.20
1.0
1.1
89.37
1168.29
iu/ml
0.48
14
113
270
2400
1.13
1.19
2.8
2.4
2.83
2.93
g/l
1.01
229
2152
6
26
2.31
1.18
1.2
1.3
275.17
329.81
umol/24h
—
6
26
77
613
1.26
1.18
1.2
1.2
—
—
—
0
0
0
33
0.00
1.16
0.0
1.1
—
0.17
—
0
11
17
103
1.65
1.12
20.8
7.8
5.46
5.35
kpa
0.08
17
103
251
2238
1.13
1.07
2.9
2.3
9.67
10.18
g/l
1.26
207
1963
122
1437
0.85
1.07
4.7
4.5
—
—
—
0
0
51
391
1.31
1.06
3.1
2.0
1195.11
1098.49
e6/l
0.37
44
350
43
322
1.34
1.05
2.6
1.7
—
—
—
0
0
104
870
1.20
1.03
1.7
1.5
0.87
0.85
nmol/l
0.13
89
727
7
34
2.06
1.02
1.1
1.0
—
—
—
0
0
26
179
1.45
1.02
1.2
1.2
157.15
165.19
mmol/24h
0.20
26
179
39
292
1.34
0.97
1.2
1.3
9.41
9.47
mmol/l
0.03
39
277
9
50
1.80
0.96
1.1
1.0
—
—
—
0
0
15
235
0.64
0.95
1.0
1.1
—
—
—
0
0
6
118
0.51
0.93
1.3
1.2
—
—
—
0
0
34
251
1.36
0.93
1.6
1.7
9.40
7.22
umol/l
0.41
22
171
62
498
1.25
0.93
1.3
1.3
213779.33
139455.58
e6/l
0.25
30
336
50
634
0.79
0.93
4.0
3.9
55.07
58.82
%
0.64
42
528
409
4420
0.92
0.91
5.0
4.4
0.47
0.26
%
0.33
106
1219
23
326
0.70
0.91
1.0
1.1
1.02
3.17
u/ml
1.86
11
147
82
682
1.21
0.90
1.5
1.5
—
—
—
0
0
82
682
1.21
0.90
1.5
1.3
0.67
0.68
nmol/l
0.08
77
649
12
71
1.69
0.88
1.5
1.4
33.71
118.24
ug/l
—
7
45
284
2588
1.10
0.87
2.7
2.3
4.23
4.19
g/l
0.46
243
2344
6
30
2.00
0.87
1.0
1.7
13.53
22.14
pmol/l
—
6
24
284
2590
1.10
0.86
2.7
2.3
7.46
7.47
g/l
0.02
243
2342
283
2582
1.10
0.85
2.7
2.3
3.83
3.66
g/l
0.47
243
2337
139
1218
1.14
0.83
1.6
1.9
15.10
12.34
mg/l
0.38
124
1118
8
46
1.74
0.82
1.6
1.7
—
—
—
0
0
84
993
0.84
0.82
3.9
3.9
1.10
1.61
%
0.79
72
866
113
977
1.16
0.81
1.5
1.5
32.35
31.02
g/l
0.62
107
875
150
1324
1.14
0.81
1.5
1.6
17034.92
14025.05
e6/l
0.35
106
908
47
373
1.26
0.81
1.7
1.8
—
—
—
0
0
71
591
1.20
0.79
1.6
1.5
62.18
60.61
%
0.11
43
381
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
158
1403
1.13
0.78
15.5
11.4
—
—
—
0
0
413
4427
0.93
0.78
4.9
4.3
0.16
0.12
%
0.50
118
1307
26
349
0.74
0.77
1.1
1.1
1.86
2.33
u/ml
0.24
14
177
211
1910
1.11
0.76
1.3
1.2
—
—
—
0
0
536
5050
1.07
0.76
4.5
4.8
7.37
7.36
ph
0.33
395
3627
18
124
1.45
0.75
1.2
1.2
140.40
138.31
mmol/l
—
10
98
5
24
2.08
0.74
1.6
1.4
—
—
—
0
0
9
54
1.67
0.74
1.0
1.2
2.13
1.77
umol/24h
—
9
54
2112
20621
1.04
0.73
14.7
12.6
0.00
0.00
e9/l
0.61
1683
16710
32
411
0.78
0.70
2.0
2.2
759.60
633.30
ml
0.61
20
250
40
318
1.26
0.70
1.1
1.1
—
—
—
0
0
54
652
0.83
0.69
1.3
1.3
—
—
—
0
0
14
93
1.51
0.69
1.1
1.1
—
—
—
0
0
413
4400
0.93
0.68
4.5
4.1
1.01
0.73
%
1.04
141
1408
61
725
0.84
0.67
2.5
2.4
4.09
4.12
mmol/l
0.26
61
716
61
725
0.84
0.67
2.5
2.4
105.89
105.30
mmol/l
0.43
61
716
215
1965
1.10
0.67
3.5
4.2
24.76
24.82
mmol/l
0.13
194
1781
5
94
0.53
0.66
1.0
1.2
—
—
—
0
0
60
713
0.84
0.66
2.5
2.5
1.20
1.20
mmol/l
0.04
60
704
52
625
0.83
0.65
3.0
2.6
—
—
—
0
0
62
733
0.84
0.65
1.6
1.6
—
—
—
0
0
70
597
1.17
0.64
1.4
1.3
0.16
0.20
nmol/l
3.01
59
481
14
95
1.47
0.64
1.6
1.5
—
—
—
0
0
53
441
1.20
0.63
1.5
1.5
21.30
28.23
%
0.75
34
275
34
426
0.80
0.63
2.5
2.3
—
—
—
0
0
92
1050
0.87
0.62
1.1
1.1
—
—
—
0
0
15
104
1.44
0.62
1.3
1.6
—
—
—
0
0
6
103
0.58
0.62
1.0
1.1
—
—
—
0
0
45
370
1.22
0.61
1.0
1.1
—
—
—
0
0
16
113
1.42
0.61
1.5
1.9
—
—
—
0
0
80
694
1.16
0.60
1.3
1.2
285.45
285.12
u/ml
0.00
52
411
39
477
0.82
0.59
1.1
1.1
—
—
—
0
0
33
263
1.26
0.59
1.2
1.6
—
—
—
0
0
22
166
1.33
0.58
1.0
1.1
—
—
—
0
0
192
1761
1.09
0.58
1.7
1.6
6.87
7.73
iu/ml
0.20
44
396
80
697
1.15
0.58
1.8
2.2
29.95
24.76
mg/l
0.24
22
244
36
292
1.23
0.56
1.1
1.1
—
—
—
0
0
10
149
0.67
0.56
1.2
1.1
—
—
—
0
0
10
149
0.67
0.56
1.2
1.1
—
—
—
0
0
10
149
0.67
0.56
1.2
1.1
—
—
—
0
0
19
252
0.75
0.56
1.3
1.6
39.74
39.76
g/l
0.00
19
252
99
878
1.13
0.56
1.2
1.2
53.69
44.36
u/ml
0.19
11
93
5
89
0.56
0.56
2.6
2.1
8.52
9.00
mg/l
—
5
74
95
1071
0.88
0.55
1.2
1.3
—
—
—
0
0
43
357
1.21
0.55
2.3
2.4
24.85
31.84
iu/ml
—
10
54
198
2145
0.92
0.54
3.3
3.2
257.70
3291.57
u/ml
1.58
162
1848
13
182
0.71
0.54
1.8
1.9
15364.29
26958.62
e6/l
—
7
98
20
152
1.32
0.52
36.0
37.9
6.29
7.23
ug/l
1.39
20
135
6
40
1.50
0.51
1.3
1.5
—
—
—
0
0
6
100
0.60
0.51
5.3
6.5
7.82
8.31
mmol/l
—
6
100
15
109
1.38
0.50
4.3
2.1
1.19
0.83
ug/l
0.67
15
100
23
290
0.79
0.48
1.0
1.0
0.19
0.27
u/ml
0.16
11
111
16
212
0.75
0.48
1.6
2.0
9905.09
6859.53
e6/l
0.11
11
146
25
199
1.26
0.47
1.5
1.4
26.56
29.54
umol/l
1.03
25
184
525
5469
0.96
0.45
1.4
1.4
—
—
—
0
0
102
923
1.11
0.44
1.9
2.1
0.97
0.88
%
0.96
69
638
66
582
1.14
0.44
1.6
1.3
—
—
nmol/l
—
0
0
43
367
1.17
0.43
1.3
1.3
—
—
—
0
0
13
95
1.37
0.43
1.0
1.1
—
842.86
—
0
21
48
414
1.16
0.43
1.4
1.4
—
—
—
0
0
5
31
1.61
0.43
1.2
1.0
—
3.90
—
0
5
90
812
1.11
0.42
1.4
1.3
—
—
—
0
0
71
795
0.89
0.41
3.1
2.8
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
0.26
—
0
7
0
15
0.00
0.41
0.0
1.0
—
0.08
—
0
7
0
16
0.00
0.41
0.0
1.1
—
0.04
—
0
16
27
222
1.22
0.41
1.3
1.4
1.86
3.79
%
—
7
47
79
710
1.11
0.40
1.3
1.6
0.63
0.87
g/l
2.40
63
555
8
60
1.33
0.40
2.3
1.5
48.88
49.53
umol/l
—
8
60
11
149
0.74
0.40
2.6
2.3
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
134.40
97.83
titre
—
5
35
48
419
1.15
0.38
1.4
1.4
0.44
0.43
g/l
0.05
37
303
48
419
1.15
0.38
1.4
1.4
6.76
6.66
g/l
0.05
37
306
48
419
1.15
0.38
1.4
1.4
3.06
2.91
g/l
0.16
37
305
80
723
1.11
0.37
1.5
1.3
163.95
156.77
au/ml
0.18
19
200
1183
12085
0.97
0.36
1.3
1.4
—
—
—
0
0
19
153
1.24
0.35
1.5
1.5
—
—
—
0
0
14
108
1.30
0.35
2.6
1.5
9.35
9.30
ug/l
0.02
14
108
14
178
0.79
0.34
2.0
1.9
—
—
—
0
0
12
154
0.78
0.32
1.4
1.8
0.00
0.06
estimate
1.08
12
154
124
1157
1.07
0.31
6.2
2.5
62.23
60.40
%
0.39
124
1149
261
2493
1.05
0.31
1.4
1.3
309.59
245.17
u/ml
0.41
237
2291
795
7759
1.03
0.31
1.3
1.3
40.53
37.39
iu/ml
0.17
236
2338
7
97
0.72
0.30
1.7
2.6
16.59
14.66
ml/dl
—
7
92
107
996
1.08
0.29
1.3
1.2
—
—
—
0
0
7
56
1.25
0.29
1.3
1.0
—
—
—
0
0
37
326
1.14
0.28
1.9
1.6
0.29
0.26
nmol/l
0.21
28
243
91
980
0.93
0.28
1.4
1.5
—
1.00
—
0
7
82
758
1.08
0.27
1.9
2.3
0.88
1.21
g/24h
0.75
48
439
174
1653
1.05
0.27
1.2
1.2
0.48
1.03
u/ml
0.91
13
140
111
1041
1.07
0.26
3.6
3.8
24.97
29.15
mg/l
0.74
79
746
38
338
1.13
0.26
2.5
2.2
1.44
2.22
ug/l
2.70
32
285
112
1052
1.07
0.25
1.2
1.3
26.48
39.47
u/l
1.15
94
907
40
446
0.90
0.25
1.0
1.1
6.12
3.49
u/ml
0.39
23
218
9
73
1.23
0.25
1.7
1.7
3.08
2.89
mmol/l
—
9
62
81
752
1.08
0.25
1.5
1.5
100452.56
60622.98
e6/l
0.27
55
426
39
435
0.90
0.25
1.2
1.1
6.15
2.68
eliau/ml
0.53
14
149
46
507
0.91
0.24
2.1
2.0
—
—
—
0
0
6
81
0.74
0.24
1.2
1.3
—
—
—
0
0
267
2576
1.04
0.23
3.3
4.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
192
1844
1.04
0.21
2.8
3.1
316.26
472.62
mg/l
0.67
87
810
0
12
0.00
0.21
0.0
1.0
—
0.11
—
0
5
0
12
0.00
0.21
0.0
1.1
—
26.32
—
0
12
5
43
1.16
0.21
1.2
1.0
—
—
—
0
0
56
518
1.08
0.20
1.2
1.2
—
—
—
0
0
368
3779
0.97
0.20
3.1
3.0
6.30
6.06
ph
5.38
253
2646
9
111
0.81
0.20
1.0
1.1
—
—
—
0
0
387
3773
1.03
0.19
2.4
2.3
12.79
12.79
nmol/l
0.00
336
3346
28
251
1.12
0.18
4.0
2.9
232.14
208.72
u/l
0.64
28
246
63
589
1.07
0.18
1.2
1.3
—
—
—
0
0
53
570
0.93
0.18
1.3
1.2
—
—
—
0
0
133
1274
1.05
0.18
1.2
1.2
60.24
41.47
u/ml
—
7
59
67
629
1.07
0.17
1.1
1.1
1.57
1.55
g/l
0.07
61
562
227
2338
0.97
0.16
1.2
1.2
—
—
—
0
0
14
120
1.17
0.16
1.0
1.1
—
—
—
0
0
36
391
0.92
0.16
1.1
1.1
0.60
1.18
u/ml
1.06
26
208
155
1496
1.04
0.15
3.5
2.6
1.69
1.76
mg/l
0.41
140
1325
35
322
1.09
0.15
1.5
1.3
—
—
—
0
0
20
224
0.89
0.15
2.8
4.0
—
—
—
0
0
20
224
0.89
0.15
1.4
1.2
—
—
—
0
0
21
188
1.12
0.14
1.0
1.1
1.07
1.07
ratio
0.05
14
145
56
590
0.95
0.12
1.2
1.2
2.33
5.10
u/ml
2.09
27
272
24
261
0.92
0.11
2.2
2.1
52.56
106.15
ug/min
—
9
68
28
300
0.93
0.10
1.9
1.6
—
—
—
0
0
456
4620
0.99
0.10
4.7
4.2
1.08
0.99
%
0.30
161
1499
5
44
1.14
0.10
1.2
1.7
—
—
—
0
0
5
47
1.06
0.09
1.2
1.5
—
—
—
0
0
386
3807
1.01
0.09
5.6
4.5
—
—
—
0
0
118
1212
0.97
0.09
1.2
1.2
4.31
7.18
u/ml
0.85
17
179
729
7230
1.01
0.08
1.3
1.3
13.36
14.15
u/ml
0.09
227
2579
91
936
0.97
0.08
2.0
1.9
187.58
204.83
pmol/l
1.12
84
884
19
177
1.07
0.06
4.2
1.7
27.00
31.62
%
0.77
19
177
19
203
0.94
0.06
1.2
1.3
155.41
195.34
ug/l
0.11
11
100
50
484
1.03
0.05
1.3
1.2
—
—
—
0
0
52
536
0.97
0.05
1.1
1.1
0.43
1.80
u/ml
3.18
32
298
42
433
0.97
0.04
1.0
1.1
1.25
1.31
u/ml
0.03
22
182
251
2488
1.01
0.04
2.1
2.2
0.16
0.38
estimate
0.24
67
689
28
291
0.96
0.04
1.6
2.0
488.17
492.63
min
0.05
18
200
26
250
1.04
0.03
1.2
1.4
126.45
200.10
pmol/l
1.13
26
250
11
102
1.08
0.03
1.5
1.6
—
—
—
0
0
36
370
0.97
0.03
1.2
1.2
62.86
143.87
titre
—
7
62
24
249
0.96
0.02
2.7
3.8
—
—
—
0
0
19
182
1.04
0.02
4.6
3.4
47.05
55.18
%
0.99
19
173
10
107
0.93
0.02
1.0
1.2
279.40
274.35
pmol/l
—
5
75
57
577
0.99
0.01
1.1
1.1
—
—
—
0
0
52
522
1.00
0.00
1.1
1.2
—
—
—
0
0
24
245
0.98
0.00
1.7
2.4
2493.75
1846.76
ml
0.38
16
208
31
305
1.02
0.00
1.4
1.4
1.41
1.58
u/ml
0.05
24
184
37
375
0.99
0.00
1.5
1.9
83.22
118.81
ng/l
2.83
37
375
25
254
0.98
0.00
1.1
1.2
173.90
330.41
u/l
1.55
20
235
15
147
1.02
0.00
1.1
1.5
7.68
7.91
mmol/l
0.09
15
147
12
119
1.01
0.00
1.2
1.3
27.92
28.73
s
0.24
12
119
25
249
1.00
0.00
1.0
1.1
—
—
—
0
0
6
66
0.91
0.00
2.7
2.2
0.67
0.66
ug/l
—
6
66
0
8
0.00
0.00
0.0
1.4
—
39.80
—
0
8
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
1614.29
—
0
7
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
3.08
—
0
8
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
121
1210
1.00
-0.00
1.2
1.2
3.80
2.82
u/ml
—
9
105
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.03
—
0
6
0
6
0.00
-0.00
0.0
5.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
52
0.96
-0.00
3.6
10.0
0.18
0.21
%
—
5
52
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
12
120
1.00
-0.00
1.2
1.6
6.67
7.02
%
—
6
63
0
5
0.00
-0.00
0.0
1.0
—
3260.00
—
0
5
5
52
0.96
-0.00
1.2
2.2
0.20
0.38
u/field
—
5
52
8
83
0.96
-0.00
10.3
12.4
6.22
5.08
mmol/l
—
8
83

Mortality – FinRegistry

↥

Association

Association between endpoint F5_MENTORG and mortality.

Females

Parameter HR [95% CI] p-value
F5_MENTORG 1.767 [1.59, 1.96] < 0.001
Birth year 0.995 [0.99, 1.0] 0.17

During the follow-up period (1.1.1998 — 31.12.2019), 5878 out of 15508 females with F5_MENTORG died.

Males

Parameter HR [95% CI] p-value
F5_MENTORG 2.012 [1.79, 2.26] < 0.001
Birth year 0.989 [0.98, 1.0] 0.017

During the follow-up period (1.1.1998 — 31.12.2019), 5467 out of 13461 males with F5_MENTORG died.

Mortality risk

Mortality risk for people of age

years, who have F5_MENTORG.

N-year risk Females Males
1 0.131% 0.396%
5 0.88% 2.335%
10 2.406% 6.05%
15 4.816% 11.203%
20 8.233% 18.621%

Relationships between endpoints

↥

Index endpoint: F5_MENTORG – Other mental disorders due to brain damage and dysfunction and to physical disease

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data